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Introduction: Type 2 diabetes (T2D) is one of the most prevalent non-
communicable diseases in the world and its cardiovascular complications 
present a huge socio-economic burden. In 2015, in the UK alone, 3.8 million 
people have been diagnosed with T2D and cardiovascular disease accounts 
for almost 1.7 million episodes throughout the country. Early diagnosis of 
cardiovascular disease in people with T2D thus becomes critical. 
The retina gives a unique opportunity to study the human microcirculation, 
which can then offer insights into the pathophysiology of cardiovascular 
disease. By using semi-automatic software, retinal images can provide 
quantitative traits derived from the microvasculature. Previous research has 
found that arteriolar and venular calibres are associated with cardiovascular 
outcomes such as hypertension and stroke. Moreover, retinal vascular 
tortuosity, a novel quantitative biomarker which measures the degree to 
which blood vessels visible in the retina twist and turn, has been associated 
with traditional cardiovascular risk factors in the general population. However, 
this area needs to be further explored, especially in the population with T2D 
and in prospective analyses. 
 
Aims: To determine whether quantitative retinal traits such as vessel widths, 
vessel tortuosity and multifractal dimensions are associated with the 
subsequent development of major cardiovascular events such as ischaemic 
heart disease and stroke in people with T2D. Also, to use a genome-wide 
association approach to investigate if these quantitative retinal traits are 
associated with cardio-metabolic genetic variants, which could help identify 




Methods: Analyses used the Edinburgh Type 2 Diabetes Study, a 
prospective cohort of 1066 men and women with T2D aged 60-75 years at 
baseline with eight years of follow-up for cardiovascular events. A total of 
1028 retinal images from baseline were analysed using the semi-automatic 
retinal software VAMPIRE (Vascular Assessment and Measurement Platform 
for Images of the Retina). Cross-sectional analyses including ANOVA and 
Chi-square test were performed along with prospective analysis using Cox 
regression. Additionally, a genome-wide association study was performed to 
explore the association of 12 quantitative retinal traits with cardio-metabolic 
genetic variants. Imputation of variants included in the MetaboChip array was 
used. 
 
Results: In an unadjusted model, there was a significant association 
between arteriolar tortuosity and incident stroke (Hazard Ratio (HR) 1.26; 
95% CI 1.02, 1.57; p=0.03). This association remained significant after full 
adjustment for age, sex, cardiovascular risk factors (body mass index, HbA1c, 
total cholesterol, duration of diabetes, renal dysfunction) and previous 
cardiovascular events (HR 1.26; 95% CI 1.01, 1.58; p=0.04). Multifractal 
dimensions, a novel retinal biomarker which provides an insight into vascular 
geometry, was inversely associated with incident stroke (unadjusted HR 
0.73; 95% CI 0.57, 0.94; p=0.01). This association also remained significant 
after adjustment for age, sex, cardiovascular risk factors and previous 
cardiovascular event (HR 0.73; 95% CI 0.56, 0.94 p=0.02). Associations 
between other retinal traits and stroke, and between traits and ischaemic 
heart disease, tended not to be statistically significant, especially after 
multivariable adjustment.  
The genome-wide association analysis of arteriovenous ratio (ratio of 
arteriolar to venular vessel width) revealed a genome wide significant locus, 
rs73198094 (p = 5.27 x 10-8), an intergenic variant located between ASAH1 
and LOC101929066 genes in chromosome 8. The ASAH1 gene has been 
associated with atrial fibrillation. Although no further single nucleotide 
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polymorphisms reached genome-wide significance, some additional 
promising findings emerged. Analysis for retinal arteriolar width revealed a 
genome-wide suggestive intronic locus, rs4944903 (p= 8.5x10-7), of the gene 
POLD3 in chromosome 11. Identified loci for minimum arteriolar tortuosity, 
rs7991332 (p=1.54 x 10-6) and rs2172724 (p=2.46 x10-6), are located in the 
COL4A2 gene in chromosome 13 and another identified variant, rs7319323 
(p=3.53 x 10-6), is located in an intron of the neighbouring COL4A1 gene. 
Previous studies showed the relevance of these genes including an 
association with stroke and intracerebral haemorrhage. These two genes 
encode collagen protein chains, which are major components of the vascular 
basement membrane. Another promising variant identified was the 
rs34013641 locus, associated with minimum venular tortuosity (p=2.81 x 10-
6), which is located in the MYH11 gene in chromosome 2. This gene encodes 
smooth muscle myosin heavy chain protein, which is highly expressed in 
human arteries. Finally, identified loci for the multifractal dimension D0, 
rs10963694 (p=8.53 x 10-7) and rs4977506 (p=4.95 x 10-6), located on the 
ADAMTSL-1 gene in chromosome 9, are also strong candidates in the 
pathophysiology of vascular disorders.  
 
Conclusions: In older people with T2D, arteriolar tortuosity and multifractal 
dimensions were significantly and independently associated with incident 
stroke. GWAS findings for these and other quantitative retinal traits offer 
insight into pathophysiological changes of the vasculature, which may result 
in cardiovascular disease. These findings, in the context of further research, 
could potentially be used to reveal biological mechanisms related to major 
cardiovascular complications of T2D and to guide efforts on prevention and 






Type 2 diabetes is a leading risk factor for morbidity and mortality in the UK 
and worldwide, and it has been shown to increase the risk of cardiovascular 
disease namely heart attacks and stroke. People who are overweight, often 
as a result of multiple environmental factors, are more likely to develop 
diabetes. This disease leads to the development of changes in the vessels 
which has been shown to increase risk of develop cardiovascular events 
particularly stroke. There is uncertainty around the main risk factors for these 
specific events in people with type 2 diabetes. The aim of this study was to 
find the association of the measurements of the retinal vessels with 
cardiovascular events namely heart attacks and stroke.  
The Edinburgh Type 2 Diabetes study uses information collected over a 
period of eight years from a large group of men and women aged 60-75 
years, with type 2 diabetes, living in Scotland. Cardiovascular events was 
measured using data records from the NHS Lothian that is linked to the 
medical history of the people recruited in the aforementioned dataset. Other 
medical information on lifestyle such as smoking, previous diseases such as 
heart attacks, and medications was also collected. A baseline photography of 
the eyes was taken for each person. After eight years, the number of people 
who developed cardiovascular events were recorded. By using a state-of-art 
software different parameters of the vessels of the retina were measured. In 
addition, using advanced statistical techniques, associations between retinal 
parameters and heart attacks and stroke were modelled as were the 
associations between the curvature (tortuosity) and multifractal dimensions 
with people who developed stroke. 
This study found that the curvature of the vessels and the 
‘decomplexification’ of the retinal vasculature were associated with incident 
events of cerebrovascular stroke. Further research using the findings of this 
study can help in developing strategies to prevent major cardiovascular 
complications in people with diabetes who are already at a higher risk than 
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Chapter 1 Background: Type 2 diabetes, 
cardiovascular disease and quantitative 
retinal traits 
 
1.1 Type 2 diabetes 
The World Health Organisation (WHO) defines diabetes mellitus as a “metabolic 
disorder of multiple aetiology characterised by chronic hyperglycaemia with 
disturbances of carbohydrates, fat and protein metabolism resulting from defects in 
insulin secretion, insulin action or both” (World Health Organisation, 2014). The vast 
majority of cases of diabetes mellitus are classified as type 2 diabetes (T2D). This 
condition is characterised by insulin resistance, hyperinsulinaemia and pancreatic ß 
cell dysfunction. It negatively affects multiple organs including the liver, skeletal 
muscle, kidneys, brain, small intestine and adipose tissue. Importantly, the incretin 
effect changes in the colon and microbiome and immune dysregulation and 
inflammation have emerged as significant pathophysiological factors in T2D. Type 1 
diabetes, commonly referred to as “insulin-dependent diabetes”, is mainly caused by 
autoimmune destruction of ß cells in the pancreas, leading to insulin deficiency. 
Although Type 1 diabetes is becoming more prevalent, it is still considerably less 
common than T2D.  
Diabetes mellitus is one of the most prevalent non-communicable diseases in the 
world, and the number of people living with this condition has quadrupled in the past 
three decades (WHO, 2016). This rising prevalence indicates that the number of 
people with diabetes mellitus has increased dramatically from 108 million in 1980 to 
422 million in 2014. Overall, about 1 in 11 adults aged  20-79 years (425 million) 
worldwide now have diabetes mellitus, 90% of whom have T2D (International 
Diabetes Federation, 2017). Asia is a major contributor to the rapidly emerging T2D 
global epidemic, including China and India. The estimate of affected people with T2D 
is projected to rise to 642 million by 2040, and the largest increases will come from 
regions undergoing economic transition (International Diabetes Federation, 2017). 
The rise of obesity (defined as a Body Mass Index or BMI ≥30 kg/m2), a sedentary 
life-style, energy-dense diets and population aging are the main drivers of the global 
epidemic of T2D (Chatterjee et al, 2017). Evidence has shown that many cases of 
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T2D could be prevented by maintaining a healthy body weight (BMI ≤ 25 kg/m2), 
following a restrictive calorie diet, exercise and avoiding smoking and excess alcohol 
consumption (Zheng et al, 2018). 
Mortality and morbidity from the complications directly associated with diabetes 
mellitus, such as cardio-metabolic diseases and renal failure, accounted for 
approximately five million deaths globally in 2017 (International Diabetes Federation, 
2017). The loss of quality of life in people with diabetes mellitus and further 
complications cause severe disability and despair. Global expenditure on T2D has 
also been increasing steeply. The International Diabetes Federation (2017) 
conservatively estimated that in 2015, 673 billion US dollars (nearly 12% of global 
health expenditure) was spent on treating diabetes mellitus and its complications. 
This expenditure is three times higher in people with diabetes mellitus than the 
general population without diabetes.  
Clinically, the signs and symptoms of T2D include polyuria, polydipsia, polyphagia, 
weight loss, paraesthesia in the extremities, blurred vision or recurring infections. 
Severe cases may present acid-base electrolyte-metabolic disturbances including 
ketoacidosis (seen mainly in Type 1 diabetes) and hyperosmolar hyperglycaemic 
state. Confirmation of T2D involves fasting plasma glucose concentration greater 
than 7mmol/l (126mg/dL) (World Health Organisation, 2016). Glycated haemoglobin 
(HbA1c) is also commonly used in clinical settings to help diagnose T2D. HbA1c is an 
approximate measure of glucose control in the previous 6-8 weeks. The World 
Health Organization (WHO) recommends that an HbA1c of 6.5% (7.7 mmol/l) or 
greater should be used as a diagnosis of T2D, although lower levels of HbA1c  do not 
exclude T2D in the presence of elevated blood glucose (World Health Organisation, 
2016). The onset of diabetes mellitus frequently occurs years before the signs and 
symptoms of the disease develop. Globally, 45.8% of all diabetes mellitus cases in 
adults have been estimated to be undiagnosed (Beagley et al, 2014). 
Management of T2D aims to relieve and reverse symptoms and minimise 
development and progression of microvascular and macrovascular complications. 
T2D is managed, in the vast majority of cases, with a combination of balanced diet, 
exercise and either oral antidiabetic medication (e.g. sulphonylureas or biguanides) 
or the addition of injected insulin, if necessary. 
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Impaired metabolic management leads to microvascular and macrovascular 
complications. The former includes retinopathy, nephropathy and neuropathy while 
the latter comprises cardiovascular complications such as acute coronary syndrome 
(myocardial infarction, angina) and ischaemic stroke. People with T2D require 
regular screening (urine test, eye examination, foot care) to detect early signs of 
potential complications and to self-monitor for symptoms. Despite increasing 
knowledge regarding risk factors for T2D, the predicted worldwide increase in the 
incidence and prevalence of T2D is likely to lead to severe complications, which 
require regular monitoring from health care providers. The burden of T2D in the UK 
and globally, therefore, poses one of the most challenging health problems of human 
history.  
 
1.2 Cardiovascular disease 
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality 
worldwide and in the UK (Zheng et al, 2018). This burden is a major barrier to human 
development and the United Nations has formally recognised non-communicable 
diseases, including CVD, as a major concern for global health, and set up an 
ambitious plan to reduce the effect of these diseases in all regions (Roth et al, 2017). 
The cost of CVD to the UK economy (including premature death, disability and 
informal costs) is an estimated £19 billion each year according to the British Heart 
Foundation statistics (BHF analysis of European Cardiovascular Disease Statistics, 
2017). Scotland (Glasgow) had the highest CVD death rate for men and women 
among the four nations in the UK. CVD accounted for almost 1.7 million episodes in 
the National Health Service (NHS) hospitals throughout the UK and this number has 
been increasing (Bhatnagar et al, 2016).  
According to the WHO, CVD includes coronary heart disease (CHD) or ischaemic 
heart disease (IHD), cerebrovascular disease, and peripheral vascular disease 
(PVD). CHD is characterised by an impaired supply of the blood flow to the myocytes 
of the heart due to narrowing or blocking by fatty deposits (atheroma) of the inner 
walls of coronary arteries. This chronic process makes the arteries hard and swell, 
restricting oxygen and nutrients from the blood flow to the heart. This may lead to 
angina and eventually, if the coronary artery is completely blocked, then the myocyte 
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is starved of oxygen, which results in necrosis or myocardial infarction. 
Cerebrovascular disease encompasses two types of stroke - ischaemic and 
haemorrhagic. Ischaemic strokes include thrombotic strokes, embolic strokes, and 
hypoxic strokes, which may involve the development of symptoms with a duration of 
a few minutes (transient ischaemic stroke) without evidence of structural damage 
(e.g. infarcts). Haemorrhagic strokes include subarachnoid haemorrhages (e.g. 
ruptured aneurysm) and intracerebral haemorrhages (e.g. due to hypertension or 
anticoagulant medication). Finally, peripheral arterial disease (PAD) occurs when 
blood vessels develop atherosclerosis, which results in impaired blood supply 
(ischaemia) mainly in the lower limbs.   
Individuals with T2D are twice as likely to develop CVD as those without T2D, 
independent of age, smoking status, BMI and systolic blood pressure (Rao 
Kondpally Seshasai et al, 2011; Emerging Risk Factors Collaboration, 2010) and 
despite considerable advances in the management of CVD, it remains the leading 
cause of death globally in people with T2D. The incidence and mortality of these 
cardiovascular complications are particularly high in specific groups of the diabetic 
population. For instance, this excess risk disproportionally affects women such that 
T2D eliminates or decreases the reduced risk of CVD that is generally seen in 
premenopausal women (Zhang et al, 2017). 
 
1.3 Cardiovascular risk factors  
 
1.3.1 Traditional cardiovascular risk factors 
Traditional cardiovascular risk factors can be sub-categorised in two groups, non-
modifiable and modifiable. The former includes age, sex and ethnicity and the latter 
includes hypertension, dyslipidaemia, high BMI, smoking, reduced physical activity 
and diabetes. 
Age is a well-established contributor to risk of CVD, with the risk increasing as both 
sexes age. Among adults, men are approximately twice as likely to develop CVD as 
women; although this difference is reduced when women age, reaching menopause, 
leading to vascular changes (Bots el al, 2017). There are also ethnic differences in 
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the presentation of CVD, which extend to sub-populations with T2D. For example, 
Chinese individuals with T2D had lower rates of CHD than those from other 
countries, whereas individuals with an ethnic Indian subcontinent background who 
had T2D had double the risk of CHD deaths compared with those with white 
European ethnicity who had T2D, independent of traditional risk factors (Zhang et al, 
2017). 
Modifiable risk factors include cardiometabolic factors (e.g. high blood pressure and 
abnormal blood lipid) and lifestyle factors such as obesity, smoking, and physical 
inactivity. High blood pressure or hypertension is one of the biggest contributors to 
mortality from CVD across all age groups and in both sexes (Pazoki et al, 2018). The 
risk of developing CVD is on average between two and three times higher in people 
with hypertension (Nayor et al, 2018). Dyslipidaemia is also an important risk 
contributor to developing CVD. This disorder occurs when total cholesterol, low-
density lipoprotein (LDL) cholesterol or triglycerides are elevated or when levels of 
high-density lipoprotein (HDL) cholesterol are reduced. Other lipids such as 
lipoprotein (a) and apolipoproteins A1 and B are also involved in developing CVD 
(Lacey et al, 2017). However, large epidemiological studies such as Framingham 
Heart Study have tended to focus on the analysis of the most commonly measured 
lipids (e.g. triglycerides, cholesterol and its subtypes). 
There is a strong association between lifestyle factors and the risk of CVD. Obesity 
has increased dramatically over the last decade, doubling between 1980 and 2008, 
and reaching epidemic proportions globally (Piché et al, 2018). Obesity is linked to 
several cardiovascular risk factors and outcomes, including cardiac structure, 
hypertension, metabolic abnormalities, ischaemic heart disease, and atrial fibrillation 
(Parto et al, 2017). Moreover, previous studies have shown that obesity is an 
independent risk factor not only for CVD but also for other morbidities (e.g. cancer) 
(Avgerinos et al, 2019). 
Smoking is another well-known risk factor for CVD, and over the last decade, 
compelling evidence has emerged that exposure to passive smoking is also 
associated with CHD, increasing the risk by 25% among non-smokers (Heindrich et 
al, 2007). Public policies have been instituted (e.g. increasing the price of cigarettes) 
to reduce this preventable cause of CVD. There is also a broad consensus that 
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regular physical activity improves cardiovascular health. In the 1960s, Morris 
investigated the association between physical activity and cardiovascular disease 
prevalence (Morris, 1961). Recently, in the UK, the EPIC Norfolk prospective study 
(Lachman et al, 2018) found an inverse association between physical activity and the 
risk of CVD in middle-aged and elderly adults. Among individuals aged over 65 
years, hazard ratios for CVD were 0.86 (95% CI 0.78-0.96), 0.87 (95% CI 0.77-0.99) 
and 0.88 (95% CI 0.77-1.02) in moderately inactive, moderately active and active 
people, respectively compared with inactive people. The results of this association 
were similar among people aged 55-65 years and less than 55 years.  
 
1.3.2 Cardiovascular risk factors in people with type 2 diabetes 
In general, people with type 2 diabetes tend to present more detrimental levels of 
cardiovascular risk factors (WHO, 2016). There are also some ‘diabetes-specific’ risk 
factors associated with T2D. The duration of diabetes is a key determinant and risk 
factor for CVD in people with T2D. Individuals with T2D with a duration longer than 
10 years can be considered at a higher risk of developing CVD (Einarson et al, 
2018). In a prospective study, it was found that people with a mean duration of T2D 
of 16.7 years showed similar CHD risk as those with previous myocardial infarction 
(MI) without T2D (Bertoluci et al, 2017). 
The increased risk of CVD in this population is due to the complex combination of 
various traditional and non-traditional risk factors that play an important role in the 
beginning and the evolution of atherosclerosis and an impaired endothelial function, 
which lead to CV events (Martin-Timon et al, 2014). 
Non-traditional risk factors include insulin resistance, hyperinsulinaemia, 
postprandial hyperglycaemia, glucose variability, microalbuminuria, thrombogenic 
factors, elevated inflammation markers (e.g. C-reactive protein), visceral adiposity, 
and genetic factors. 
Insulin resistance is characteristic of T2D and it develops in multiple organs involving 
the skeletal, liver, adipose tissue and the heart. In fact, elevated hyperglycaemia and 
diabetes are often preceded by several years of insulin resistance, which is 
influenced by the presence of visceral adiposity and accumulation of fat. Importantly, 
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hyperinsulinaemia as a consequence of insulin resistance precedes the onset of T2D 
and could be related to vascular disease.  
Insulin resistance is measured by surrogate methods including the HOMA index, the 
intravenous glucose tolerance test, and the insulin suppression test. Insulin 
resistance is followed by compensatory hyperinsulinaemia. Molecular 
physiopathology of insulin resistance are yet poorly understood but includes the 
mechanism of insulin action on GLUT-4 translocation, glucose transport, and the 
activation of nitrous oxide (NO) synthase. These signalling pathways are implicated 
in the mitogenic, nonmetabolic, proinflammatory, and proliferative effects of insulin 
(Martin-Timon et al, 2014). Insulin resistance leads to decreased glucose uptake and 
impaired NO synthesis. Additionally, compensatory hyperinsulinemia stimulates in 
vascular smooth muscle and endothelial cells, an increased production of 
vasoconstrictors including endothelin, interleukins and an augmented surface 
expression of adhesion molecules. These mechanisms influence  the blood vessels 
through the activation of endothelium-derived NO mainly mediated by insulin. This 
state of increased NO production leads to its anti-atherogenic effects and becomes 
pro-atherogenic.  
Postprandial hyperglycaemia is associated with increased postprandial triglycerides 
levels, and these are related to increased oxidative stress, systemic inflammation 
and endothelial dysfunction, all of which are associated with atherosclerosis. A study 
conducted in 505 T2DM patients followed up for 14 years in a hospital in Turin, Italy 
(Cavalot et al, 2011), indicated that both postprandial blood glucose and HbA1c 
predict cardiovascular events and all-cause mortality, showing the independent 
predictive power of postprandial glycaemia on cardiovascular events after correction 
for HbA1c. Moreover, a meta-analysis of five randomized controlled trials showed 
that, in T2D subjects, intensive glycaemic control considerably decreases coronary 
events without an increased risk of death (Ray et al, 2009). 
In people with diabetes, glycated haemoglobin (HbA1c) is a biomarker to measure 
glucose levels over the previous two to three months. Cross-sectional and 
longitudinal studies have shown that higher levels of glycaemia have been 
associated with higher cardiovascular events rates and a recent meta-analysis 
(Cavero-Redondo et al, 2017) found HbA1c to be a reliable risk factor for all-cause 
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cardiovascular mortality in both diabetic and non-diabetic individuals. This study also 
found optimal HbA1c levels, for the lowest all-cause and cardiovascular mortality, 
ranging from 6% to 8% (7 mmol/l to 10.1mmol/l) in people with diabetes and from 5% 
to 6% (5.4 – 7.0 mmol/l) in those without diabetes.  
Impaired renal function is an independent risk factor for CVD. Approximately 10% of 
deaths in people with T2D are attributable to renal failure (Zheng et al, 2017).There 
is evidence which shows that both decreased glomerular filtration rate and 
proteinuria independently increased cardiovascular risk (Bertoluci et al, 2017). Thus, 
targeting multiple biomarkers of CVD risk can, hopefully, offer a substantial chance 
of improving CVD events in this population. 
The complex interaction of the risk factors in people with T2D make it necessary to 
apply a rounded approach in the management of this metabolic disorder. While diet 
and life style changes are key to the successful control of T2D, different types of 
medications help to regulate the glycaemic control in this population. Metformin (a 
type of Biguanide) was as effective as sulphonylurea or insulin in glucose control and 
reduction of microvascular risk in the UK Prospective Diabetic Study (UKPDS) 
(Holman et al, 2008). 
Although glucose control is a high priority for the prevention of vascular 
complications, blood pressure control is also necessary to prevent progression of 
cardiovascular disease. Ideally, all patients should therefore aim to have their HbA1c 
levels < 8.6 mmol/l in order to reduce the risk of long-term microvascular 
complications. Additionally, blood pressure control is essential and this can be 
achieved using usually angiotensin-converting enzyme (ACE) inhibitors or 
angiotensin II receptor antagonists. A large systematic review found that lowering 
blood pressure was associated with improved mortality and clinical outcomes 
including stroke and heart failure (Emdin et al, 2015). Another recent systematic 
review, which included randomised controlled trials, showed that in adults with T2D 
and hypertension, lowering the blood pressure at 120-130/80 mmHg reduced risk of 
stroke (Aronow and Shamliyan, 2018).  
Also, inhibitors of HMG-CoA reductase (Statins) have shown to improve endothelial 
dysfunction and microvascular dysfunction in people with T2D and dyslipaemia, 
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suggesting improvement of cardiovascular morbidity and mortality (Abdul-Ghani et 
al, 2017). This intervention has shown slow atherosclerosis.  
1.4 The retina and its vasculature 
The eye (Bulbus oculi) of an adult is an organ forming part of the central nervous 
system. It is made up of a number of complex structures, including the retina, the 
vasculature of which forms the topic of this thesis. Over the years, scientists have 
been searching for evidence for the concept of “the eyes as the window of the soul”. 
The retina is the only place where blood vessels can be directly visualised non-
invasively in vivo, and several studies have confirmed the association of retinal 
vascular changes with systemic diseases and cardiovascular disorders (London et 
al, 2013; Flammer et al, 2013). This section discusses the details of the anatomy and 
physiology of the human retina, followed by details of its vasculature and links with 
cardiovascular disease.  
 
1.4.1 Anatomy and physiology of the retina 
The embryological development of the retina and optic nerve extended from 
diencephalon and hence both are considered part of the central nervous system. 
These new vessels initially form a flat plexus that subsequently develops into the 
retina forming a deeper plexus. Retinal vasculature development is closely 
associated to the retinal astrocytes. These are part of the glial cells, which provide 
the foundation for retinal angiogenesis (London et al, 2013). Furthermore, immature 
retinal astrocytes start emerging from the optic disc into the retina as extended 
spindle cells filling the nerve fibre layer, and they migrate to the inner limiting 
membrane, which is rich in extracellular matrix proteins (Selvam et al, 2018). These 
proteins serve as an adhesive substance and contain instructive signals and growing 
factors such as glycosaminoglycans and proteoglycans, which play an important role 
in the neural network structure. Hence, the retinal vessels tightly interact with the 
astrocytes and as a consequence, vascular growing factors (e.g. vascular 
endothelial growth factor) express and stimulate blood vessel growth.  
Anatomically, the retina consists of layers composed of neurones, which 
intercommunicate through synapses (Selvam et al 2018; London et al, 2013). 
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Physiologically, the capture of light is made by the photoreceptor cells in the 
outermost layer of the retina, which results in a cascade of neuronal signs and 
biochemical processes reaching the retinal ganglion cells (Country et al, 2017). 
These axons, which are part of the optic nerve, extend to the lateral and geniculate 
nucleus in the thalamus and the superior colliculus in the midbrain. In this region, 
information is further transmitted to the visual processing centres that enables us to 
perceive an image of the world. As a part of the central nervous system, the eye – 
particularly the retina – must preserve the regulated interaction with the immune and 
vascular systems (De Boever et al, 2014). In fact, the eye consists of unique 
structures such as an array of blood-ocular barriers that share structures, 
characteristics and mechanisms with the central nervous system gating system 
(Pournaras et al, 2008). 
 
1.4.2 Retinal vascular system  
The microcirculation (including the retinal microvasculature) makes up a large part of 
the circulatory system and plays a crucial role in maintaining cardiovascular health 
(De Boever et al, 2014). Over the last few years, the retinal vasculature has been 
widely studied because it is easily accessible by non-invasive technical methods, 
extending its study into several fields in medicine. The retina has a complex vascular 
supply, which, as described above, functions to maintain the physiological and 
metabolic homeostasis of the inner part of the retina via a laminar network that 
permeates the neural tissue. Conversely, the outer retina (the region with 
photoreceptors) is avascular, and receives its nutrients from the choroidal 
vasculature.  
Blood flow in the brain and therefore in the retina is essential because the brain is 
energetically costly and accounts for 20% of total energy consumption in resting 
humans, despite weighing 2% of total mass (Country et al, 2017). Retinal vascular 
alterations occur in response to metabolites (such as glucose and oxygen) in order 
to match tissue demand and to drain waste products and carbon dioxide (De Boever 
et al, 2014). The retinal circulation is an end-arterial system, which does not contain 
anastomoses at outer layers. The central retinal artery emerges at the optic disc, 
dividing into two major branches, which further split into arterioles, each supplying 
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one quadrant of the retina (Kur et al, 2012). In general, retinal arteries divide by 
dichotomous and side-arm branching. The venous system presents some similarity 
with the arteriolar arrangement, with the central retinal vein leaving the eye through 
the optic nerve to drain venous blood into the cavernous sinuous.  
Retinal arteries differ from arteries of the same size in other organs in several 
respects. The rheological properties of the retinal microvasculature differ from larger 
arteries in its unusually developed smooth muscle layer and lack of an internal 
elastic lamina (Selvam et al, 2018). The smooth muscle cells are oriented both 
circularly and longitudinally, each of them surrounded by a basal lamina that 
contains a considerable amount of collagen toward the cellular adventitia. 
Innervation of the retinal vessels is also complex compared to other vascular regions 
of the human body (e.g. coronary vessels). For instance, the distal retinal vessels to 
the central retinal artery are not innervated. However, α and β adrenergic and 
angiotensin II receptors have been found along the optic nerve head and within the 
retina, (Pournaras et al, 2008; Senanayake et al, 2007). 
Several extracellular structures interact with the retinal vessels including extracellular 
matrix and blood retinal barriers. The former assembles numerous components (e.g. 
integrins) that are secreted in a cell type specific manner. Both major barrier tissues, 
epithelium and vascular endothelium of the retinal vessels, produce a specialized 
extracellular matrix scaffold, namely basal lamina which provides elasticity and 
tensile strength to the vessels. These extracellular structures are synthesised mainly 
in the endothelium of the retinal vessels (Xu et al, 2014; Lee et al, 2012). The blood 
retinal barriers include structures such as the pericytes and the glial cells (e.g. 
astrocytes). Moreover, the endothelium plays an important role in the regulation of 
the blood flow in the retina (Selvam et al, 2018). The blood flow and vessel tone in 
the retina are controlled by a myogenic as well as a metabolic mechanism. The 
endothelium releases a number of metabolic factors such as oxide nitric, 
endothelins, and metabolites of the arachidonic acid, and these regulate the tone of 




1.4.3 Retinal vessel system and cardiovascular disease 
The retinal microvasculature consists of a regulated mechanical system that 
maintains the internal pressure due to blood flow and variations in axial stretch as a 
result of tethering to other tissues. The vascular network has a branching pattern that 
can be considered as a fractal structure (Causin et al, 2016). Many factors influence 
retinal haemodynamics and tissue oxygenation, including blood pressure, blood 
rheology, oxygen arterial permeability and tissue metabolic demand. Alterations in 
the retinal circulation, including ischaemic conditions, are associated with many local 
and systemic pathologies. For instance, reduced retinal blood flow and retinal tissue 
hypoxia have been associated with diabetic retinopathy (Causin et al, 2016). 
However, whilst the scientific community has been investigating the relationship 
between haemodynamic alterations, ischaemic conditions and retinal and systematic 
disorders, the main mechanisms governing these relationships remain poorly 
understood (Causin et al, 2016).  
The cerebral microcirculation and therefore the retinal microvasculature is regulated 
by the general physiological principles of the small vessels system. The arterioles 
are very small vessels, and even when they are relaxed, the site offers most of the 
flow resistance (Hill et al, 2015). This is because there are many smooth muscle 
cells in their walls, and active reduction of the diameter of the vessel can have a 
significant effect on the resistance. Previous studies have found that contraction of 
the third of the original diameter of an arteriole may increase the flow resistance up 
to 81-fold (Vanzetta et al, 2005; Dobrin et al, 1988). Therefore, it is evident that the 
microvasculature (including the retinal microcirculation), but not necessarily the 
conduit arteries, can have a significant effect on the distribution of blood flow. 
Changes in the retinal microvasculature have been associated with multiple 
cardiovascular complications in healthy individuals and in individuals with type 2 
diabetes, such as hypertension and diabetic retinopathy. Retinal microvascular 
changes have also been associated with major cardiovascular outcomes including 
ischaemic heart disease (discussed on the following chapter) and stroke.  
Epidemiological studies have provided accumulating evidence that cerebrovascular 
disease occurs in the context of a much broader vasculopathy that affects target 
regions in multiple organs, including the retina, heart and kidney. Recent studies 
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have found associations between retinal vascular abnormalities and cerebral white 
matter lesions. These are biomarkers for small vessel disease and indeed, these are 
surrogates of cardiovascular dysfunction (Kwa and Lopez, 2010).   
In the context of retinal vessel abnormalities, it is particularly relevant to study 
cerebrovascular disease as the retina and the brain share similar anatomic, 
physiologic and embryologic features ( e.g mesenchymal cells).  
A study found a correlation between the loss of branching complexity of the retinal 
vessels (decreased multifractal dimensions) and cerebral lacunar strokes (Doubal et 
al, 2010). Furthermore, an association was found between loss of branching 
complexity and increasing age. This suggests that changes occur in the retinal 
vasculature with increasing age. Measures of complexity derived from the field of 
nonlinear dynamics (fractals theory) may help to assess age-related anatomic and 
physiologic changes and possibly predict pathology (Lipsitz and Golderberg, 1992). 
Microvascular dysfunction of the heart may share underlying pathophysiological 
mechanisms with that of the brain, including endothelial dysfunction, thrombosis, 
vascular remodelling and capillary rarefaction (Mejia-Renteria et al, 2018). The 
coronary microcirculation is constituted by arterioles, capillaries and venules and 
vessels of size less than 300 micrometres  represents a major vascular contributor to 
the heart’s density. This microcirculation plays an essential role in resistance of heart 
circulation through modulation of the vascular tone of the arterioles (Mejia-Renteria 
et al, 2018).  Capillaries are abundant in the heart and their highest density is in the 
myocardium, accounting for 90% of the intramyocardial blood volume.  
Endothelial cells play a key role in both the coronary and cerebral microcirculation. 
These mediate vasodilation and vasoconstriction from different triggers, including 
nitrous oxide and other factors such as metabolic, neurohumoral, shear stress and 
adaptative responses to changes in blood pressure. Cerebral  microcirculation 
features include the presence of the blood-brain barrier, the absence of energy 
reserves and the influence of astrocytes and neurovascular nerves of the cerebral 
blood flow self-regulation (Mejia-Renteria et al, 2018). 
There has also been an interest in the relationship of the renal microcirculation with 
the  retinal vasculature. Chronic kidney disease is associated with low-grade 
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inflammation, endothelial dysfunction and platelet activation. These characteristics 
have been also found in the pathogenesis of impaired coronary and cerebral 
microcirculation.  Progression of renal dysfunction may also be associated with 
retinal vessel constriction (Nagaoka and Yoshida, 2013).  Recent clinical studies 
have reported that the calibre of retinal arterioles and venules decreased 
progressively with each CKD stage of renal failure (Yau et al, 2011), suggesting that 
progression of renal dysfunction might be associated with retinal vessel 
abnormalities. Although these studies did not include patients with diabetes, the 
findings seemed to support the finding that vessel diameter and blood flow in the 
retinal arterioles were significantly lower in patients with stage 3 CKD compared with 
those without CKD in patients with type 2 diabetes and no or minimal retinopathy 
(Ooi et al, 2011). 
 
1.5 Measurement of retinal vessels 
The first direct ophthalmoscope, named “Augenspiegel” or “the mirror of the eye,” 
was developed by the German doctor Hermann von Helmholtz in 1851. It allowed for 
the first time, the examination of the fundus of the eye through the pupil (McGinnity 
et al, 2019). Since then, there has been a great interest to analyse and measure the 
components of the retina, including the microvasculature. Retinal vasculature 
analysis is important for the early diagnostics of the various eye and systemic 
diseases. Characteristics of the retinal vasculature make potentially useful novel 
biomarkers (MacGillivray et al, 2014). Both qualitative and quantitative assessment 
have been widely used in numerous studies using state-of-the-art computerised 
methods (McGrory et al, 2018). These semi-automatic computerised methods use 
retinal photographs. 
Methodologically, the retina is photographed directly through the dilated pupil using a 
specialised fundus camera illuminating the fundus of the eye. An external source of 
light is captured in the retinal surface, which in consequence, is reflected back to the 
camera, capturing the image of the retinal surface. This two-dimensional image of 
the retinal surface is called a retinal fundus image. A typical fundus camera is 
located between 30-50 degrees of the retinal surface, and it is magnified 2.5 times 
(Panwar et al, 2016).  
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Fundus images can be focused on different retinal features, depending on the 
medical purpose. The most common sites analysed are: the optic disc (e.g. 
glaucoma), macula (e.g. macular degeneration) and characteristics between the 
optic disc and the macula (e.g. diabetic retinopathy) (Trucco et al, 2013). The vast 
majority of epidemiological studies describing the association of retinal vessel with 
different disorders have used images centred around the optic disc or between optic 
disc and the macula (Fraz et al 2015; Bankhead et al, 2012). These regions provide 
detailed traits of the retinal microvasculature as they capture the areas where the 
vessels enter and leave the retina. These features of the retinal vasculature can be 
analysed by using a highly specialised computer software and could possibly be 
used as imaging biomarkers. This is because there is a considerable heterogeneity 
in cardiovascular risk in people with T2D and there exists a need for additional risk 
predictors to explain the CVD risk. In this context, there has been a significant 
interest in the potential utility of imaging biomarkers as possible clinical tools that 
might facilitate risk prediction and could inform therapeutic and preventative 
decision-making in cardiovascular disease (Selleck et al, 2017).  
Traditional CVD biomarkers should possess certain key features to be used 
optimally in clinical practice/settings. First, there needs to be a robust association 
between the imaging biomarker and the clinical outcome. Importantly, although it is 
essential, such association does not in and of itself ensure that measurement of the 
imaging biomarker can improve risk prediction, which is a second critical feature that 
must be present. Third, there are practical considerations to consider, including the 
availability of a reliable method or technique for measurement of the imaging 
biomarker and the cost-effectiveness to support its application in clinical practice. In 
the natural history of the development of a new imaging biomarker, these three 
features are typically addressed in turn, with the practical considerations 
representing the final steps before clinical uptake. 
 
1.5.1 Software to detect and measure retinal images 
Measuring retinal microvasculature manually is time consuming, laborious, prevents 
the assessment of a large number of individuals, and impedes the detection of small 
differences. Over the last few years, engineers, scientists and doctors have together 
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developed computerised approaches to analyse retinal images on a larger scale. 
Several institutions have different computerised approaches to analyse the retinal 
traits. Retinal microvascular parameters have been measured from digitalised 
images using, for example, custom written programs running such as MATLAB® 
programming environments on a personal computer. These include software such as 
Singapore “I” Vessel Assessment (SIVA), and Vascular Assessment and 
Measurement Platform for Images of the Retina (VAMPIRE). Both are available 
commercially and publicly, respectively. Several studies have used these platforms 
and validation of such software applications has been carried out (McGrory et al, 
2018). 
SIVA is a software developed by the National University of Singapore. This platform 
can automatically compute a spectrum of retinal vascular parameters including 
retinal vascular calibres, tortuosity, branching angle, fractal dimension and junction 
exponent deviation from retinal fundus photographs to quantify the retinal 
vasculature. Other automation of SIVA includes retinal vasculature tracing, vessel 
type classification (venule or arteriole) and optic disc detection. 
VAMPIRE is a software application for semi-automatic quantification of the retinal 
vessel properties with large collections of fundus camera images (Perez-Rovira et al, 
2011). This software has been developed and validated by an international 
collaboration of the University of Edinburgh and clinical centres of Europe, Asia and 
the UK. VAMPIRE aims to provide efficient and reliable detection of the retinal traits 
including the optic disc, the retinal zones, fovea, macula and the vasculature. It 
computes quantitative retinal traits including arteriovenous ratio, arteriolar and 
venular calibres, arteriolar tortuosity (mean, minimum and maximum), venular 
tortuosity (mean, minimum, maximum) multifractal dimensions (D0, D1, D2) and 
Monofractal. Additionally, this software automatically detects, vasculature tracing, 
vessel classification, and optic disc detection. 
Traditional computational methods for retinal vascular analyses have also measured 
branching angle, branching coefficient, and monofractal dimensions. These 
measurements have shown association with several systemic pathologies. Other 
methods to quantify the vasculature include ocular coherence tomography and 
smartphone-based platforms (Panwar et al, 2016), which are novel techniques to 
44 
 
quantify the retinal vasculature. However, they can be costly and demand further 
resources and devices to analyse the retinal vessels.   
 
1.6 Quantitative retinal vessel traits and their investigation 
in major epidemiological studies  
Numerous retinal vessel traits have now been measured in a range of clinical and 
epidemiological studies. This section describes the quantitative retinal traits related 
to vessel widths (arteriolar, venular and the ratio of these), tortuosity (arteriolar and 
venular) and multifractal dimensions, including their measurement in major 
epidemiological studies where they have been associated with traditional 
cardiovascular risk factors, systemic diseases and cardiovascular outcomes (table 
1.1).   
Each retinal trait may be associated with specific anthropometric, or characteristics 
of the population. For instance, narrower arterioles –an indicative sign of lower 
CRAE and decreased AVR- has been associated with increasing age, male gender, 
high blood pressure and chronic kidney disease. Further details of these 
associations are found in table 1.1 
Moreover, venular dilation – a sign of higher CRVE and increased AVR – has been 
associated with increased blood pressure, inflammatory markers (e.g. CRP, 
fibrinogen, interleukin 6), obesity and dyslipidaemia. As for tortuosity, decreased 
arteriolar tortuosity has been associated with increased aging (Cheung et al, 2011), 
higher blood pressure (Taarnhoj et al, 2008) higher BMI (Cheung et al, 
2008;Taarnhoj et al 2009) and increased Hb1Ac (Sasongko et al, 2013). Moreover, 
increased venular tortuosity is associated with higher blood pressure and lower HDL 
cholesterol levels.  
Finally, lower retinal monofractal dimensions have been associated with increasing 
age and with high blood pressure (Doubal et al, 2010). Detailed description of the 
association of  these retinal traits with cardiovascular outcomes (rather than CV risk 






1.6.1 Vessel widths 
Retinal vessel calibres have been analysed in relation to subclinical cardiovascular 
disease, metabolic outcomes, and vascular events such as stroke and ischaemic 
heart disease (Flammer et al, 2013). The associations of retinal arteriolar and 
venular narrowing with cardiovascular disorders such as hypertension and increased 
macrovascular stiffness have often shown opposing results, so these traits are 
considered separately in this section. Initially, calibre measurements included the 
width of the streaming column of reflective erythrocytes (red blood cells). However, 
this measurement did not include the vessel wall and the plasma volume, which are 
transparent in fundus photography. In some studies, it was not clear whether 
computer-assisted methods actually measured the outer vessel diameter (vessel 
wall and lumen), central red blood column or even the overall lumen (Pakter et al, 
2011). 
The arteriolar diameter is often expressed in terms of CRAE (Central 
Retinal Arteriolar Equivalent), which summarises the mean diameter of six arterioles. 
Similarly, the venular diameter is frequently presented as CRVE (Central Retinal 
Venular Equivalent), which summarises the mean of the diameter of six venules. The 
arteriovenous ratio (AVR) is the ratio of the diameter of the arterioles to that of the 
venules. This is a dimensionless retinal parameter, which means that a smaller AVR 
signals a relatively smaller arteriolar diameter and wider venular diameter. As such, 
this retinal biomarker has limitations, as arterioles and venules can have different 
responses to different cardio-metabolic pathology.  
Many studies have described a decreased arteriolar diameter as a lower value of 
AVR. For example, Wong et al (2002) quantified retinal arteriolar narrowing to 
examine the association between this biomarker and incident coronary heart disease 
in The Atherosclerosis Risk Communities Study. After full adjustment, it was found 
that in women, each decrease of standard deviation of AVR was associated with an 
increased risk of incident coronary heart disease and acute myocardial infarction. 
AVR was unrelated to any incident coronary heart disease events in men. Further 
studies using AVR have found contradictory findings including the Cardiovascular 
Health Study, which showed no consistent association between the smaller AVR and 
large artery atherosclerosis (Wong et al, 2003). 
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Several epidemiological studies have associated narrower arterioles with increasing 
age including ARIC (Hubbard et al, 1999), DTRS (Taarnhøj et al, 2006), BMES 
(Sherry et al, 2002) and BDES (Wong et al, 2003). Additionally, cardiovascular 
disorders such as hypertension have been explored in studies. The Multi-Ethnic 
Study Atherosclerosis (MESA) found hypertension associated with narrower retinal 
arteriolar diameter and wider venular diameter (Wong et al, 2006). A large study 
from the US, the Atherosclerosis Risk in Community (ARIC) which included nearly 
11,000 participants, found that any degree of generalised arteriolar had statistically 
mean arterial blood pressure approximately 8 mmHg higher than those without 
(Hubbard et al, 1999). Moreover, the Blue Mountain Eye Study (BMES) from 
Australia, found that after adjusting for age, sex, BMI, smoking, glucose and total 
cholesterol, retinal arteriolar narrowing at baseline was associated with increased 
risk of severe hypertension (OR 2.6; 95%CI, 1.7, 3.9) when comparing the narrowest 
versus the widest quintile (Smith et al, 2004). 
Chronic kidney disease and impaired renal function in people with cardiovascular 
risk factors represents a major public health problem associated with adverse renal 
and cardiovascular complications and premature deaths. Impaired renal function has 
been widely explored in the aforementioned datasets. The Singapore-Malay Eye 
Study using a multivariable analysis and follow-up period of 6 years, found that 
smaller retinal arterioles (HR 1.34; 95%CI 1.00, 1.78), larger retinal venules (HR 
2.35; 95%CI 1.12, 5.94) and the presence of retinopathy (HR 2.54; 95% CI 1.48, 
4.36) were associated with chronic kidney disease (Yip et al, 2017). However, an 
Irish study with data from 1233 participants, did not find any association between 
retinal arteriolar and venular parameters and chronic kidney disease (McGowan et 
al, 2015). 
In terms of major cardiovascular outcomes such as stroke, an association between 
the narrower arterioles and increased risk of stroke has been described in several 
cross-sectional and cohort studies and smaller studies (Kawasaki et al, 2012; Kwa et 
al, 2002; Wong et al, 2001). In the ARIC study, ischaemic stroke was associated with 
narrower arterioles (but wider venules). However, other studies have not shown any 
association between decreased arteriolar diameter and stroke (MacGeechan et al, 
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2009). Overall, there is no conclusive evidence in the association between arteriolar 
diameter with either haemorrhagic or ischaemic stroke.  
Several studies have also shown that retinal venules are associated with traditional 
cardiovascular risk factors, subclinical CVD, and major cardiovascular outcomes. For 
instance, larger venular calibre but not arteriolar calibre, was related to 
anthropometric measurements of obesity (higher BMI and waist-hip ratio) and 
dyslipidaemia (higher levels of LDL and triglyceride and lower HDL cholesterol) in 
the Rotterdam study (Ikram et al, 2004). Moreover, prospective analysis from the 
Blue Mountains Eye Study further indicated that a larger retinal venular calibre may 
predict the incidence of obesity (Wang et al, 2006). Data from the Dutch Hoorn study 
showed that retinal venular dilatation was associated with increased subclinical 
atherosclerosis such as intima-media thickness. Likewise, larger venular calibre has 
been associated with peripheral vascular disease such as lower ankle-arm index 
(Ikram et al, 2004). 
Results from several population-based studies have showed a significant association 
between larger retinal venular calibre and inflammatory markers including C-reactive 
protein (Ikram et al, 2004) and similar findings were found in a Singaporean cohort 
(Yim-Lui et al, 2010). In the Beaver Dam Study eye, increased venular calibre was 
associated with biomarkers related to endothelial dysfunction including soluble 
intercellular adhesion molecule-1 and serum-E selectin (Klein et al, 2006). Increased 
dilatation of retinal venules may be the outcome of increased production of nitric 
oxide secondary to release of pro-inflammatory mediators.  
Importantly, retinal venular calibre has been associated with stroke. In The 
Rotterdam Study, larger venular calibre was associated with 12% higher risk of 
stroke and a 15% higher risk of cerebral infarction (Ikram et al, 2006). The 
association of wider retinal venular calibre with an increased risk of stroke has also 
been confirmed in a meta-analysis (McGeechan et al, 2009) 
 
1.6.2 Vessel Tortuosity 
Normal retinal blood vessels are straight or gently curved, but they tend to dilate and 
start to become tortuous with age and with a number of retinal and systemic 
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disorders (Cheung et al, 2011). Tortuosity can be defined as full of turns and twists. 
However, this is not quite accurate when it comes to describing the tortuosity of the 
retinal vasculature. Bearing in mind that the retinal vasculature is spread in a 
spherical structure, these vessels are naturally slightly curved and twisted. 
Qualitatively, there is no established agreement among graders on abnormal 
tortuosity of the retinal vasculature or on the general levels of vessel tortuosity. 
Commonly, image graders or ophthalmologists describe the retinal vasculature 
based on their experience. This is done by identifying characteristics such as 
differences from normal healthy vessels, length, width, location, type and numbers of 
twists. Currently, the tortuosity of the retinal vasculature can be quantitatively 
examined with improved image processing software and algorithm implementation, 
and more consistent results can be obtained to prevent misclassification. 
The tortuosity of the retinal vasculature may be attributed to build-up of the natural 
capabilities to avoid or adapt to physiological changes including aging, hemodynamic 
factors or systemic disorders. Vessel tortuosity may result from the ability of the 
blood vessel to dilate, gain more length and become more curvy and twisty to an 
abnormal state. Severe vessel tortuosity has been associated with aging and it rarely 
occurs in children (Han et al, 2012). In terms of mechanical changes that occur in the 
tortuous vasculature, experimental and physiological studies have shown strong 
associations between tortuous vessels and mechanical factors such as blood 
pressure, blood flow, axial tension and structural vessel wall changes (Ciuricā et al, 
2019). Retinal arteries and venules are subject to mechanical stress generated by 
lumen blood flow, pressure and surrounding tissue tethering (Han et al, 2013). These 
mechanical characteristics are influenced by many physical and mechanical factors 
such as exercise and gravity. Previous studies have documented that these 
mechanical factors play an important role in regulating the vascular endothelium 
(Hartnett et al, 2008). These factors may restrict, partially or completely, the blood 
flow, which as a result may lead to stroke, transient ischaemic attack, or hindrance of 
arteriogenesis and tissue regeneration. Moreover, thrombosis (the formation of a 
blood clot or thrombus within a blood vessel), which has been observed in tortuous 
blood vessels may lead to vessel occlusion with subsequent myocardial infarction or 
stroke (Owens and Mackman, 2010).  
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Extensive clinical studies have shown that vessel tortuosity is associated with 
cardiovascular conditions, including atherosclerosis, abdominal aortic aneurysms, 
hypertension, diabetic retinopathy, and arterial tortuosity syndrome (Chessnut et al, 
2011). Indeed, tortuosity of the retinal vasculature has been identified as one of the 
earliest developing biomarkers for a number of systemic vascular disorders (Han et 
al, 2011), and, interestingly, there is an association of retinal tortuosity with tortuosity 
of major vessels such as the abdominal aorta (Beyons et al, 2016). Hence, it may be 
important to detect retinal vessel tortuosity early to potentially help identify systemic 
vascular disorders in their early stages and reduce further complications.   
Tortuous retinal arterioles are a fairly common finding, and while mild tortuosity is 
asymptomatic, severe tortuosity can lead to serious clinical symptoms or ischaemic 
damage (Han et al, 2012). Arteries may take a more tortuous path due to abnormal 
development or vascular disease. Retinal arteriolar tortuosity has been associated 
with increased age (Cheung et al, 2011) and with arterial hypertension, diabetic 
retinopathy, cerebral vessel disease, stroke and familiar arteriolar tortuosity 
(Chessnut et al, 2011; Ciuricā et al, 2019). Interestingly though, Taarnhøj et al 
(2008) found hypertension to be associated with decreased retinal arteriolar 
tortuosity, while higher BMI was associated with reduced tortuosity.  
Tortuosity, specifically of the retinal venules, has been investigated in several 
epidemiological studies. The Singapore-Malay cohort (Cheung et al, 2011) found 
retinal venules to be significantly more tortuous than retinal arterioles, and greater 
venular tortuosity was independently associated with younger age, female gender, 
higher blood pressure and lower HDL cholesterol level. This study also showed that 
non-diabetic subjects with retinopathy signs had significantly more tortuous venules 
than those without retinopathy, although venular tortuosity was not significantly 
associated with diabetes.  However, findings from Sasongko and colleagues showed 
that individuals with diabetes had more tortuous retinal arterioles and venules 
(Sasongko et al, 2011) and that retinal venular tortuosity was associated with any 
grade of diabetic retinopathy compared with individuals without diabetic retinopathy. 
Recently, in a study carried out in the Norfolk (UK) found that increased venular 
tortuosity was associated with higher BMI, HbA1c, and prevalent type 2 diabetes. 
These associations persisted after full adjustment. Interestingly, arteriolar tortuosity 
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but not venular tortuosity, increased with those with prevalent stroke. No 
associations were seen with prevalent myocardial infarction (Owen et al, 2019). 
In the cross-sectional Multi-Centre Retinal Stroke study, Singaporean individuals 
were recruited and it was found that after full adjustment, increased venular 
tortuosity and increased arteriolar tortuosity were associated with stroke (Ong et al, 
2013). Lastly, in a recent study which included individuals from Orkney Scotland 
(ORCADES study) and data from the isolated  population Korčula Croatia, larger 
venular tortuosity was found to be associated with longer cardiac QT interval and 
that arteriolar tortuosity was associated with carotid intima media thickness (Kirin et 
al, 2017).  
 
1.6.3 Multifractal dimensions 
In recent years, fractal analysis has attracted much interest as a novel biomarker 
from the biomedical imaging communities, and has been used in several cohorts to 
analyse the retinal vasculature. Fractal dimensions is the link between fractal theory 
and practical applications to cardiovascular medicine. This is a unitless number that 
measures nontrivial, self-similar scaling (Captur et al, 2017). A phenomenon is self-
similar if the whole resembles its scaled parts, and its self-similarity is non-trivial if, in 
essence, the design detail and repetitive arrangement creates a pattern too 
‘irregular’ to be defined by Euclidean geometry (Captur et al, 2017). Fractal 
dimensions measures a phenomenon’s complexity, which is the logarithmic ratio of 
the change in detail to the change in scale. The retinal vasculature typically shows 
fractal properties or self-similarity at multiples scales and over the last decade, there 
has been increasing interest in using fractal dimensions to quantify the “state” of the 
human retinal vasculature (considered as a geometrical object). 
Fractal dimensions include measurements such as mono-fractal (Df) and multifractal 
dimensions. Fractal dimension (monofractal) describes how much space is filled, but 
does not indicate how the space is filled by the fractal structure. An object (e.g. 
retinal vasculature) is considered multifractal when its different regions have different 
fractal properties. In fact, Costa and Nogueira (2015) observed that not only the 
entire retinal vasculature, but also several regions of the retina follow a multifractal 
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behaviour. Multifractal dimensions detects the multifractal scaling using the box 
counting technique, which takes into account the distribution of pixel values in a 
digital image. This methods gathers information about the distribution of pixel values 
which leads to calculation of multiple scaling rules. 
One value of the generalized multifractal dimension D0 (Q=0) is equal to what is 
called the "capacity dimension", which can be understood as the box counting 
dimension. Multifractal dimension D1 (Q=1) is equal to what  is called the 
"information dimension", and multifractal D2 (Q=2) to the "correlation dimension" 
(Stosić et al, 2006). These traits are measured with VAMPIRE software. 
Previously, it was stated that the vascular network of retinal regions presents 
multifractality and not only the vascular network of the whole retina, but its regions, 
can also be considered a superposition of monofractal structures (Costa and 
Nogueira, 2015).   
Fractal dimension (Df) has been studied widely in different cohorts. In a prospective 
cohort of adults, participants with suboptimal Df (lowest and highest quartiles) had 
50% higher 14-year ischaemic heart disease mortality than those with optimal Df  
after full adjustment (Liew et al, 2011). In a cross-sectional study performed in an 
Asian population, the history of hypertension was significantly associated with Df , as 
was age (Zhu et al 2014). Indeed, in this study, blood pressure exhibited a stronger 
association with Df  than with central retinal arteriolar equivalent. In a recent study 
(Wang et al, 2018), Df  was lower in women, decreased with increasing age and was 
significantly associated with coronary artery disease vessel score. These results 
showed that a sparser retinal microvasculature (smaller Df) was not only associated 
with older age and female gender but also with more diffuse and severe coronary 
artery disease.  
There is great interest in the association of retinal fractal dimensions with cerebral 
small vessel disease and cerebrovascular disease. Higher retinal fractal dimension 
(highest vs lowest quartile and per standard deviation increase) has been 
independently and positively associated with lacunar stroke (OR 4.27; 95% CI 1.49-
12.7 and OR 1.85; 95% CI 1.20-2.84, respectively) (Cheung et al, 2010). 
Conversely, in the Blue Mountains Eye Study, each standard deviation decrease in 
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baseline fractal dimension was associated with 40% greater risk of stroke events 
(OR 1.39, 95% CI 1.06 -1.83). Individuals in the smallest quartile of fractal 
dimensions were twice as likely to have a subsequent stroke than those in the 
largest quartile (OR 2.30, 95% CI 1.06 - 4.97) (Kawasaki et al, 2011). This study may 
suggest that reduced complexity in the branching pattern of the retinal 
microvasculature indicated by reduced fractal dimensions affects perfusion, which 
might increase vulnerability to hypoxia. Consistent with the BMES study findings, a 
cross-sectional analysis found that decreased mono-fractal and multifractal traits 
were associated with increasing age and lacunar stroke after correcting for 
hypertension, diabetes, stroke severity and white matter hyperintensity scores 
(Doubal et al, 2010). 
These findings are likely to be related to focal manifestation of a widespread non-
atheromatous small vessel vasculopathy, perhaps resulting from an increased 
blood–brain barrier permeability associated with endothelial dysfunction. This 
mechanism results in decreased diametre of the retinal vessels  causing decreased 
branching complexity, and therefore, reduced multifractal dimensions (Doubal et al, 
2010). 
 
1.7 Genetics of retinal microvasculature 
The identification of genetic variants in complex diseases such as cardiovascular 
and metabolic disorders has been studied widely. The identification of novel 
susceptibility genetic variants offers new insights into pathophysiological pathways 
and may help to better understand the physiopathology and factors, which contribute 
to the rapid development of the disease. These findings may also help to enrich 
genetic risk profiling alongside traditional cardiovascular risk factors.   
The genome-wide association study (GWAS) is an experimental design used to 
detect associations between genetic variants (also called single nucleotide 
polymorphisms, SNPs) and traits in samples from populations (Visscher et al, 2017). 
The main goal of these studies is to better understand the biology of disease under 
the assumption that this will help to prevent and better treat the disorder. GWAS 
have been successful in exploring the relative role of genes in a disorder and 
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interaction with the environment, assisting in risk prediction (personalised medicine) 
and investigating differences among the populations (Visscher et al, 2017). GWAS 
have also driven the discovery of over 10,000 robust associations with complex 
diseases and disorders, quantitative traits and genomic traits (Visscher et al, 2017).  
The retinal vasculature is an important area to identify novel variants as the retinal 
microvasculature shares structural and physiological characteristics with the cerebral 
and coronary circulation (Mejía-Renteria et al, 2018). 
Few studies have investigated the contribution of genetic variants to retinal 
microvasculature traits. Heritability of the retinal microvasculature has been studied, 
showing that retinal traits have different percentages of heritability. Lee et al (2004) 
performed the first study to report on family aggregation of quantitative retinal vessel 
traits. This study found a high correlation of the arteriolar and venular calibre (CRAE 
and CRVE, respectively) and AVR among relatives (more highly correlated than 
between unrelated individuals). Twin studies have shown different proportions of 
heritability among the quantitative retinal vessel traits. Taarnhøj et al (2006) 
analysed 55 monozygotic and 50 dizygotic same-sex healthy twin pairs. Heritability 
was found to be 70% for CRAE and 83% for CRVE. This study also concluded that 
retinal vessel calibres are involved in risk of vascular disease due primarily to genetic 
characteristics. However, a range of heritabilities have since been demonstrated for 
the retinal traits. In a cohort in the UK, Fahy et al (2011) found heritability estimates 
for CRAE and CRVE of 66% and 72% respectively using a bivariate model, while 
Kirin et al (2017) showed heritabilities of 35.9% for CRAE, 39.6% for CRVE, 30.2% 
for AVR, 50% for arteriolar tortuosity, 22.9% for venular tortuosity and just 21.1% for 









(2010) scanned 1737 African Americans searching for genomic regions where 
individuals have narrower retinal arteriolar calibre or wider retinal venular calibre. 
The percentage of African ancestry was positively correlated with retinal venular 
calibre, particularly in hypertensive individuals. They showed that the association 
was found on chromosome 6p21.1 especially in individuals with hypertension. The 
6p21.1 region contains genes that are biologically relevant in the development and 
modulation of the retinal vessels. One of these genes in this region includes the 
vascular endothelial growth factor gene. These genes plays a critical role for retinal 
vessels, as an endothelial-cell selective mitogen intimately associated with 
vasculogenesis, angiogenesis and vascular permeability.  
Larger scale GWAS and meta-analyses have been performed over the last few 
years. These studies have reported on genetic associations mainly for retinal 
arteriolar and venular calibres. Sim et al (2013) found one loci significantly 
associated with CRAE on chromosome 5. The SNP rs2194025 on chromosome 
5q14 near the myocyte enhancer factor 2C MEF2C gene was associated in the 
discovery cohorts with p-value <5x10-8. This variant in combined meta-analysis and 
replication cohorts showed that rs2194025 reached a p-value=2.11x10-12.  In a large 
meta-analysis, Ikram et al (2010) reported that four loci were associated with CRVE 
in cohorts from North America, Europe, Asia and Australia. The top SNPs were 
rs2287921 on chromosome 19q13 (p = 1.61 x 10-25) within the RASIP1 locus and 
rs225717 on chromosome 6q24 (p =1.25 x 10-16). This SNP is located adjacent to 
the VTA1 and NMBR loci. Moreover, the SNPs rs10774625 on chromosome 12q24 
(p = 2.15 x 10-13) located in the region ATXN2, SH2B3 and PTPN11 loci and 
rs17421627 on chromosome 5q14 (p = 7.32 x 10-16) next to MEFC2C locus. Further, 
replication in two independent samples showed that locus 12q24 was also 
associated with ischaemic heart disease and hypertension. Another large-scale 
genome-wide association study carried out by Jensen et al (2016) with 24 000 
individuals reported 4 new loci associated with CRVE. The rs7926971 in TEAD1 
gene (p = 3.1 x 10-11), rs201259422 in TSPAN10 (p = 4.4x10-9), rs5442 in GNB3 (p = 
7.0 x 1010) and rs1800407 in OCA2 (p = 3.4 x 10-8).  
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The latter SNP, rs1800407 was also associated with CRAE. Further analyses in the 
dataset, showed that rs201255422 was also associated with cardiovascular 
parameters including systolic (p=0.001) and diastolic blood pressure (p=8.3 x 10-4).  
Literature on the associations of retinal vascular traits with ischaemic heart disease 
including angina, myocardial infarction and coronary ischaemia are presented in the 



















Chapter 2 Literature Review: Association of retinal 
vascular traits with ischaemic heart 
disease in people with diabetes  
 
Whilst examining the epidemiological literature on associations between retinal traits 
and cardiovascular disease, it became apparent that the association of retinal traits 
with ischaemic heart disease in people with diabetes was not well covered by the 
major epidemiological studies discussed in chapter 1. I chose this association as the 
topic of a detailed and comprehensive review using a systematic literature search, to 
better understand the current state of knowledge on this area and to inform my own 
subsequent analyses for this thesis. I present the methods and findings of this 
literature review in this chapter. 
 
2.1 Objectives 
The objectives of this review were to: 
• Systematically identify the relevant epidemiological literature on the 
association between quantitative retinal traits and ischaemic heart disease in 
people with diabetes 
• Describe the associations between quantitative retinal traits and ischaemic 
heart disease in the identified literature  
• Consider the quantity and quality of the evidence found and therefore the 




2.2.1 Inclusion criteria 
2.2.1.1 Types of studies 
I included longitudinal cohort studies, cross-sectional studies and case-control 
studies in this analysis. I analysed articles in English and Spanish language as it was 
not feasible to find translators for articles in other languages for the purposes of my 
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PhD. I decided to include studies performed from 1970 onwards because the 
technology to assess the retinal vasculature started to be used in the mid-1970s. I 
reviewed full text articles to ensure good quality information.  
2.2.1.2 Participants 
Participants were adults with diabetes (either type 1 or type 2), including male and 
female, from any population in the world. I excluded studies on individuals with 
infections or other inflammatory medical conditions (liver disease, malignancy) or 
with other retinal conditions (such as age-related maculopathy, retinal artery/vein 
occlusion). Although, for the purposes of this review I included only adults with 
diabetes, I also retrieved studies on the general population in order to identify 
relevant literature for other sections of my thesis.   
2.2.1.3 Retinal traits 
I considered assessment of any quantitative retinal microvascular trait. This included 
characteristics associated with retinopathy (e.g. microaneurysms, hemorrhages) as 
well as quantitative retinal vascular traits such as arteriovenous ratio (AVR), central 
retinal arteriolar equivalent (CRAE), central retinal venular equivalent (CRVE), 
tortuosity and fractal dimensions.  
2.2.1.4 Outcomes measures 
The main cardiovascular outcome of interest was ischaemic heart disease (IHD). 
This included coronary artery disease, ischemic heart disease and myocardial 
infarction (fatal and/or non-fatal).  
 
2.2.2 Exclusion criteria 
I excluded any articles, which were systematic reviews, notes, conference abstracts and 
editorials, from this review.  
2.2.2.1 Search strategy  
I identified articles using a sensitive search strategy across two major medical 
databases to gather potentially relevant literature. I used free-text terms and indexed 
keywords (MeSH for MEDLINE; EMTREE for EMBASE) in Medline and EMBASE 
electronic databases. I developed a comprehensive list of different free-text terms to 
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identify as much as possible of the relevant literature. I also conducted an analysis of 
the references of the relevant articles and reviews to find other potential papers.The 
full search strategy is included in appendix 1. I screened the titles and abstracts of 
potentially relevant articles and then obtained the full text of these articles. This 
systematic review search was carried out on December 2, 2017. Although the 
Cochrane guidelines for systematic reviews (Higgins and Green, 2011) suggest that 
two reviewers should carry out this process, this was not practical for my PhD 
project.  
2.3 Results 
2.3.1 Study selection 
The search strategy conducted in MEDLINE and EMBASE databases retrieved a 
total of 1421 potentially relevant articles. The PRISMA flow diagram, describing the 
study identification process, is shown in Figure 2.1. 
 
Figure 2.1. Prisma Flow diagram 
I exported 1421 articles returned by the search, to Endnote. A total of 171 duplicate 
papers were identified using Endnote and removed, leaving 1250 articles to be 
screened. These 1250 papers were screened by the title and abstract and 1221 
records were removed at this stage, as they were irrelevant and did not meet the 
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criteria. This resulted in 29 articles remaining for a full-text assessment against the 
eligibility criteria. 
After an examination of the full text articles, 25 studies remained of which eight 
included populations with diabetes. The findings from these eight papers are 
discussed in detail below, and information from the other 17 studies (on the general 
population) was incorporated into other sections of the thesis (a table summarizing 
these studies is given in (appendix 2).  
 
2.3.2 Study findings  
2.3.2.1 Studies on individuals with type 2 diabetes 
Five studies on individuals with type 2 diabetes were identified (table 2.1). Klein et al 
(2007) analysed a subset of the study population in the Wisconsin Epidemiologic 
Study of Diabetic Retinopathy cohort. This was a prospective study with a follow-up 
of 22 years, which included incident diabetic complications such as nephropathy, 
neuropathy, and lower extremities amputations as well as all-cause mortality and 
mortality from ischaemic heart disease (IHD) and stroke, although non-fatal incident 
cardiovascular events were not analysed separately. The main results showed 
significant independent associations of the narrower retinal arteriolar calibre (lower 
CRAE) with lower extremity amputations and all-cause mortality and stroke mortality 
(HR, 1.47; 95% CI, 1.04-2.07; p = 0.03) in the multivariate model, adjusted for age, 
sex, HbA1c, hypertension, proteinuria and previous cardiovascular history. However, 
no association was seen with IHD mortality. Wider venular calibres (higher CRVE) 
were independently associated with incidence of nephropathy and stroke mortality 
(HR 1.71; 95% CI, 1.20-2.44; p = 0.003), but not with IHD mortality. It is important to 
highlight that the quantitative retinal measurements were classified into quartiles in 
this study. The reference group for CRAE included the second, third and fourth 
quartiles while the reference group for CRVE included the first, second and third 
quartiles. A more powerful and informative analysis may have resulted from keeping 




Phan et al (2016) analysed and compared individuals with and without type 2 
diabetes in a cross-sectional study of 1677 individuals in which both retinal arteriolar 
and venular calibres were measured. Associations with coronary heart disease were 
investigated using Gensini and Extent scores from findings on coronary angiograms. 
Three different scores were used, including the vessel score of obstruction (stenosis, 
IV grade), the Gensini scores (severity score) and the Extent score (for the detection 
of atheroma). In a model adjusted for age, sex, BMI, hypertension, smoking status 
and eGFR, individuals with undiagnosed (newly diagnosed in this study) and 
diagnosed diabetes versus those with no diabetes had increased odds of being in 
the highest quartile of Gensini scores odds ratio (OR)= 7.02 (95% CI, 2.04-24.1) and 
(OR) =2.76 (95% CI, 1.67-4.55), respectively. Similarly, using a model with the 
abovementioned covariates, recruited individuals with newly diagnosed and 
diagnosed diabetes versus those with no diabetes also had increased odds of being 
in the highest quartile of Extent scores, OR =7.63 (95% CI, 2.15 -27.10) and OR = 
3.72 (95% CI, 2.22-6.27), respectively. The results showed no significant differences 
in the association of any of the angiograms scores and the retinal arteriolar and 
venular calibres with undiagnosed versus diagnosed diabetes in the unadjusted and 
fully adjusted models.  
Drobnjak et al (2016) carried out a prospective analysis in individuals from 
Copenhagen, Denmark, with type 2 diabetes diagnosed by the oral glucose 
tolerance test, known diabetes mellitus, or impaired glucose tolerance, aged 30 
years or older, and with a mean follow-up of 15 years. In this study, 908 individuals 
were recruited, CRAE and CRVE were measured and the end points included 
mortality from ischaemic heart disease (IHD defined as bypass, recanalization, 
reconstruction of coronary arteries), as well as stroke mortality and non-
cardiovascular mortality. This study found  narrower CRAE to be associated with 
higher systolic blood pressure but with higher HDL cholesterol and lower smoking 
levels, while wider CRVE was associated with higher smoking levels and lower HDL 
cholesterol. In age-adjusted models and using linear regression model, an 
association between wider CRVE and risk of IHD was found (p < 0.001), but no 
significant association was reported between CRAE and IHD. Although, wider CRVE 
was associated with all-cause mortality (HR=2.02, (95% CI, 1.0 – 3.8); p=0.03) in a 
basic model, the association was attenuated in a model which was fully adjusted for 
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age, sex, blood pressure and smoking. It is important to highlight that these results 
were obtained when the third tertile of CRVE was compared to the first tertile of 
CRVE. This study confirmed an association of retinal arteriolar and venular calibres 
with traditional cardiovascular risk factors as well as reporting on associations 
between the traits and IHD as a disease outcome.   
Guo et al (2016) recruited 229 individuals (79 with cardiovascular disease and 150 
controls who were free from cardiovascular disease) from the urban area of Hong 
Kong. Participants were aged 18 years and older. In this study, several quantitative 
retinal parameters were measured including CRAE, CRVE, AVR, arteriolar and 
venular standard deviation of the vessel width (BSTD), fractal dimensions, tortuosity, 
branching angles, branching coefficient, asymmetry factor, junctional exponent, 
angular asymmetry, length to-diameter ratio and diabetic retinopathy. In this cross-
sectional analysis, individuals with stroke, transient ischaemic stroke and CHD were 
defined as cases (n=79). Three models were created. The first model included 
traditional cardiovascular risk factors such as diabetes duration, hypertension and 
HDL cholesterol, of which only diabetes duration was associated with CVD (OR 1.09; 
95%CI 1.04-1.14 p <0.001). In the second model, only retinal traits were analysed, 
including AVR, diabetic retinopathy and junctional exponent (a novel quantitative 
retinal trait that describes the deviation from optimality at a bifurcation). The results 
in this second model showed an association of the junctional exponent with 
cardiovascular events (OR 0.19; 95%CI, 0.06-0.62; p=0.006). In the third model, 
both the traditional cardiovascular risk factors and the retinal traits were included. 
Interestingly, the results showed that diabetes duration (OR 1.08; 95%CI 1.03-1.14; 
p=0.001), HbA1c (OR 1.29; 95%CI 1.02-1.61; p =0.03) and junctional exponent (OR 
0.03; 95%CI 0.003-0.33; p=0.004) were associated with cardiovascular events.  
Phan et al (2018) carried out another analysis in The Australian Heart Eye Study. 
They recruited 748 individuals, which included 96 with impaired fasting glucose and 
189 with diabetes mellitus. Associations with coronary heart disease were 
investigated using Gensini and Extent scores from findings on coronary angiograms. 
Two scores were used, including the Gensini scores (severity score) and the Extent 
score (for the detection of atheroma). No association was found between CRAE and 
individuals with impaired fasting glucose or diabetes. In an analysis stratified by 
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gender, males with the second and third tertiles were associated with diabetes in a 
model adjusted for age, BMI, alcohol, smoker, hypertension, history of diabetes, 
cholesterol total, HDL, use of statin, and CRAE, OR 2.45 (95% CI, 1.31 – 4.5) p = 
0.005 and OR 2.76 (95% CI, 1.46-5.21) p = 0.002, respectively. CRVE was 
associated with the first tertile Gensini Score in a model adjusted for age and sex in 
people with diabetes OR 1.56 (95% CI, 1.04 – 2.34). Moreover, this association was 
also seen in participants below the median Extent score (i.e. less diffuse coronary 
artery disease) OR 1.67 p = 0.008). However, in both the models, the associations 
were attenuated in a multivariate adjustment. Conversely, there were no 
associations between CRVE and diabetes in women. No associations were found in 









2.3.2.2 Studies in type 1 diabetes 
Three studies on individuals with type 1 diabetes were identified (table 2.2). 
Klein et al (2004) recruited 996 individuals with type 1 diabetes. In this study, 
it was found that the severity of diabetic retinopathy was associated with an 
increased odds of angina (OR 1.2, 95% CI 1.0-1.5) and stroke (OR 1.6, 95% 
CI 1.1-2.3). In a model including diabetic retinopathy and AVR, the AVR 
quartile was associated with myocardial infarction (MI) (OR 0.8, 95%CI 0.6-
0.9,). Whereas in a multivariable analysis adjusted for age, sex, diastolic 
blood pressure, neuropathy, pulse pressure, smoking and history of CVD, 
severe diabetic retinopathy was associated with mortality from heart disease 
(e.g. angina and myocardial infarction) (HR 1.3, 95%CI 1.1-1.5) and the AVR 
fourth quartile (HR 0.8, 95%CI 0.6-0.9). CRAE and CRVE were not included 
in the multivariable analysis of this study, and it is likely that there was no 
association. Furthermore, when nephropathy was considered in the model in 
addition to retinopathy, the results showed that nephropathy was significantly 
associated with the cardiovascular outcome and retinopathy was no longer 
significantly associated.  
Miller et al (2009) studied 468 African American children with type 1 diabetes, 
measuring retinal CRAE and CRVE. In this prospective study, it was found 
that after full adjustment for diabetes duration, gender, hypertension, serum 
lipids, and smoking status, smaller arteriolar calibre was significantly 
associated with coronary artery disease (HR 1.42; 95% CI 1.04- 1.96, 
p=0.03). There was no association between coronary artery disease and 
venular calibre. There was a statistically significant vessel diameter-gender 
interaction (p= 0.006) and in an analysis stratified by gender, smaller 
arteriolar calibre was significantly associated with incidence of coronary 
artery disease in females (HR 1.92, 95% CI 1.24 - 3.16) in a full adjusted 
model (p= 0.004) but not in males. Retinal venular calibre was not associated 
with coronary artery disease in either gender. These results showed that for 
each standard deviation decrease in retinal arteriolar calibre, there was a 
42% increased risk of coronary artery disease after adjustment for other risk 




defined coronary artery disease (e.g. coronary artery disease death, MI, 
revascularization or stenosis >50%) incident events (n=47) showed a 
somewhat weaker association with smaller arteriolar (HR 1.48, 95% CI 1.05, 
2.09; p = 0.02) than previously described models that included ischemic ECG 
and Angina. However, this association remained attenuated after full 
adjustment.  
Roy et al (2012) measured CRAE and CRVE in individuals with type 1 
diabetes living in New Jersey. In this study, CRAE and CRVE were 
measured in 468 African American persons. Cardiovascular disease was 
defined as foot or leg amputation for a circulatory problem, myocardial 
infarction, stroke, hypertension and mortality. After full adjustment, narrower 
CRAE (lowest quartile) at baseline, significantly and independently predicted 
6- year incidence of any cardiovascular disease (HR 1.60, 95% CI 1.14 – 
2.26) and amputation  (HR 1.94, 95% CI 1.10 -3.42) whereas larger retinal 
venular diameter (highest quartile) at baseline, significantly and 
independently predicted 6-year incidence of hypertension (HR 1.41, 95% CI 
(1.03 – 1.94). Proteinuria and diabetic retinopathy (ETDRS) were stronger 
predictors of mortality than retinal arteriolar and venular calibres. This study 
did not present results separately for ischaemic heart disease. 
 
2.4 Discussion 
This literature review found a small number of studies, with generally 
inconsistent results, on the association of quantitative retinal traits with 
ischaemic heart disease in people with type 2 diabetes.  
Although the study carried out by Klein et al (2007) was performed 
prospectively and the results showed significant independent associations of 
smaller values of CRAE with lower extremity amputations, all-cause of 
mortality and stroke mortality, there was no association with ischaemic heart 
disease in this population with type 2 diabetes. The ability of this study to 




rather than using the traits as continuous variables. Similarly, in the cross-
sectional analysis by Phan et al (2016), no association was found between 
retinal venular calibres and coronary disease measured by angiograms. As 
angiograms have been used as a gold standard measure of stable 
anatomical coronary disease (Kochar et al, 2013), it could usefully be 
considered as an outcome in future studies analysing the association of 
quantitative retinal traits with coronary disease in prospective studies. In the 
final study on people with type 2 diabetes, Drobnjak et al (2016) found a 
statistically significant association between wider CRVE and risk of ischaemic 
heart disease. However, after multivariable adjustment, this association was 
attenuated and all-cause mortality and cardiovascular mortality were no 
longer associated with retinal arteriolar and venular calibres. 
Interestingly, in people with type 1 diabetes, the results were more promising. 
For instance, AVR and signs of diabetic retinopathy were significantly 
associated with myocardial infarction in the study carried out by Klein et al 
(2004); although the results were attenuated after adjustment for 
nephropathy. In the cohort of children with type 1 diabetes analysed by Miller 
et al (2009), smaller calibre arterioles (lower CRAE) were associated with 
incident coronary artery disease, and this association remained significant in 
multivariable analysis in females. This latter finding supports further 
investigation into the use of CRAE as an early quantitative retinal trait 
biomarker in female populations. The presentation and diagnosis of 
ischaemic heart disease are different in women from men, which make 
women prone to under-treatment for these diseases, stressing the need for 
more gender-based research and interventions on risk factors for ischaemic 
heart disease.  
The studies included in the population with type 1 diabetes were more 
homogenous. All these studies were designed prospectively and also were 
carried out for a significant amount of time (e.g.  6, 18 and 20 years of follow-
up). Additionally, in these studies CRAE and CRVE were measured. The 




when comparing to the studies included in the subgroup with type 2 diabetes 
individuals.  
Overall, in terms of the retinal traits, which have been most extensively 
investigated, there is some evidence that calibres of arterioles (CRAE) and 
venules (CRVE) and the dimensionless parameter AVR may be predictive of 
risk of coronary heart disease in relatively young adult diabetic populations, 
especially in women and in type 1 diabetes. The results in such populations 
are in the same direction as those found in the general population (Appendix 
2), as discussed further elsewhere in this thesis.  
 
2.5 Conclusion 
To date, traditional cardiovascular risk factors such as age, sex, blood 
pressure, hypercholesterolaemia, smoking and even qualitative retinal 
characteristics (such as diabetic retinopathy) have been used as 
cardiovascular risk predictors. More recently, studies are beginning to 
explore a number of quantitative retinal traits (such as CRAE, CRVE, AVR, 
tortuosity and fractal dimensions) as additions to such models, but studies on 
such traits are scarce, especially in diabetes. This suggests that there is a 
gap in cardiovascular research for further investigation of the retinal 
microcirculation.  
Further research must consider key methodological issues. First, prospective 
studies will be more informative than cross-sectional studies, and, since 
sample size plays a key role in obtaining valid results, such studies should 
include an appropriately large number of incident cardiovascular events. 
Second, it might be particularly productive to analyse whether the 
quantitative retinal traits are useful predictors of ischaemic heart disease 
especially in younger adults free of cardiovascular disease and in women 
with type 2 diabetes. It will be necessary to carry out these explorations in 
large datasets in populations with type 2 diabetes. Finally, a key finding from 




measurement of quantitative retinal traits. For instance, in some studies the 
retinal images were scanned whereas in more recent studies digitised 
images were used (directly from the ophthalmoscope). Differences in such 
technical approaches may interfere with the comparability of the 
measurements and cause bias, especially when measuring the calibres of 
the arterioles and venules.  
This literature review has thus identified a paucity of high quality, prospective 
studies on a range of retinal vascular traits as potential risk factors for 
cardiovascular disease in type 2 diabetes, especially ischaemic heart 
disease. A previous review of the literature on retinal traits and stroke 
(Doubal et al, 2009) also failed to identify many studies concentrating on 
retinal traits as predictors of stoke in people with diabetes. These findings 
therefore support my rationale for undertaking further analysis on the 
association of retinal vascular traits with coronary artery disease and stroke 
outcomes in people with type 2 diabetes, as well as highlighting key 














Chapter 3 Aims and objectives 
 
3.1 Aims  
The main aim of this thesis was to explore the association of quantitative 
retinal traits with major cardiovascular outcomes such as stroke and 
ischaemic heart disease and with cardio-metabolic genetic variants in people 
with type 2 diabetes. 
Specific objectives were to: 
(i) Determine whether the measured quantitative retinal traits are 
associated with a cross-sectional analysis with traditional 
cardiovascular risk factors and with cardiovascular outcomes 
including ischaemic heart disease and stroke. To achieve this, 
prevalent events from the ET2DS were used, followed by detailed 
data analysis.  
 
(ii) Determine the association prospectively of the measured 
quantitative retinal traits with cardiovascular outcomes using Cox 
regression analysis. To achieve this, incident cardiovascular 
events were identified using the record linkage in an established 
prospective cohort, namely ET2DS. 
 
(iii) Determine the association of the measured quantitative retinal 
traits with cardio-metabolic genetic variants included in the 
MetaboChip array and its imputed genetic data using genome-wide 
association methodology. To achieve this, the genetic variants 
included in the MetaboChip were imputed to the 1000 Genomes 





3.2 Thesis outline 
Background information on traditional risk factors for cardiovascular disease 
in people with type 2 diabetes, cardiovascular disease, retinal 
microvasculature and information of the analysis of the retinal traits has been 
summarised in Chapter 1. Chapter 2 presents a review of the literature on 
quantitative retinal traits and its association with ischaemic heart disease. 
This literature review not only pointed out to the paucity of studies in this 
area; it also helped me refine my research aims and objectives (outlined in 
this current chapter) and formulate the models for statistical analyses for this 
study.  
In chapter 4, I describe the methods employed for data collection and 
analysis, including details of the software used to collect the quantitative 
retinal traits, the design of the epidemiological models used cross-sectionally 
and prospectively in the ET2DS and the statistical modelling of the GWAS. 
I describe the results of this study in three chapters. The first section of the 
results (in chapter 5) presents relevant descriptive statistics from the ET2DS. 
The second section of the results (in chapter 6), describes the findings of the 
cross-sectional analyses. Furthermore, the prospective results of the 
association of the quantitative retinal traits with cardiovascular outcomes are 
described here. The third section of the results chapter (in chapter 7) 
presents the results of the genome-wide association analyses and the 
statistically associated SNPs with the quantitative retinal traits using the 
aforementioned method. 
Finally, this thesis ends with a discussion (Chapter 8) summarising the key 
findings of this research and discussing the strengths and the limitations of 
this study. Additionally, recommendations for future research are provided at 






Chapter 4 Methods 
In this chapter, I describe the methods of data collection and analyses 
performed in this study. First, I describe the design and follow-up of the 
Edinburgh Type 2 Diabetes Study (ET2DS) on which my own research is 
based. I then summarise the data collection for baseline variables (including 
demographic and cardiovascular risk factor data, genetic data and retinal 
images) and the eight-year follow-up for cardiovascular events. These data 
were collected by current and former ET2DS team members and the 
methods have been published in detail previously (Price et al, 2008). I 
describe the methods that I used to measure quantitative retinal traits by 
means of the stored retinal images taken at baseline. Finally, I describe the 
details of the statistical analyses, which I undertook. While, in the literature, 
the term ‘arterial’ has been used to refer to the arteries found in the retinal 
microcirculation, for the purpose of this thesis, I use the concept ‘arteriolar’ to 
refer to the same. 
 
4.1 Recruitment of the Edinburgh Type 2 Diabetes 
Study population 
The ET2DS is a population-based prospective study of 1066 individuals aged 
between 60 and 75 years at baseline (2006-2007) with an established 
diagnosis of type 2 diabetes, living in the Lothian region in Scotland. Details 
of the study protocol have been published previously (Price et al, 2008). The 
overarching aim of the ET2DS was to investigate the role of risk factors in the 
development of microvascular and macrovascular complications of diabetes, 
including cognitive impairment, diabetic retinopathy, renal impairment, 
ischaemic heart disease, and cerebrovascular disease. The ET2DS dataset 
comprises biochemical, clinical and genetic data from both baseline and 
follow-up phases of the study, including the eight-year follow-up for 




Although epidemiological studies may be carried out cross-sectionally, 
prospective analysis provides a clear and consistent definition of predictors 
and outcomes. These studies can assess multiples exposures and outcomes 
and they provide the ability to control for multiple cofounders (Thiese et al, 
2014). The ET2DS, therefore, constituted an ideal study population for my 
research aimed at investigating the predictive role of retinal vessel traits. 
Potentially eligible participants for the ET2DS were identified from the Lothian 
Diabetes Register (LDR). This is a large automated dataset containing 
clinical data on 20,000 individuals who have been diagnosed in primary or 
secondary care with type 2 diabetes, living in the Lothian region of Scotland. 
The diagnosis of type 2 diabetes was confirmed, based on the WHO criteria 
for type 2 diabetes, using the following criteria: 
• Individuals taking oral anti-hyperglycaemic medication and/or insulin 
• Glycated haemoglobin (HbA1c) measure >6.5% (7.8mmol/l) at baseline 
if the individual was controlled with dietary modification only 
Those individuals with HbA1C below 6.5% (7.8 mmol/l)  and not using 
medication or insulin were reviewed by a consultant diabetologist to confirm 
the diagnosis. Additionally, those individuals using insulin within one year of 
diagnosis of diabetes, those who reported pancreatic disease at the clinic 
and those who were treated with insulin and aged under 35 years at 
diagnosis, were assessed by the consultant diabetologist.  
Exclusion criteria used in the ET2DS included non-English speakers and 
individuals with poor eyesight (defined as corrected visual acuity worse than 
6/36 for distance vision or unable to read large print text), since these are 
pre-requisites for accurate completion of cognitive function tests. Also 
excluded were individuals who were unable to provide signed consent and 
those who were physically unable to complete all assessment elements.  
The aim of the study was to recruit at least 1000 subjects to provide 90% 




correlation coefficient of ≥0.10 between a continuous outcome and a 
continuous predictor variable. The sample size was also calculated for 
detection of any risk factor that contributed 1% or more to the variance in the 
outcome for observed associations, both at baseline and during follow-up 
analysis. 
A flow diagram illustrating recruitment of the ET2DS participants is presented 
below in figure 4.1. 
 
Figure 4.1 ET2DS Recruitment (Adapted from Price et al, 2008) 
 
All ET2DS participants provided written, informed consent prior to recruitment 
into the study and the start of data collection. Ethical approval was granted 





appointments or rescheduling was offered to encourage participation. 
Participants underwent an overnight fast before attending the clinic; then 
blood samples were obtained through venepuncture. In addition, urine 
samples were collected and a 12 lead electrocardiogram was taken. All 
examinations were carried out by trained nurses and qualified technicians 
who were following standard operating protocols and procedures, ensuring 
consistency in the evaluations. In order to obtain body mass index (BMI), 
height in metres (International system units), was measured without shoes 
using a wall-mounted vertical ruler and weight (in kilograms) was measured 
without outdoor clothing using calibrated electronic scales. BMI was defined 
as weight/height2 (kg/m2).  Blood pressure (systolic and diastolic) was 
measured in the right arm (± 2 mmHg), with the participants in the supine 
position with their arm extended and resting using  a standard stethoscope 
and sphygmomanometer cuff (Acceson TM, AC Cossor & Son (Surgical) Ltd, 
Harlow, UK). 
  
4.2.2 Self-completion questionnaire and ISD record linkage 
Participants completed baseline self-completion questionnaires including 
questions on demographic characteristics, diabetes history, cardiovascular 
disease (CVD), smoking, and medications. This included age (date of birth), 
sex, duration of diabetes (date of diagnosis of diabetes), ethnicity and social 
class. Answers to questions on diabetes treatment were used to define three 
groups, (i) diet controlled only, (ii) oral anti-diabetic medication only (this 
included medication such as Metformin, Sulphonylureas and 
Thiazolidinediones), and (iii) insulin (with or without additional oral anti-
diabetic medication). Data on smoking were collected using a standard 
smoking questionnaire, which has been used widely in epidemiological 
studies. Participants were asked whether they currently smoked, and if so, 
how many cigarettes, cigars or tobacco they usually smoked per week. 




were considered to be current smokers for the purposes of this thesis as in 
previous ET2DS analyses (Marioni et al, 2010).  
Data linkage to the Scottish Morbidity Records scheme was performed at 
baseline (and repeated at 8-year follow-up) by the ISD of the National Health 
Service (NHS) Scotland to locate information on medical and surgical 
hospital discharges. Answers to questions on past medical history and 
current medications in the self-completion questionnaire were used in 
combination with this ISD hospital discharge data and with electrocardiogram 
(ECG) findings to identify and confirm diagnoses of cardiovascular disease.   
 
4.2.3 Blood sampling, genotyping and imputation 
Fasting blood samples taken at the research clinic were used to measure 
fasting glucose, total cholesterol, high-density lipoprotein (HDL) cholesterol 
and glycated haemoglobin (HbA1c). Total cholesterol, HDL cholesterol, 
HbA1c and eGFR were all determined using Vitros Fusion Chemistry System 
(Ortho Clinical Diagnostics, Bucks, UK) at the Western General Hospital, 
Edinburgh UK.  
Furthermore, at baseline, blood samples for DNA extraction were taken for 
subsequent genotyping. Genomic DNA was isolated from whole blood 
following standard procedures at the Wellcome Trust Clinical Research 
Facility Genetics Core, Western General Hospital, Edinburgh, UK. 
Genotyping using the Illumina MetaboChip was undertaken at Kbiosciences.  
The Illumina Metabochip is a custom genotyping array. This array provides 
coverage for over 200,000 tag single nucleotide polymorphisms (SNPs) of 
the human genome. The array was designed from SNPs based on genome-
wide association study (GWAS) meta-analyses of 23 cardiometabolic traits. 
SNPs were selected from the catalogues of the HapMap Project and 1000 
Genomes Project, allowing the inclusion of SNPs across a wide range of 




Genotyping procedures and quality control in the ET2DS have been 
described in detail previously (McLachlan et al, 2016, Shah et al, 2013). In 
summary, all samples were assessed for consistency. Quality control 
consisted of exclusion of SNPs or samples with Illumina GenCall score 
<0.15, sample and SNP rates <0.95, Hardy Weinberg Equilibrium p value ≤ 
0.001, replicate discordance, discrepancy in sex, ethnicity and relatedness 
checks or against previous genotype data. No minor allele frequency (MAF) 
cut-off was applied at this stage.  
Data used for this thesis included imputed genotype data. Imputation was 
used to increase the number of genome-wide SNPs. This method has been 
used in many previous studies and is a statistical technique for predicting 
unobserved genotypes in the population studied, based on the correlation of 
observed study haplotypes and guided by the reference haplotypes of the 
same genetic population (Howie et al, 2009). Imputation was carried out by 
Dr. Stela McLachlan (ET2DS data manager) for the purposes of a previous 
genetic analysis. Metabochip variants were imputed using as reference panel 
the 1000 Genomes (Phase 1, CEU haplotype set). Imputation was carried 
out on cleaned genotypes in three phases – chunking, phasing and imputing 
- using MACH1 and Minimac software (McLachlan et al 2016). The final file 
contained ~4.5 million autosomal SNPs (R2 > 0.3, MAF > 0.001). The data 
were collated and stored in the University of Edinburgh secure data servers 
ready for use by the R package snpStats. 
 
4.2.4 Retinal Images 
Retinal images were collected at baseline between 2006 and 2007. People 
recruited into the study at the Wellcome Trust Clinical Research Facility 
research clinic were given a second appointment for an ‘eye’ clinic, held in 
the major ophthalmology department for NHS Lothian. Retinal photographs 
were taken between 9.30 am and 3.00 pm from Monday to Friday and by a 




analysing data from  individuals with poor vision because anatomico-
physiological factors may influence the measurement of retinal vasculature. 
Moreover, cataract develops earlier in people with T2D than in the general 
population. Refractive errors are common findings in people with poor vision 
and these include near sightedness (myopia), farsightedness 
(hypermetropia) or blurry vision (astigmatism).  Lim et al (2011) found that 
myopic refractive errors and longer axial length are associated with narrower 
retinal arterioles and venules, less tortuous arterioles, and increased 
branching coefficients in the vessels.   
During the assessment, digital retinal images were stored electronically. 
Subjects had 1% tropocamide drops instilled into both eyes to allow pupillary 
dilatation before having the image captured. Inspection of the pupils was 
carried out. If dilatation was insufficient, a further 1% tropocamide dose was 
given. Retinal images were taken using a high-resolution digital retinal 
camera (TOPCON TRC-50FX, Topcon Optical Company, Tokyo, Japan). All 
the individuals provided standard 7-field non-stereoscopic retinal colour 
photographs. An example of the 7-field non-stereoscopic retinal colour 
photographs is seen in Figure 4.2. The seven standard photographic fields 
were stored as JPEG or TIFF format files on a laptop attached to the retinal 
camera. Specially trained optometrists working in the Scottish Diabetes 
Retinal Screening programme used these images for grading of diabetic 
retinopathy.  
Evaluation of stages of diabetic retinopathy was performed following ETDRS 
protocols. According to the NICE guidelines, full laser scatter treatment is 
indicated for retinal new vessels (e.g. new vessels in the disc and new 
vessels elsewhere). Importantly, treatment should be considered in people 
with only eye (e.g. first eye lost due to proliferative diabetic retinopathy),  and 
in people with  poor clinical attendance. In the ET2DS,  there were a small 






Images were backed up onto an external drive and subsequently transferred 
to a local server at the University of Edinburgh for long-term backup and 
storage. 
 
Figure 4.2. Screenshot of VAMPIRE software. The vessels are highlighted (red for arteries and blue for veins). On 
the right side, the measurements taken are displayed. With permission from Dr T MacGillivray 
 
4.3 Retinal image analysis  
Whereas the data described previously in this chapter were collected by 
other members of the ET2DS team, I conducted all the analyses of retinal 
images described here, to collect data on retinal vessels traits. I obtained the 
retinal images from the server where they were stored and I chose the 
central field image to perform the analysis.  
Retinal images for analyses were taken from the central field. This central 
image has two important eye structures, the optic disc and the fovea (Figure 




blood vessels that supply the retina and also is the exit point for the ganglion 
cell axons leaving the eye. This is small blind spot in each eye. The latter, 
fovea centralis, is located in the centre of the macula lutea, a small flat spot 
located exactly in the centre of the posterior portion of the retina. Fovea is 
responsible for high-acuity vision and is densely saturated with cone 
photoreceptors. Blood supply is not provided by central retinal arteries or any 
of its branches, instead is supplied by choroid.  
 
Figure 4.3. Retinal diagrams showing 7-field definition in right eye. Field 1 (Left) is centred on the optic disc, field 2 
on the macular. Field 3 is temporal to the macula. Fields 4 to 7 are tangential to horizontal lines passing through the 
upper and lower poles of the disc and to a vertical line passing through its centre Taken from Diabetic retinopathy 
grading protocol for ET2DS, 2007). 
 
Initially, I only analysed one image (mainly the right eye) of the field 1 (figure 
4.3)  from each subject using the semi-automated (VAMPIRE) software 
described below, if the quality was good enough to run the analysis with the 
software (e.g. no blurry image). After completing the analyses, if the image 
had good quality but the software proved unable to determine the required 
traits successfully, the image from the opposite eye was analysed. This was 
carried out to achieve the highest number of analysed images possible.  All 




myself. This was carried out to ensure that vessels (e.g. arterioles and 
venules) were correctly selected by the semi-automated software. 
Correlations of the measurements made from the right eye versus the left 
eye, together with results of an inter and intra-observer reliability study (both 
performed on small subgroups of the total study population), are described 
below. Importantly, qualitative findings used for grading diabetic retinopathy 
should be careful interpreted as the presence of abnormalities  (e.g. 
microaneurysms) in one eye may not represent systemic diseases and these 
traits may not be  present in the opposite eye. As stated above, the diabetic 
retinopathy grading was performed according to protocols in the ET2DS. 
4.3.1 Correlations of retinal images 
In the early stages of retinal image analysis, an exploration of the correlation 
of the quantitative retinal traits between the right and left eyes was 
undertaken. A randomly selected subgroup of 50 individuals with images 
from both the right and left eyes was analysed. This was carried out to inform 
my decision on which eye to use for measurement of the retinal traits.   
Results are shown in the table 4.2 For AVR, there was a moderate 
correlation of 0.47 between right and left eye. The correlations for CRAE and 
CRVE were both 0.42. Correlations for arteriolar tortuosity were slightly 
higher (0.53 for minimum arteriolar tortuosity and 0.48 for maximum arteriolar 
tortuosity), with the highest correlation seen for mean arteriolar tortuosity 
(0.64).  Correlations for venular tortuosity traits were generally lower (mean 
venular tortuosity was moderately correlated 0.43), with lowest values for 
minimum venular tortuosity (0.10) and maximum venular tortuosity (0.21). 
Multifractal dimensions D0, D1 and D2 were moderately correlated showing a 








as the area analysed with the software is dependent on the area of the retina 
photographed by the camera (this area is different in each eye).  
As previously decsribed, one image was ultimately selected to be included in 
the analysis, rather than selecting either both eyes or always the right or left 
eye. This was done because it was not feasible to measure the traits in both 
eyes within a realistic timeframe for my PhD and since a majority of other 
large longitudinal studies have also adopted this approach. This also means 
that higher quality measurements (from higher quality images) could be 
expected on average. 
Analyses using intra-class correlation coefficients were carried out to assess 
the reliability and repeatability of all retinal quantitative traits within the same 
grader (myself) at two different time points and between different graders 
(myself and one other grader). A randomly selected subgroup of 50 
individuals was selected for these analyses.  The analyses were necessary 
to determine the reliability of the measurements, as the software (VAMPIRE) 
used is a semi-automated software and human input accounts for a 
significant part of the measurement process. Analyses were carried out to 
determine inter-grader and intra-grader reliability (correlation of the 
quantitative retinal traits results with one operator and correlation of the 
results between two different operators using the same VAMPIRE 3.1 
software).  
The purpose of intra-class correlation is to determine the proportion of 
variation in the measurements that affects a particular group. The technique 
is performed firstly by carrying out two-ways analysis of the variance and 
then, the results of the mean sum squares (between graders) are compared. 
If there is no significant difference in the residual error, then concordance is 
achieved.  
Previous cross-sectional and longitudinal studies have reported from 
moderate to strong reliability of the quantitative retinal traits. In my study, 






4.3.2 Software to analyse retinal images (VAMPIRE 3.1)  
VAMPIRE (version 3.1) is a software developed by a consortium from the 
Universities of Edinburgh and Dundee, UK. It is a semi-automated software 
which quantifies retinal blood vessel parameters, and was used in this study, 
to measure the retinal vessel traits used in my analyses – vessel widths 
(arteriovenous ratio (AVR)), central retinal arteriolar equivalent (CRAE), 
central retinal venous equivalent (CRVE), arteriolar tortuosity (mean, 
minimum and maximum of several readings in a single subject), venular 
tortuosity (mean, minimum and maximum) and multifractal dimensions (three 
traits D0, D1 and D2 depending on the precise retinal area from which 
readings are taken).  
Analyses of the images is a computationally demanding task. Initially, the 
software was installed, and the images were analysed, on a Windows 
desktop PC (Intel M5, 1.3 GHz, 6 Gb RAM). However, analysis of the images 
took more time than expected as the average pre-processing time 
(visualisation and selection of the vessels for each image) was around 12 to 
15 minutes. Therefore, the software was subsequently installed on a 
MacBook (Intel Core i7, with 4 cores, 2.2GHz, 16Gb RAM). Processing 
images with this processor proved much faster and the analysis was 
completed using this computer. 
The correct procedure for operating the software has been described in detail 
previously (MacGillivray et al, 2015). First, the boundaries of the optic disc 
(OD) in a retinal image were detected and a conventional OD-centred circular 
measurement zone was established (see figure 5.3 for the zones detected 
and labelled in VAMPIRE software). Second, the software attempted to 
detect the retinal blood vessels present in the image and locate bifurcations. 
If the software was able to detect the vasculature within the measurement 
zone the image was classified as processable; otherwise it was classified as 




to identify, visually, the six thickest arteries and the six thickest venules in the 
measurement zone.  
The software then calculated the mean of the arteriolar and venular 
diameters (CRAE and CRVE, respectively) and the median for each set of 
arteriolar and venular tortuosity measurements in order to summarise 
arteriolar and venular parameters for each image. Successful completion of 
the measurement protocol categorised the image as analysable, i.e. there 
was sufficient detection of retinal vessels in the image to enable the 
measurement of the target parameters; otherwise the image was recorded as 
non-analysable (MacGillivray et al, 2015). 
 
4.3.3 Vessel widths (CRAE and CRVE) and arteriovenous 
ratio (AVR) 
To measure vessel widths, vessels were selected from zone B in an area 0.5 
and 1 disc diameters from the optic disc (see figure 4.3). Measurements of 
the widths of the six largest arteries and the six largest venules that crossed 








4.3.4 Vessel tortuosity 
Tortuosity was calculated by the software using the six widest arteries and 
venules crossing zone C (see figure 4.3). VAMPIRE implements a tortuosity 
measure integrating axis curvature, length and thickness of the vessel for 
both the arteriolar and venular tortuosity. The outcome of these 
measurements included the median of vessels tortuosity, the median of the 
minimum values of vessels tortuosity and the median of the maximum 
vessels tortuosity. A summary of the algorithm has been described 
elsewhere (Patton et al, 2006; Azegrouz et al, 2006). 
 
4.3.5 Multifractal dimension 
Multifractal dimension is a novel retinal biomarker, which is characterised by 
complex, repeated geometrical patterns at different spatial scales. Multifractal 
dimensions measure the degree of branching complexity of the vascular tree 
(including arteries and venules) in two dimensions. An example of the 
visualisation of multifractal dimension is showed in figure 4.5. The 
measurement of multifractal dimensions was performed by using the 
generalised sand-box method. This method measures a random set of pixels 
and counts the vessel pixels in square regions centred at the selected pixels 
with an increasing linear dimension (Patton et al, 2006; Stošić et al, 2006).  
 
Figure 4.5 Visual representation of multifractal dimensions using VAMPIRE software. This represent the entire 





4.3.6 Manual input for the semi-automated VAMPIRE 3.1 
software 
After the processing of the images, manual input is required to double-check 
that the arteries and venules have been correctly selected by the software. 
This process requires visualisation of the fundus images to differentiate 
between arteries and veins by taking into account several features. In 
general, arteries appear brighter and thinner than venules. Importantly, the 
central reflex is usually wider in arteries and conversely, smaller in venules. 
Nevertheless, there are other factors, which can influence the appearance of 
the retinal vessels. For instance, patient ethnicity, age, lesions and images 
quality. These factors were considered in the selection of the vessels. 
 
4.4 Identification of cardiovascular events  
To meet one of the primary aims of this thesis, I planned to associate retinal 
vessel traits measured on baseline retinal images with cardiovascular events 
occurring during follow-up. The current section describes the data collection 
and event definitions for both prevalent and incident cardiovascular events in 
the ET2DS. 
 
4.4.1 Prevalent events 
Several sources were used to identify prevalent cardiovascular events at 
baseline. This included  participants’ self-reported medical diagnoses and or 
treatment (medical and/or surgical) for angina, myocardial infarction, stroke 
and peripheral arterial disease, as well as the WHO chest pain questionnaire, 
a 12-lead electrocardiogram coded using the Minnesota coding system and 
data linkage to hospital discharge data from ISD. Additionally, when 
necessary, clinical notes from general practices and hospitals were obtained 
to confirm or refute a possible cardiovascular event. The specific criteria used 




4.4.2 Incident events 
Incident and recurrent cardiovascular events were recorded at the four-year 
follow-up phase of the ET2DS and again after eight years. At year four, 
events were identified using self-reported questionnaires completed in the 
research clinic, questionnaires from general practitioners, ECGs and record 
linkage from ISD (Morling et al, 2015). If necessary, clinical notes from the 
hospital were searched to confirm clinical information. Also, senior clinicians 
and researchers were contacted to discuss cases with uncertain diagnoses 
or with unclear clinical information. After eight years from baseline, repeat 
record linkage at ISD was undertaken to identify further cardiovascular 
events. The specific criteria used to define an incident cardiovascular event 
during the total eight years of follow-up are given in Appendix 6. 
 
 
4.5 Data processing and analysis 
 
4.5.1 Data entry and cleaning for ET2DS master database 
ET2DS data from baseline, year four and year eight follow-up were coded 
and transcribed into a master database (Microsoft Access 2003/2010; 
Microsoft Corporation, Washington USA). When data entry was carried out, 
double data entry was undertaken by members of the ET2DS team for quality 
control purposes. All data were double entered at baseline. At year four, a 
10% random sample of data was double entered - error rates were found to 
be very low and no systematic sources of error were identified, so no further 
double data entry was undertaken. All input errors were checked against the 
original data source and changed to the correct value. Further quality 
assessment using descriptive analysis of the data was carried out after 
completing data entry to inspect for missing values and outliers. Those 
values, which were extremely high or low and could not be explained were 




high or low true values. Missing data was also scrutinised, and, wherever 
possible, data were retrieved from alternative sources (for example from the 
Lothian Diabetes Register rather than the original research clinic) to ensure a 
minimum amount of missing data in the master ET2DS dataset.  
All the variables in this thesis apart from the retinal variables came from this 
master database file, and were provided to me by Dr. McLachlan, the ET2DS 
data manager.  All individuals in the ET2DS are assigned a study ID number 
(a unique five-digit number) and these were used to match the retinal image 
data with all the other variables used in this thesis. 
 
4.5.2 Data analysis 
I developed a statistical analysis plan in discussion with my supervisors and 
experts in relevant analysis techniques. I carried out the statistical analysis 
using SPSS v21 (StataCorp, College Station, TX, USA) and R, a free widely 
available software (R: A language and environment for statistical computing, 
Vienna Austria). For the non-genetic analyses, a p value of less than 0.05 
was taken as statistically significant, as is standard in most scientific and 
epidemiological studies. All variables were examined for outliers/extreme 
values and missing values prior to undertaking any statistical analyses.  
All the continuous variables used in this thesis were assessed visually for 
normality using histograms. Those variables that were not normally 
distributed included duration of diabetes, mean arteriolar tortuosity, minimum 
arteriolar tortuosity, maximum arteriolar tortuosity, mean venular tortuosity, 
minimum venular tortuosity and multifractal dimensions D0, D1 and D2. 
Logarithmic natural transformation was used to normalise the distribution of 
diabetes duration, mean arteriolar tortuosity, minimum arteriolar tortuosity, 
maximum arteriolar tortuosity, mean venular tortuosity, minimum venular 
tortuosity and maximum venular tortuosity. Rank transformation was used to 
normalise the distribution of multifractal dimensions. Histograms after 




been achieved. For normally distributed variables, means and standard 
deviations (SD) were quoted and for skewed variables, medians and 
interquartile ranges (IQR) were described.  
 
4.5.3 Bivariate statistical analysis  
Unadjusted associations between two continuous variables were analysed 
using Pearson correlation coefficients if the general assumptions were 
achieved (normal distribution, no significant outliers). The r value and the p 
value were reported to determine the direction, strength and statistical 
significance of the relationship. Adjusted Pearson correlation (partial 
correlation) was used to analyse the association between two continuous 
variables adjusted for categorical variables (e.g. sex and age). The 
corresponding r partial association and p values were reported. For 
categorical variables, unadjusted and age-sex adjusted associations with 
continuous variables were assessed using ANOVA (mean values and p 
values were reported). Chi squared tests were used to explore relationships 
between two categorical variables (chi square and p-value reported). The 
Mann-Whitney U Test or Kruskal-Wallis test was applied to assess the 
differences in median levels of non-normally distributed quantitative retinal 
traits and incident cardiovascular events. 
 
4.5.4 Prospective statistical analysis (association of 
quantitative retinal traits with incident cardiovascular 
events) 
Cox regression analyses were used to examine the association of the retinal 
traits with incident cardiovascular events. Variables were selected as 
possible cofounders to build different models and assess the strength and 
independence of the association of the quantitative retinal traits with 
incidental cardiovascular outcomes. Co-variables were selected according to 




factors described previously in the literature. In people with diabetes, the 
traditional risk factors associated with cardiovascular disease include 
hyperglycaemia, duration of diabetes, high levels of HbA1c, high levels of total 
cholesterol and lower levels of high-density cholesterol. These variables are 
also included in the UKPDS risk score and were selected as co-variates for 
my models because they specifically take into account diabetes status. 
Analyses were fitted in five different models for all the quantitative retinal 
data, presented below: 
(i) Model 1: Unadjusted model. 
(ii) Model 2: Adjusted for sex and age. 
(iii) Model 3: Adjusted for sex, age, duration of diabetes, HbA1c, total 
cholesterol, systolic blood pressure, and smoking. 
(iv) Model 4: Adjusted for sex, age, duration of diabetes, HbA1c, total 
cholesterol, systolic blood pressure, smoking and eGFR. 
(v) Model 5: Adjusted for sex, age, duration of diabetes, HbA1c, total 
cholesterol, systolic blood pressure, smoking, eGFR and prevalent 
cardiovascular disease. 
The association between baseline events and future cardiovascular events 
was assessed using Cox Hazard regression. Hazard ratios with their 
respective 95% confidence intervals and the statistical significance 
represented by p-values were reported. Time to event was calculated from 
the baseline until the eight-year follow-up according to the number of weeks 
during this period of time. All variables used met the proportional hazards 
assumptions for each outcome event. This type of analysis is richer than 
cross-sectional analyses and helps elucidate the prospective association of 
the predictor variable with the outcome. After completing the analyses of the 
Cox Regression models, assessment of any improvement on addition of the 




determining the area under the curve (AUC). For each model, predicted 
individual risk (X Beta) was calculated and plotted. 
Finally, little work has been done for multiple testing is descriptive statistics. 
Examples of multiple comparisons tests include the Bonferroni correction and 
false discovery rate . Bonferroni correction is the most popular family wise 
error rate control: for fixed level α of probability of type I error, it consists in 
doing m hypothesis tests controlling the significance level per test at α*=α/m. 
This approach is extremely conservative whenever the number of tests is 
large (Catelan et al, 2010). Those approachs should be considered as 
complementary procedures to point estimates and confidence intervals in 
data analysis and genomics data analysis. 
 
4.5.5 Genetic analysis (association of retinal traits with 
genetic variants) 
The associations between genotyped and imputed SNPs and retinal traits 
were tested by linear regression using an additive genetic model. Further 
adjustment was made for age and sex. Analyses for all retinal traits were 
carried out using R package snpStats. Imputed data were analysed with 
SNPstats. SNPstats carries out the association analysis by using a linear 
regression model with a quantitative phenotype. This software performs the 
regression analysis in a fast and memory efficient way as it deals with 
millions of SNPs. SNPstats provides a set of results for the analysis, 
including descriptive statistics such as (for quantitative phenotypes), the 
absolute frequencies, means, standard errors, mean differences with respect 
to the reference category and 95% CI of the differences. For each SNP, it 
describes the allele and genotype frequencies and Hardy–Weinberg 
equilibrium is calculated.  
For all retinal traits, genomic-control inflation factors (λGC) were calculated 
and used to correct test statistics for each retinal trait. Genome-wide 




suggestive significance threshold was set at p-value < 5×10−6. Also, the 
SNPs with MAF frequency <0.005 were filtered out. 
After these analyses, taking into account the sample simple, the SNPs 
reaching the suggestive significance threshold were analysed further. Given 
the high number of the variants surpassing this suggestive threshold, I 
decided to filter out variants using a cut off of MAF ≥ 0.05 and p-value 
<1×10−6. This was used as the SNPs with low MAF are rare, hence, power 
may be lacking for detecting SNP-phenotype associations and these SNPs 
are also more prone to genotyping errors (Marees et al, 2018). The MAF also 
depends strongly on the sample size and for this reason; it was decided to 
have a MAF greater or equal to 0.05. The SNPs showed in the results 
chapter followed this stringent approach. 
I performed a locus analysis using Locus Zoom for the suggestive locus. 
Locus Zoom is an internet-based tool where loci can be plotted and 
visualised to assess relevant independence with other nearby SNPs. The 
locus zoom was defined as all SNPs below the threshold with SNPs located 
less than 500 Kb apart. Locus Zoom (Pruim et al, 2010) was used to display 
results, using 1000 Genomes Phase 1 CEU haplotype set for linkage 
disequilibrium (LD) calculation. The positions of SNPs are given based on 
human genome build 19. 
 
4.5.6 Analysis of linkage disequilibrium  
Linkage disequilibrium (LD) is a term used in population genetics to 
determine the non-random association of alleles at two or more loci (SNPs). 
The term was firstly used by Lewontin and Kojima in 1960 (Lewontin and 
Kojima, 1960). The concept of LD is useful to determine gene mapping, to 
understand past evolutionary and demographic events and the joint evolution 
of linked sets of genes. The LD was calculated with the purpose of 
determining the independence of the SNPs, which showed association with 




of LD and related quantities are descriptive statistics. Their magnitude does 
not indicate whether or not there is a statistically significant association 
among the loci (SNPs) in the haplotypes. For the purposes of this thesis, the 
correlation coefficient, r squared results are presented to test the 




















Chapter 5 Results I: Descriptive analysis  
In this chapter, I describe the baseline characteristics and representativeness 
of the ET2DS study population. I also describe the incident cardiovascular 
events which occurred during follow-up are also described and present the 
descriptive statistics for the quantitative retinal traits. Lastly, I present an 
assessment of missing data. 
 
5.1 Baseline demographics characteristics 
The baseline demographic characteristics of the ET2DS population are 
summarised in table 5.1. The baseline cohort included 1066 individuals 
recruited from the Lothian region of Scotland, UK. A total of 547 (51.31%) 
participants were male and the mean age was 67.9 years. Baseline numbers 
(prevalence) of participants with prior myocardial infarction (MI), angina, 
stroke, transient ischaemic attack (TIA), and coronary intervention were 150 
(14.1%), 298 (28.0%), 62 (5.8%), 31 (2.9%) and 110 (10.3%), respectively. 
The prevalence of diabetic retinopathy at baseline was 31.8%; mild non-
proliferative diabetic retinopathy (n=292, 27.4%), moderate non-proliferative 
diabetic retinopathy (n=21, 2%), severe non-proliferative diabetic retinopathy 
(n=11, 1%) and proliferative diabetic retinopathy (n=15, 1.4%). A summary of 














5.4 Descriptive statistics for quantitative retinal traits 
Descriptive statistics for the baseline quantitative retinal traits are presented 
in table 5.6. The values for the median, minimal and maximal arteriolar and 
venular tortuosity were right skewed. These values were converted by 
logarithmic transformation (natural logarithm) for use in subsequent statistical 
analysis. The distributions for multifractal dimensions D0, multifractal 
dimensions D1 and multifractal dimensions D2 were left skewed. Both 
logarithmic transformation (commonly used because it is a strong 
transformation with a major effect on distribution shape) and square 
transformation (often applied to left skewness) were attempted, and although 
square transformation had a moderate effect on the distribution, left 
skewness remained and a rank transformation was finally used to normalise 
these traits (table 5.7). A summary of the normal distribution of the 




















Figure 5.1. Graphs of the distr bution of the quantitative retinal traits, either untransformed, or following 
transformation where data initially skewed. Arteriovenous ratio, AVR; central retinal arteriolar equivalent, CRAE; 
central retinal venular equivalent, CRVE; Arteriolar tortuosity, Log_A; Minimum arteriolar tortuosity, Log_A_min; 








Figure 5.1 (cont.) Graphs of the distr bution of the quantitative retinal traits. Venular tortuosity, Log_V; Minimum 
venular tortuosity, Log_V_min; Maximum venular tortuosity Log_V_max; Multifractal dimensions D0, 
rank_tranforsformed_completed_amended_D0; Multifractal dimensions D1, 





5.5 Inter-relationship between quantitative retinal 
traits   
This section describes the association between all the quantitative retinal 
traits (table 5.8).  
Arteriovenous ratio (AVR) was highly and inversely correlated with arteriolar 
tortuosity (r = -0.081, p < 0.001) and minimum arteriolar tortuosity (r = -0.088, 
p < 0.001). Central retinal arteriolar equivalent (CRAE) was highly correlated 
with central retinal venous equivalent (CRVE) (r = 0.58, p < 0.001) and 
multifractal dimensions D0, D1 and D2 (all r = 0.42, p < 0.001). Similarly, 
CRVE was highly correlated with multifractal dimension traits (all r = 0.48, p < 
0.001). As expected, log transformed arteriolar tortuosity was highly 
correlated with log transformed minimum arteriolar tortuosity (r = 0.68, p < 
0.001) and log transformed maximum arteriolar tortuosity (r = 0.75, p < 
0.001). Although log transformed arteriolar tortuosity was inversely correlated 
with CRAE (r = -0.13, p < 0.001) and multifractal dimension traits (all r = -
0.11, p < 0.001), these correlations were weaker. Log transformed minimum 
arteriolar tortuosity was highly correlated with log transformed arteriolar 
tortuosity and log transformed maximum arteriolar tortuosity (r = 0.67, p < 
0.001 and r = 0.51, p < 0.001 respectively). Log transformed minimum 
arteriolar tortuosity was inversely correlated with CRAE (r = -0.15, p < 0.001) 
and multifractal dimension traits (all r = -0.11, p < 0.001). Log transformed 
maximum arteriolar tortuosity was highly correlated with log transformed 
arteriolar tortuosity (0.75, p < 0.001). There were inverse correlations 
between log transformed maximum arteriolar tortuosity and both CRAE (r = -
0.11, p < 0.001) and multifractal dimension traits (all r = -0.12, p < 0.001). 
Log transformed venular tortuosity was correlated with log transformed 
minimum venular tortuosity and log transformed maximum venular tortuosity 
(r = 0.59, p < 0.001 and r = 0.68, p < 0.001 respectively). As for other 
tortuosity traits, log transformed venular tortuosity was negatively correlated 
with multifractal dimension traits (all r = -0.15, p < 0.001).  Not surprisingly, 




transformed venular tortuosity (r = 0.59, p < 0.001) and log transformed 
maximum venular tortuosity (r = 0.40, p < 0.001) and there was an inverse 
correlation with multifractal dimension traits (all r = -0.11, p < 0.001). 
Multifractal dimension traits were highly inter-correlated (r = 0.99, p < 0.001).  
The other strongest correlations for these traits were with CRAE (r = 0.42, p 
< 0.001) and CRVE (r = 0.48, p <0.001). The remaining retinal traits were 
negatively correlated with multifractal dimensions and only AVR did not show 






retinal data could not be extracted from the initially selected image, the image 
from the opposite eye was selected; but adequate quality could not be 
assured. Therefore, an important cause of missing data in the quantitative 
retinal traits was the original quality of the images taken at baseline in the 
ET2DS.  
In total, data were available from 1028 images for measurement of 
quantitative retinal traits including AVR, CRAE, CRVE, arteriolar tortuosity, 
minimum arteriolar tortuosity, maximum arteriolar tortuosity, venular 
tortuosity, minimum venular tortuosity and maximum venular tortuosity. Due 
to technical issues, data from 13 of the 1028 images were unavailable for 
multifractal dimensions D0, multifractal dimensions D1 and multifractal 
dimensions D2.  
A summary of the missing data for each of the individual quantitative retinal 
traits is presented in table 5.10. Overall, the loss of retinal data due to 
missing data was less than 5% for the traits used in this thesis. This suggests 
a small risk of bias due to missing data affecting association estimates or 






Figure 5.2. Flow diagram for missing retinal images and retinal trait data in the ET2DS. The total number of 
individuals in the retinal ET2DS dataset at baseline included 1066 individuals.  A total of 22 ET2DS subjects had no 







Chapter 6 Results II - Cross sectional and 
prospective association between 
quantitative retinal traits and 
cardiovascular disease  
 
In this chapter, I present the results of the cross-sectional and prospective analyses 
of the association of quantitative retinal traits with cardiovascular events and diabetic 
retinopathy. First, I describe the associations of retinal traits with cardiovascular 
events, retinopathy and traditional cardiovascular risk factors at baseline (including 
risk factors used in the UKPDS risk score), and, then  present the association of 
baseline quantitative retinal traits with incident major cardiovascular events occurring 
during follow up. 
 
6.1 Association of quantitative retinal traits with traditional 
cardiovascular risk factors, cardiovascular events and 
diabetic retinopathy at baseline 
The unadjusted and adjusted (for age and sex) Pearson correlation coefficients for 
associations of quantitative retinal traits with continuous cardiovascular risk factors, 
together with ANOVA parameter estimate coefficients for associations with 
categorical risk factors, cardiovascular events and diabetic retinopathy at baseline, 
are shown in tables 6.1 to 6.6. The ANOVA statistic quoted quantifies the difference 
in the mean value of the variable between the test group and the reference category.  
First, I present the results on vessel diameter and the arteriovenous ratio, followed 







6.1.1 Association of vessel diameters and arteriovenous ratio with 
traditional cardiovascular risk factors, prevalent 
cardiovascular events and diabetic retinopathy  
In cross-sectional analyses of baseline data, a number of demographic factors, 
cardiovascular risk factors and disease variables were significantly associated with 
the quantitative retinal traits reflecting vessel widths; central retinal arteriolar 
equivalent (CRAE), central retinal venular equivalent (CRVE) and the arteriovenous 
ratio (AVR) (table 6.1).  Increasing age was associated with a lower CRVE (r=-0.076, 
p =0.01) and a correspondingly higher AVR (r=0.068, p=0.02). Men had significantly 
lower mean AVR (ANOVA 0.01, p=0.04), CRAE (ANOVA 1.05, p<0.0001) and CRVE 
(ANOVA 0.73, p=0.02) than women.  
In terms of associations with cardiovascular risk factors, CRVE was positively 
associated with BMI (r= 0.080, p=0.01), although this association was not statistically 
significant after adjustment for age and sex. Participants using tablets for diabetes 
treatment had a higher AVR compared with those who were diet controlled (ANOVA 
0.01, p=0.03), and higher AVR was also associated with lower total cholesterol (r=-
0.099, p=0.002). Both associations remained statistically significant after age and 
sex adjustment, whereas an association between higher AVR and lower diastolic 
blood pressure (r=-0.069, p=0.02) was not significant in the adjusted model. CRAE 
(r=-0.07, p<0.05) and CRVE (r=-0.07, p<0.05) were both negatively associated with 
plasma glucose (r=-0.068, p =0.03 and r=-0.063, p=0.04 respectively) in both 
unadjusted and adjusted models.  
There were few statistically significant associations between retinal traits and either 
cardiovascular events or diabetic retinopathy. After adjustment for age and sex, 
individuals with prevalent cardiovascular disease (e.g. one or more of MI, angina, 
stroke and TIA) were found to have significantly higher CRAE than those without 
prevalent cardiovascular disease (ANOVA 0.43, p=0.01), and a similar result was 
found for  individuals who had angina alone versus those without angina (ANOVA 
0.60, p=0.02).  Individuals with prevalent diabetic retinopathy had higher CRVE than 






6.1.2  Association of arteriolar and venular tortuosity with 
traditional cardiovascular risk factors, prevalent 
cardiovascular events and diabetic retinopathy 
Associations of arteriolar and venular tortuosity with traditional cardiovascular risk 
factors, prevalent cardiovascular events and diabetic retinopathy are shown in tables 
6.3 to 6.6. All analyses were cross-sectional and the models used were unadjusted 
(tables 6.3 and 6.5) or adjusted for sex and age (tables 6.4 and 6.6). Values for 
arteriolar and venular tortuosity were normalised using logarithmic transformation. 
Logarithmic transformations follow the same direction as the original values and 
hence these ease the interpretation of the results.  
 
6.1.2.1 Association of arteriolar tortuosity with traditional cardiovascular risk 
factors, prevalent cardiovascular events and diabetic retinopathy 
Increasing age was associated with lower mean arteriolar tortuosity (r=-0.072, 
p=0.02) and men had significantly higher mean arteriolar tortuosity than women 
(ANOVA 0.013, p=0.0002).  
There were very few statistically significant associations between any of the 
measures of arteriolar tortuosity and either the cardiovascular risk factor or disease 
variables, although raised diastolic blood pressure was associated with higher mean 
arteriolar tortuosity (r=0.090, p=0.004). This association remained significant after 
adjusting for sex and age (r=0.063, p=0.04). Total cholesterol showed a positive 
association with maximum arteriolar tortuosity) in both the unadjusted (r=0.062, p 
=0.04) and adjusted models (r=0.070, p=0.03). No further significant associations 
were found between arteriolar tortuosity and either prevalent cardiovascular events 
or diabetic retinopathy.  
 
6.1.2.2 Association of venular tortuosity with traditional cardiovascular risk 
factors, prevalent cardiovascular events and diabetic retinopathy. 
Results of association with venular tortuosity are presented in table 6.5 (unadjusted) 
and table 6.6 (adjusted for age and sex). A number of statistically significant 
associations were found between mean venular tortuosity and cardiovascular risk 
factors.  Body mass index was positively associated with mean venular tortuosity 




associations remained significant in the adjusted model for both venular traits 
(r=0.115, p=0.0002 and r=0.086, p=0.006). Systolic blood pressure was also 
significant associated with mean venular tortuosity (r=0.081, p=0.009) in the 
unadjusted model and this statistical significance persisted after adjustment for age 
and sex (r=0.083, p=0.008). Although duration of diabetes did not show a statistically 
significant association with venular tortuosity traits, it is important to notice that it 
followed a consistent negative trend with all venular tortuosity traits.  
Individuals with prevalent cardiovascular disease had higher mean venular tortuosity 
than those without prevalent cardiovascular disease (ANOVA p-value) in both the 
unadjusted and adjusted models (ANOVA 0.15, p=0.01 and p=0.02 respectively). In 
the sub classification of these prevalent events, individuals with stroke had higher 
mean venular tortuosity than those without stroke (ANOVA 0.30, p=0.01 and p=0.03 
for unadjusted and age/sex adjusted models respectively). No further statistically 
significant associations were found between other venular tortuosity traits and any of 








6.1.3 Association of multifractal dimensions with traditional 
cardiovascular risk factors, prevalent cardiovascular events 
and diabetic retinopathy  
Results of the association of multifractal dimensions D0, D1 and D2 with 
cardiovascular risk factors and with disease variables are presented in table 6.7 and 
table 6.8. All multifractal dimensions traits were left-skewed and distributions were 
normalised using rank transformation prior to analysis.  There were high levels of 
correlation between the multifractal-dimensions traits D0, D1, D2 (described above), 
such that the results presented in this section proved very similar or identical across 
these traits.  
Overall, analyses did not show statistically significant associations for multifractal-
dimensions with risk factor or disease variables, in either the unadjusted or adjusted 
models. Despite this, it is important to highlight the direction of the correlations. This 
is because multifractal dimension is a novel biomarker, which is poorly understood. 
Thus, there was a trend for multifractal-dimensions D0, D1 and D2 to be negatively 
correlated with age, systolic blood pressure, plasma glucose, total cholesterol and 











6.2 Prospective analysis of quantitative retinal traits with 
incident cardiovascular events   
In this section, I present the results of the longitudinal analyses of the relationship 
between quantitative retinal traits and incident cardiovascular events. I describe the 
incident event rates as well as the traditional cardiovascular risk factor profile of 
those who presented with an incident event. I then present the results of survival 
analyses exploring the relationship between quantitative retinal traits and incident 
cardiovascular events.  
 
6.2.1 Incident cardiovascular events in the ET2DS 
During the eight-year period of follow-up in the ET2DS, there were 200 incident 
cardiovascular events in a total of 1028 individuals with quantitative retinal trait 
measurements (event rate 19.5%). An incident cardiovascular event was defined as 
the first fatal or non-fatal myocardial infarction (MI), diagnosis of angina, fatal or non-
fatal stroke, transient ischaemic attack (TIA), coronary intervention or other fatal 
ischaemic heart disease (IHD) event experienced by a participant after baseline. 
These incident events were used to explore the prospective relationship of baseline 
variables with incident cardiovascular disease (all cardiovascular events), incident 
coronary disease (fatal and non-fatal) and cerebrovascular disease (fatal and non-
fatal ischaemic or haemorrhagic stroke), before and after adjustment for sex and age 
and traditional cardiovascular risk factors.  
In the initial part of my analysis, I focused on the combined outcome of ‘all 
cardiovascular events’ because the number of individuals with incident events in the 
subcategories was relatively small and so event-specific analyses lacked power.  In 
the second part, associations which proved to be statistically significant were 
explored further by breaking the analyses down by component cardiovascular 






6.2.2 Demographics, cardiovascular risk factors, diabetic 
retinopathy and incident cardiovascular events 
Demographic variables and traditional cardiovascular risk factors were compared in 
those individuals with quantitative retinal traits measured (n = 1028) who had an 
incident cardiovascular event and those who did not (Table 6.9).  
Individuals who had an incident event were older (p<0.01) and were more likely to be 
male (p<0.001). Individuals with an incident cardiovascular event had a poorer 
metabolic profile than those with no event, with a significantly longer median duration 
of diabetes (p<0.01), significant higher HbA1c (p<0.01) and higher percentage of 
individuals using insulin  hypoglycaemics (p<0.0001). When traditional 
cardiovascular risk factors were compared between the groups, there was no 
statistically significant difference in either systolic or diastolic blood pressure, but it is 
important to highlight that there were more individuals using antihypertensive 
medication in participants who presented with an incident event (p<0.05) which could 
explain why blood pressure did not differ. There were no statistically significant 
differences in plasma glucose or total cholesterol between the two groups, however, 
HDL cholesterol was significantly lower in subjects with incident events (p<0.001). 
There was also a higher percentage of individuals using lipid-lowering medication in 
the group that did not have an incident event but this result did not reach statistical 
significance. In terms of renal function, estimated glomerular filtration rate was 
significantly lower in those who experienced an incident event (p<0.0001).  There 
was no significant difference in the percentage of current, ex or never smokers 
between the groups and BMI was also found not to be significantly different. 
The relationship of prevalent cardiovascular events and diabetic retinopathy with 
incident cardiovascular event was also analysed. Those individuals who had incident 
events were more likely to have experienced a previous cardiovascular event (p < 
0.0001). There was a significantly higher percentage of individuals without diabetic 
retinopathy in the group that did not go on to have a cardiovascular event 
(p<0.0001). In general, those individuals with presence of diabetic retinopathy at any 
grade were more likely to experience incident events. For instance, those individuals 
with mild non-proliferative diabetic retinopathy were more likely to have an incident 





6.2.3 Quantitative retinal traits and incident cardiovascular events 
To examine the association of the quantitative retinal traits with incident events, 
unadjusted analyses were first undertaken and mean or median values of traits in 
those individuals experiencing an incident event and those not having an event were 
compared.   
Tortuosity and multifractal dimensions traits which were not normally distributed were 
first analysed using non-parametric tests (e.g. Kruskal-Wallis). Subsequently, all 
quantitative retinal traits were analysed using parametric tests such as t-test 
following normalisation of skewed distributions where required. Assumptions for 
using this test include normal distribution of the data and adequacy of sample size.  
Table 6.10 compares the median values of the quantitative retinal traits with non-
normal distributions (all tortuosity measurements and the multifractal dimensions 
measurements) between the event and no event groups. In this analysis, there were 
no statistically significant differences between the two groups. In general, individuals 
who experienced an incident event had lower values for all multifractal dimension 
traits, but differences were not statistically significant.  
Table 6.11 compares means of all quantitative retinal traits (following logarithmic 
transformation or rank transformation for those variables not normally distributed) 
between the incident event group and no incident event group. Although the 
diameter of the arteries and veins represented as CRAE and CRVE, respectively, 
tended to be lower in the group with incident events, these differences were not 






6.2.4 Multivariable relationship between retinal traits and incident 
cardiovascular events - cox regression analyses  
In order to explore further the relationship between quantitative retinal traits and 
incident cardiovascular events after adjusting for a range of traditional cardiovascular 
risk factors, a series of cox proportional hazards models was used. Three main 
models were created:    
Model A: unadjusted,  
Model B: adjusted for age sex,  
Model C: adjusted for sex, age and traditional cardiovascular risk factors 
including systolic BP, duration of diabetes, Hb1Ac, total cholesterol and smoking 
status.  
If in any of these model a statistically significance association was found, two 
additional models were used to further the analysis. These models were: 
Model D: adjusted for all variables included in Model C plus estimated 
glomerular filtration rate as a measure of renal function  
Model E: adjusted for all variables included in Model D plus prevalent 
cardiovascular events  
By adjusting for these risk factors, it is possible to comment on the potential to use 
quantitative retinal traits over and above these risk factors in cardiovascular risk 
prediction.  The cox models were used to explore associations of the baseline retinal 
traits with ‘any’ cardiovascular events and with incident coronary disease (fatal and 
non-fatal) and cerebrovascular disease (fatal and non-fatal ischaemic or 
haemorrhagic stroke) separately. Fatal events were not analysed separately as the 
number of such events was small.   
Results of the cox regression analyses are presented from table 6.12 to table 6.16.   
None of the models using all incident cardiovascular events as an outcome showed 
any statistically significant results for any of the retinal traits. The same was found for 
models using coronary artery disease as the outcome. However, when 




tortuosity and minimum arteriolar tortuosity were found to be predictive. In 
unadjusted models, for 1 SD increase in the mean arteriolar tortuosity there was a 
1.26 fold increase in cerebrovascular disease, while for 1 SD increase in the 
minimum arteriolar tortuosity there was a 1.18 fold increase in cerebrovascular 
disease.  
Adjustment for sex and age resulted in the association between cerebrovascular 
events and mean arteriolar tortuosity maintaining statistical significance. This 
association also survived further adjustment for traditional cardiovascular risk factors 
(Model C, HR; 1.26, 95% CI 1.01, 1.58) and for renal function (model D, HR; 1.26, 
95% CI 1.01, 1.58), as well as full adjustment including prevalent cardiovascular 
disease in the final model (Model E, HR; 1.26, 95% CI 1.01, 1.58). The association 
of minimum arteriolar tortuosity with cerebrovascular events survived adjustment for 
age and sex (Model B, HR; 1.18, 95% CI 1.00, 1.40) and only just lost statistical 
significance after further adjustment for traditional cardiovascular risk factors (Model 
C, HR; 1.18, 95% CI 0.99, 1.40), renal function (model D, HR; 1.18 95% CI 0.99, 
1.40) and prevalent cardiovascular disease (Model E, HR; 1.18, 95% CI 0.99, 1.39). 
No significant results were seen for the association between cerebrovascular events 
and maximum arteriolar tortuosity. 
Based on further recommendations, significant models were analysed adding 
diabetic retinopathy. Fully adjusted model included additional binary covariate of 
diabetic retinopathy (e.g. absence/present diabetic retinopathy). The results for 
mean arteriolar tortuosity remained significant  (HR 1.26; 95% CI 1.003, 1.58; 
p=0.047). In this model, using the binary model for diabetic retinopathy, the presence 
of diabetic retinopathy increased 12% risk of cerebrovascular event (HR 1.12; 95% 
CI 0.64, 1.96; p=0.68)  
Multifractal dimensions also showed interesting results in the unadjusted and 
adjusted models when cerebrovascular disease was considered as a separate 
outcome. The results presented in table 6.15 were obtained from the rank 
transformed multifractal dimensions D0, D1 and D2. In the unadjusted model, for 1 
SD increase in multifractal dimensions D0, there was a 0.01 fold decrease in 
cerebrovascular disease (HR 0.01; 95% CI 0.0001, 0.39; p= 0.01). This survived 




0.0002; p=0.49). Unsurprisingly, given the high correlation among the multifractal 
dimensions traits, the results obtained for multifractal dimensions D1 and multifractal 
dimensions D2 were very similar.  
In regression analysis, different units and different scales are often used. This may 
cause difficulty in interpreting the results and comparison across findings, particularly 
for traits such as multifractal dimensions, a novel biomarker which is poorly 
understood and for which results from previous studies are contradictory (Liew, 
2011). The results of standardised analyses are therefore presented in table 6.16 for 
this trait. In the unadjusted model, for 1 SD increase in multifractal dimensions D0, 
there was a 0.73 fold decrease in cerebrovascular disease (HR 0.73; 95%CI 0.57, 
0.94; p<0.05). This survived further adjustments and full adjustment (model E) 
resulted in a (HR 0.73; 95% CI 0.56, 0.9., p<0.05). Again, corresponding significant 
results were seen in all models for multifractal dimensions D1 and D2, consistent 
with the high correlation among the multifractal dimensions traits. 
Further analyses shown that the presence of absence of diabetic retinopathy did not 
modify the results for standarised multifractal dimensions D0 which remained 
significant in the fully adjusted model  (HR 0.73; 95% CI 0.56, 0.94; p=0.017).  In this 
model, the presence of diabetic retinopathy increased 16% risk of cerebrovascular 
event (HR 1.16; 95% CI 0.66, 2.03; p=0.60).  
These results should be considered with caution. This is because a larger number of 
early progression (e.g. mild non-proliferative diabetic retinopathy) cases of diabetic 
retinopathy were available in the dataset and thus were included as covariate. As 
mentioned previously, in the ET2DS, there were few severe cases with non-
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6.3 ROC curve analysis 
The association of mean arteriolar tortuosity and multifractal dimensions D0, 
D1 and D2 with incident cerebrovascular events survived adjustment for 
traditional cardiovascular risk factors and prevalent cardiovascular disease. 
The results of further survival analyses for both of these traits is described in 
this section. The Cox regression analysis provided predicted risk (X beta) 
values which are necessary to create ROC curves. Area under the curve 
(AUC) was compared for the model containing traditional risk factors alone 
and the model containing both traditional risk factors (sex, age, duration of 
diabetes, Hb1Ac, total cholesterol, HDL and smoking) and the mean 
arteriolar tortuosity (Figure 6.1). The area under the curve for the model 
containing only traditional risk factors was found to be 0.661 (95%CI 0.592, 
0.730). Adding the mean of arteriolar tortuosity to the model, there was a 
small improvement in AUC to 0.677 (95% 0.608, 0.746) (table 6.17). This 
suggests that the mean arteriolar tortuosity may contribute additional, 
although modest, information to current risk classifications models of 
cerebrovascular disease.  
 
Figure 6.1 ROC curves of predicted risk of cerebrovascular events in a model containing traditional cardiovascular 
risk factors and model containing the mean arteriolar tortuosity and traditional risk factors. Mean arteriolar tortuosity 
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6.4 Chapter Summary 
This chapter explored the relationship between quantitative retinal traits and 
incident cardiovascular disease in older adults with type 2 diabetes. Incident 
cardiovascular events in this study population were associated with male sex, 
increased age, longer duration of diabetes, increased HbA1c, lower HDL 
cholesterol and reduced eGFR. Furthermore, there were associations with 
insulin  hypoglycaemic usage, use of anti-hypertensives, previous history of 
cardiovascular disease and history of diabetic retinopathy.  
In unadjusted and fully adjusted Cox regression models for cardiovascular 
disease, mean arteriolar tortuosity and minimum arteriolar tortuosity were 
associated with incident cerebrovascular events. Associations with these 
quantitative retinal traits survived adjustment for traditional cardiovascular 
risk factors and full adjustment.  These retinal traits were not predictive for 
‘all’ cardiovascular disease or for coronary events. 
Finally, multifractal dimensions D0, D1 and D2 were associated with incident 
cerebrovascular events in unadjusted and fully adjusted models. This shows 
that the changes in the retinal vasculature branching (sparser branching 
pattern) may play a role in predicting and/or developing cerebrovascular 
disease. Further research into the role of these microvasculature findings in 
maintaining healthy vascular systems may provide novel understating of 
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Chapter 7 Results III: Genome wide 




Genome wide association studies (GWAS) are experimental designs to 
identify associations between genetic variants (loci) and traits (e.g. 
hypertension, diabetes, cholesterol) in populations. Visscher et al (2017) 
write that the main purpose of these studies is to better understand the 
biology of disease, under the assumption that this improved understanding 
will lead to prevention or better medical management. However, results 
obtained from GWAS must be interpreted with caution, because the pathway 
from the results of GWAS to biology may not be a straightforward association 
between a single genetic variant at a given genomic locus, and a trait is not 
directly informative with respect to the target gene (Visscher et al, 2017) 
The following considerations were taken into account when interpreting the 
results presented in this chapter, (a) how many variants affecting the trait 
segregated in the ET2DS population, (b) the joint distribution of effect size 
and allele frequency at those variants (sometimes called genetic 
architecture), (c) the sample size analysed, (d) the number of genome-wide 
variants that were used in the experiment, and (e) how heterogeneous the 
trait or disease being studied was. The last consideration relates to both the 
biology of the trait and the ability to diagnose or measure it with precision, 
relevant to quantitative traits such as the retinal traits under investigation 
(Visscher et al, 2017). 
Previous GWAS of quantitative retinal traits have focused mainly on arteriolar 
and venular widths including the dimensionless arteriovenous ratio. In this 
chapter, I describe the results of genome-wide associations for twelve 
quantitative retinal traits. Directly genotyped data as well as imputed data 
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were analysed for each retinal trait, with traits transformed to better 
approximate normal distributions using the methods described in the 
previous chapter. 
7.2 Results 
None of the GWAS analyses using the MetaboChip array showed either 
significant or suggestive results. A total of 1022 individuals from ET2DS with 
the aforenmentioned quantitative retinal traits, were included in the GWAS 
with imputed data. In this chapter,  results using the genome-wide imputed 
data and QQ plots are presented.  
Q-Q (quantile-quantile) plots were obtained for each quantitative retinal trait. 
The Q-Q plot is a graphical representation of the deviation of the observed P 
values from the null hypothesis: this means that the observed P values for 
each SNP are sorted from largest to smallest and plotted against expected 
values from theoretical X2 distribution. Ideally, observed values would 
correspond to the expected values, all points are on or near the middle line 
between the x-axis and the y-axis. If the results show an early deviation of 
the line of the expected and the observed values, this means that many 
moderately significant P values are more significant than expected under the 
null hypothesis (Ehret et al, 2010). In these analyses, the results are likely to 
be  associated to population stratification (e.g. differences of allele 
frequencies in subpopulations). 
7.2.1 GWAS of arteriovenous ratio 
The GWAS of arteriovenous ratio (AVR) was performed using the ratio of 
central arteriolar retinal equivalent to central venular retinal equivalent 
obtained from measurements in Zone B of the retina. A summary of the most 
significant SNPs identified is presented in table 7.1. The Manhattan plot for 
AVR is presented in figure 7.1, the quantile-quantile (Q-Q) plot is presented 
in the appendix 6, only a modest genomic inflation factor (λ = 0.99) was 
observed for AVR. Regional plots are shown in figures 7.2a and 7.2b.  
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The GWAS of AVR identified several variants, which passed the suggestive 
significance threshold. This retinal trait showed the greatest number of 
variants which passed the threshold, had a MAF ≥ 0.05 and were in 
acceptable linkage disequilibrium (r2) (table 1). Many of these variants were 
located at intergenic regions or regulatory regions between the genes.  
The most significant variant was rs73198094 (p value = 5.27-8), an intergenic 
variant located at the intergenic region of ASAH1 and LOC101929066 genes. 
The ASAH1 gene has been associated with atrial fibrillation (p value = 5.16 x 
10-10) (Christophersen et al, 2017). Additionally, functional analysis on 
ASAH1 protein located in the lisosomes has shown oxidative stress 
generates sphingolipid death mediators in retinal cells and that induction of 
ASAH1 could rescue retinal cells from oxidative stress by hydrolyzing excess 
ceramides (Sugano et al, 2019). This plays an important role in the 
development of macular degeneration. Furthermore, rs7841239 (p value = 
1.50x10-07) is a variant located in the intronic region LOC101929066 gene. 
Although this gene has not been characterised, it plays an important role in 
the trans regulation of RNA.  
Another identified intergenic variant, rs58774739, is located between the 
genes LOC101929066 and NAT1. NAT1 is involved in the transformation of 
drugs and environmental toxins. The enzyme encoded by this gene transfers 
the acetyl group from acetyl-coenzyme A to an amino group to aromatic 
amines and hydrazine compounds. There are a number of SNPs reported in 
NAT1, which lead to slow, and rapid acetylator phenotypes (Montazeri et al, 
2016). The acetylation status of an individual might determine how they 
respond to xenobiotic exposures, therefore presenting the 2 genes as 
candidates for gene-environment interaction studies (Potts et al, 2012).  
The unique variant, rs7318262, located in an intergenic region of 
chromosome 7 of the genes LOC101928257 and LOC107986796 also 
passed the suggestive threshold. Although functional characterisation of 
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these genes has not been performed, their activity remains mainly in RNA 
translation.   
One variant in chromosome 15 passed the GWAS suggestive threshold. The 
variant, rs11071164, is located in the intronic region of the gene OTUD7A. 
The protein encoded by this gene is a deubiquitinizing enzyme and possible 
tumour suppressor. In a study carried out by Morrison (Morrison et al 2010) 
an association of this gene with mortality from heart failure in Europeans was 
found (p value = 1.37 x 10-6). This gene may play a role in heart failure 
progression and survival by contributing to inadequate degradation of 
ubiquitin-protein conjugates resulting in autophagic myocyte death (Morrison 
et al, 2010).  
Finally, 15 of the significant variants identified were located at the intron 
region of the ATP11A gene. The most significant variant was rs1625475. The 
gene ATP11A located at chromosome 13 has been associated in a previous 
GWAS with red cell distribution width (p value = 2.4x10-9) (Pilling et al, 2017). 
Importantly, this gene has also been associated with the cardiometabolic 
trait, glycated haemoglobin (Wheeler et al, 2017). In this study, one variant 
located at the ATP11A gene was associated at genome-wide significance (p 
value = 1.70 × 10−12). The ATP11A gene plays an important role in 
membrane transportation including related pathways such as transportation 
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Figure 7.1. Manhattan plot of genome-wide association of arteriovenous ratio (AVR). The plot shows -log10 p values. The blue line corresponds to the suggestive threshold and the red line 
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7.2.2 GWAS of Central Retinal Arteriolar Equivalent  
I present the results of the GWAS of central retinal arteriolar equivalent 
(CRAE) in this section. A summary of the most significant SNPs for CRAE is 
presented in table 7.2 and the Manhattan plot is shown in figure 7.3. A Q-Q 
plot  revealed a genomic inflation factor of 0.99 (QQ plot presented in the 
Appendix 6). Regional plots are shown in figures 7.4a and 7.4b. 
Although none of the SNPs reached a genome-wide level of significance, 14 
SNPs reached the suggestive threshold, including nine SNPs at chromosome 
11q13.4. The most significant variant, rs4944903 (p = 8.51x10-7) is an 
intronic variant in the POLD3 gene. This gene encodes a DNA polymerase 
delta 3 accessory subunit. Mutations in this gene have been associated with 
muscular fitness (Willems et al, 2017) at genome-wide significance (p = 3.7 
x10-12). The remaining eight variants at chromosome 11q13.4 were also 
located within the intronic region of this gene. These included rs35500564 (p 
= 1.01 x 10-6), rs35778922 (p = 1.02 x 10-6), rs35167458 (p = 1.14x10-6), 
rs34450669 (p = 1.73 x 10-6), rs71465929 (p = 1.74 x 10-6), rs67575589 (p = 
1.85 x 10-6), rs12807883 (p = 1.95 x 10-6).  These eight variants were all in 
moderate to high linkage disequilibrium (r2=0.70). 
Two variants in chromosome 2 were also identified: rs7579754 and 
rs7577561. These variants are located in the intergenic region between 
LOC101927285, long intergenic non-protein coding RNA LINC01122 and 
LOC105374754 genes. These SNPs are in weak LD (r2=0.41) and have 
previously been associated with body mass index, obesity and adiposity 
(Zhang et al, 2017). 
Two additional variants located in chromosome 5q31.1 were identified. These 
SNPs, rs10061726 (p = 1.76 x 10-6) and rs76882062 (p = 2.42 x 10-6), are 
located in the intronic region of RNA, long non-coding C5orf66 antisense 
RNA 2, C5orf66-AS2 gene. This gene has been associated with intracranial 
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ruptured aneurysms in expression levels of RNA sequencing (p = 8.4 x 10-04) 
(Kleinloog et al, 2016). 
One variant located at chromosome 6p12.3-p12.2 was also identified. The 
SNP rs1268651 is an intronic variant in the fibrocystin – polyductin PKHD1 
gene. This gene encodes a transmembrane protein highly expressed in the 
kidneys. Rare variants in this gene cause autosomal recessive polycystic 
kidney disease while common variants have been associated with diastolic 











































Figure 7.3. Manhattan plot of genome-wide association of central retinal arteriolar equivalent (CRAE). The plot shows -log10 p values. The blue line corresponds to the suggestive threshold 
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7.2.3 GWAS of Central Retinal Venular Equivalent  
The Manhattan plot for CRVE is presented in figure 7.5. The genomic 
inflation factor was modest at 1.02 and the Q-Q plot is presented in the 
appendix 6. Only one variant reached the suggestive threshold (table 7.3). 
This variant is located in an intergenic region in chromosome 4. The variant, 
rs7685417 (p = 2.74 x 10-6) is near to the LOC105374520, GBA3 and 
GPR125 genes (Figure 7. 6). The GB3 gene has been associated with 
biomarkers related to human metabolism (p = 1.83x10-39) in a recent meta-
analysis (Shin et al, 2014).  
 
7.2.4 GWAS of Mean Arteriolar Tortuosity 
A summary of the most significant SNPs identified for arteriolar tortuosity is 
presented in table 7.3, with the Manhattan plot in figure 7.7. A quantile-
quantile plot of -log10 (p values) from the GWAS showed a genomic inflation 
factor of only 0.99. The quantile-quantile plot is presented in the appendix 7.  
Nine SNPs showed significant results at the suggestive threshold. These 
variants are located at 2q36.1. The most significant variant, rs77448408 (p = 
1.33 x 10-06) is intergenic between SLC16A7 (600 Kb downstream) and 
FAM19A2 (840 Kb upstream). The latter gene has been associated with 
insulin sensitivity (p = 1.9 x 10-8) in a study performed in individuals with 
white ancestry in the United States and Europe (Walford et al, 2016). These 
genes encode the solute carrier family16 member 7 transporter and the 
family with sequence similarity 19 member A2, respectively. The locus zoom 
plot is presented in figure 7.8.  
The remaining eight variants were located within the intronic region and the 
downstream 3’ region (Figure 7.9). These included rs62178618 (p = 2.76 x 
10-6), rs13386128 (p = 2.78 x 10-6), rs13385757 (p = 3.63 x 10-6), rs17370971 
(p = 3.67 x 10-6), rs134333079 (p = 3.72 x 10-6), rs104981110 (p = 3.75 x 10-
6), rs16862630 (p = 3.77 x 10-6) and rs4674595 (p = 4.20 x 10-6). These 
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SNPs are located within the EPHA4 gene. This gene encodes the ephrin 
receptor, tyrosine kinase receptor, highly expressed in neurons. There is an 
association between mutations in EPHA4 and familial dementia with Lewy 


































Figure 7.5.  Manhattan plot of genome-wide association of central retinal venular equivalent (CRVE). The plot shows -log10 p values. The blue line corresponds to the suggestive threshold 
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Figure 7.7.  Manhattan plot of genome-wide association of mean arteriolar tortuosity. The plot shows -log10 p values. The blue line corresponds to the suggestive threshold and the red line 
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7.2.5 GWAS of Minimum Arteriolar Tortuosity 
A summary of the most significant SNPs in the GWAS of minimum arteriolar 
tortuosity is presented in table 7.4. The Manhattan plot is shown in figure 
7.10. The quantile-quantile plot of from this GWAS revealed a genomic 
inflation factor of 0.99 (plot presented in appendix 6). 
Two different regions, on chromosomes 13q34 and 20p12.3 showed 
suggestive significance. Three SNPs were located on chromosome 13: 
rs7991332 (p = 1.54 x 10-6), rs2172724 (p = 2.46 x 10-6) and rs7319323 (p = 
3.53 x 10-6). These SNPs showed weak LD (r2=0.41) and are located in the 
5’UTR region (rs7991332) and intron region (rs2172724 and rs7319323) of 
collagen type IV alpha-2, COL4A2. The regional plot for these SNPs is 
shown in figure 7.11. The COL4A2 gene has been associated with familial 
retinal arteriolar tortuosity (Zenteno et al, 2014) and lacunar ischaemic stroke 
at the genome-wide significance level (p = 6.62 x 10-8) (Rannikmäe et al, 
2017). Another variant, rs7319323, is close to this region located within 
COL4A1 gene. This gene has been associated with stroke and small vessel 
disease (p = 6.9 x 10-9) (Traylor et al, 2016). 
The remaining variants were located on chromosome 20 (figure 7.12):  20 
SNPs were suggestively significant. Three SNPs were intergenic: rs6053561 
(p = 8.87 x 10-7), rs6139776 (p = 2.72 x 10-6) and rs6139777 (p = 2.84 x 10-
6). These SNPs showed weak LD (r2=0.33) and are located between 
glycerophosphocholine phosphodiesterase 1 (GPCPD1, 24Kb upstream) and 
chromosome 20 open reading frame 196 (C20orf196, 66Kb downstream).  
The remaining variants were located in the intergenic region between 
GPCPD1 and C20orf196. These included rs6085232, rsrs665426270, 
rs6038219, rs6133240 and rs13039871. These SNPs showed LD between 
r2=0.54 and r2=0.58. These SNPs are located within the 5′UTR of GPCPD1 
gene. This gene encodes glycerophosphocholine phosphodiesterase GDE1, 
  
 
  171 
which in humans is highly expressed in the occipital cortex (p = 6.5 x 10-09) 
(Bakken et al, 2012). 
A further eight SNPs reached suggestive significance. Of these, two SNPs 
were located in the regulatory region: rs2102486 (p = 1.53 x 10-6) and 
rs2423115 (p = 2.59 x 10-6). These SNPs showed LD (r2=0.58) and are 
located between glycerophosphocholine phosphodiesterase 1 (GPCPD1, 24 
Kb upstream) and chromosome 20 open reading frame 196 (C20orf196, 66 
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Figure 7.10.  Manhattan plot of genome-wide association of minimum arteriolar tortuosity. The plot shows -log10 p values. The blue line corresponds to the suggestive threshold and the red 
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7.2.6 GWAS of Maximum Arteriolar Tortuosity 
No SNPs reached the suggestive threshold in GWAS of maximum arteriolar 
tortuosity. The Manhattan plot is shown in figure 7.13 and the quantile-
quantile plot  shown  genomic inflation factor of 1.004. This result is shown in 
the appendix 6.   
 
7.2.7 GWAS of Mean Venular Tortuosity 
A summary of the most significant SNPs in the GWAS of mean venular 
tortuosity is presented in table 7.5. The Manhattan plot is shown in figure 
7.14. A quantile-quantile plot of  revealed a genomic inflation factor of 1.01. 
The quantile-quantile plot is presented in the appendix 7. 
There were 16 SNPs located on chromosome 16, which reached the 
suggestive threshold. The most significant result was for rs6497451 (p = 7.33 
x 10-7). The regional association plot for this region is shown in figure 7.15. 
This variant is in the downstream 3’ region of SNRPEP3, a gene which 
encodes nuclear ribonucleoprotein polypeptide E pseudogene 3. This gene is 
located on chromosome 16p12.3. Another SNP, rs4474693 (p = 7.51 x 10-7), 
is also located in this region. Four SNPs are located in the upstream 5’ 
region. These included rs12598578 (p = 7.62 x 10-7), rs11074446 (p = 7.62 x 
10-7), rs4238585 (p = 7.62 x 10-7) and rs10852238 (p = 8.07 x 10-7).  The 
regional plot of such variants is shown in figure 7.16. The gene has been 
correlated with raised body mass index (Zhang et al, 2017).  
Several SNPs located in the intergenic region of 16p12.3 showed suggestive 
significance. These included rs7193901 (p = 1.11 x 10-6) and rs7203219 (p = 
7.62 x 10-7). The LD between them was weak (r2 = 0.32) and they may be 
treated as independent loci. This chromosomal region harbours GP2, a gene 
encoding an integral membrane protein that is secreted from intracellular 
zymogen granules and associates with the plasma membrane via 
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glycosylphosphatidylinositol linkage (Locke et al, 2015). The nearby UMOD 
gene is expressed in the cells of the thick ascending loop of Henle in the 
kidney and has been associated with chronic kidney disease in diabetes (p = 
4.4 x 10-12) and hypertension (van Zuydam et al, 2018).   
Several SNPs located in the 16p12.3. region also showed suggestive 
significance. These included rs8045740 (p = 7.62 x 10-7) and rs4432271 (p = 
7.62 x 10-7). The LD between them was moderate (r2 =0.46) and they might 
be treated as independent loci, but conditional analysis would be required to 
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Figure 7.13. Manhattan plot of genome-wide association for maximum arteriolar tortuosity. The plot shows -log10 p values. The blue line corresponds to the suggestive threshold and the red line 
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Figure 7.14. Manhattan plot of genome-wide association for venular tortuosity. The plot shows -log10 p values. The blue line corresponds to the p value threshold of 1.0 x 10-5 and the red line 





  182 
7.2.8 GWAS of Minimum Venular Tortuosity 
The results of the GWAS of minimum venular tortuosity are presented in this 
section. A summary of the most significant SNPs is presented in table 7.6 
and the Manhattan plot is shown in figure 7.17. A quantile-quantile plot of  
revealed a genomic inflation factor of 0.99. The quantile-quantile plot is 
presented in the appendix 6. 
Although, none of the SNPs reached genome-wide significance, five SNPs 
reached the suggestive threshold (table 7.6). The SNP rs34013641 (p = 8.53 
x 10-7) had the strongest significance level.  The association of this variant 
was detected within MYH11, a gene which encodes a smooth muscle protein 
called myosin. The gene is located on chromosome 16p13.11 and has been 
associated with familial aortic aneurysms, an autosomal dominant disorder 
associated with an abnormally high occurrence of thoracic aortic aneurysms 
and aortic dissection (Keravnou et al, 2018). The regional association plot is 
shown in figure 7.18. 
Analysis revealed that rs2021412 (p = 2.84 x 10-6), rs56287009 (p = 3.28 x 
10-6), rs79706152 (p = 3.81 x 10-6) and rs1432567 (p = 4.44 x 10-6) had the 
strongest significance on chromosome 2. The regional plot is shown in figure 
7.19. Variants are located near the CCDC85A gene. This gene has been 
associated with susceptibility of type 2 diabetes in a Japanese population at 
genome-wide significance (p = 6.97 x 10-10), a finding that has been 
replicated in a multi-ethnic study (Imamura, et al 2016).  
 
7.2.9 GWAS of Maximum Venular Tortuosity 
None of the SNPs reached suggestive significance for maximum venular 
tortuosity. The Manhattan plot is shown in figure 7.20 and the quantile-
quantile plot shown modest genomic inflation of 1.02 (Appendix 7).
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Figure 7.17.  Manhattan plot of genome-wide association for minimum venular tortuosity. The plot shows -log10 p values. The blue line corresponds to the p value threshold of 1.0 x 10-5 and the red 
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Figure 7.20.  Manhattan plot of genome-wide association for maximum venular tortuosity. The plot shows -log10 p values. The blue line corresponds to the p value threshold of 1.0 x 10-5 and 
the red line corresponds to the p value threshold of 5.0 x 10-8.  
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7.2.10 GWAS of Multifractal Dimensions 
A summary of the most significant SNPs from the three genome wide 
association analyses performed for the multifractal dimensions traits (DO, D1 
and D2) is shown in table 7.7.  A total of three different variants showed 
significance at the suggestive threshold. Given the high correlation among 
the multifractal dimensions traits, it was not surprising that one variant was 
identified for all three traits and another variant was identified for two of the 
traits. The Manhattan plots for multifractal dimensions D0 and D1 are shown 
in figures 7.21 and 7.24 respectively. A modest genomic inflation factor of 
1.01 was observed. Quantile-quantile plots are presented in the Appendix 6. 
Two SNPs reached the suggestive threshold for multifractal dimension D0: 
rs10963694 (p = 8.53 x 10-7) and rs4977506 (p = 4.95 x 10-6). Association 
was detected within ADAMTSL1, a gene which encodes a protease and 
member of the ADAMTS family (a disintegrin and metalloproteinase with 
thrombospondin motif). This gene is located on chromosome 9p22.2. 
Regional association plots of these regions are shown in figures 7.22 and 
7.23. 
For multifractal dimension D1, two SNPs reached the suggestive threshold.  
Suggestive association was detected within HNRPR. The analysis revealed 
that rs9662596 (p = 4.71 x 10-6) had the strongest significance within this 
gene. This gene encodes nuclear ribonucleoproteins (hnRNPs), involved in 
binding to RNA polymerase II transcripts, and plays an important role in both 
transcript-specific packaging and alternative splicing of pre-mRNAs. The 
gene is located on chromosome 1p36.12. It has been reported that hnRNPR 
and beta-actin mRNA are localized in axons (Glinka et al, 2010).  The second 
SNP identified (p = 1.69 x 10-6) was the variant identified for multifractal 
dimension D0, rs10963694 (figure 7.22). For multifractal dimension D2, two 
of the same SNPs identified for the other multifractal dimension traits were 
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Figure 7.21. Manhattan plot of genome-wide association for Multifractal dimension D0 .The plot shows -log10 p values. The blue line corresponds to the suggestive threshold and the red line 
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Figure 7.24. Manhattan plot of genome-wide association for multifractal dimension D1. The plot shows -log10 p values. The blue line corresponds to the suggestive threshold and the red line 
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Finally, the multifractal dimension D0 loci rs10963694 and rs4977506, located on the 
ADAMTSL1 gene, are also strong candidates in the pathophysiology of vascular 
disorders. This gene encodes a metalloproteinase, which appears to be relevant to 
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Chapter 8 Discussion 
In this chapter, I summarise the key findings of this study, and compare these with 
the results published in the scientific literature. I discuss the strengths and limitations 
of the study, including an evaluation of the methods used in the data collection and 
statistical analyses. Finally, I outline recommendations for future research on the use 
of quantitative retinal traits for prediction of major cardiovascular events. 
 
8.1 Key findings 
 
8.1.1 Association of quantitative retinal traits with cardiovascular 
disease and incident events in diabetes  
In the Edinburgh Type 2 Diabetes Study (ET2DS), a representative prospective 
study of men and women aged ≥65 years with type 2 diabetes living in the Lothian 
region of Scotland, a range of quantitative retinal traits showed statistically significant 
associations with a number of cardiometabolic risk factors and with cardiovascular 
disease measured as clinical events. Arteriovenous ratio (AVR) was inversely 
associated with total serum cholesterol. Both decreased arteriolar and venular widths 
(measured as CRAE and CRVE respectively) were associated with increased fasting 
plasma glucose. CRAE was associated with cardiovascular events independent of 
age and sex, though CRVE was associated only with diabetic retinopathy. Mean 
arteriolar tortuosity was inversely associated with age, whilst, it was associated with 
sex and diastolic blood pressure. Maximum arteriolar tortuosity was associated with 
total cholesterol. Mean venular tortuosity was associated with BMI, systolic blood 
pressure and with cardiovascular events, notably with stroke, where the association 
remained significant after adjustment for traditional cardiovascular risk factors. 
Despite these cross-sectional results, only two quantitative retinal traits, mean 
arteriolar tortuosity and multifractal dimensions (D1, D2 and D3), were significantly 
associated with incident cerebrovascular events, and these findings were only 
related for stroke or recurrent stroke. However, the latter results for association with 
stroke remained significant after full adjustment for multiple known cardiovascular 
risk factors. Thus, retinal arteriolar tortuosity and multifractal dimensions D1, D2 and 
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D3 were not associated with coronary events or composite cardiovascular events in 
the ET2DS. Rather, this study showed that these retinal parameters were exclusively 
associated with cerebrovascular events. This may reflect the importance of 
considering the embryologic origin of the retinal vasculature and its possible effect in 
developing cardiovascular events. Conversely, there might be other coronary 
endophenotypes (e.g. silent ischaemia in women or presence of vessel disease 
present in coronary angiograms), which are associated with quantitative retinal traits. 
While these were not present in the cardiovascular endpoints of this study, previous 
evidence suggests an association between these traits and coronary events (Wang 
et al, 2018). 
 
8.1.2 Vessel width traits (CRAE, CRVE and AVR) and 
cardiovascular events 
This study showed that AVR was not associated with major cardiovascular events 
(e.g. ischaemic heart disease and stroke). In the previous literature, this retinal trait 
has been associated with acute myocardial infarction and risk of coronary heart 
disease (including MI fatalities) mainly in women (Wong et al, 2002). AVR represents 
a dimensionless parameter and its value depends on the measurement of diameters 
of arterioles and venules, raising a number of considerations. First, the retinal vessel 
classification depends on visual and geometric features, which discriminate 
arterioles and veins in semi-automated measurements. Generally, venules are wider 
and darker than arterioles and the central reflex is more recognizable (brighter) in 
arterioles. Importantly, arterioles and venules usually alternate near the optic disc 
and before branching off. Although, identification of the vessels was carried out 
carefully, selection of the vessel may be biased, as vessels in the outer regions of 
the image are dark because of the shading effect of the image. Therefore, 
misselection of arterioles and veins may lead to misclassification. The value of AVR 
has different components. For instance, narrower arterioles and wider venules may 
both lead to smaller values of AVR. Hence, a small AVR cannot differentiate specific 
changes in arteriolar and venular calibres.  
Values of AVR could also explain the lack of association between CRAE and CRVE 
and cardiovascular events. The measurements of CRAE and CRVE have been 
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obtained differently across previous studies (Seidelmann et al, 2016; Wong et al, 
2002). The algorithm for measurements used in VAMPIRE differs from that used in 
the other retinal softwares. McGrory and colleagues (2017) also found that 
agreement between retinal parameters including vessel width, tortuosity and fractal 
dimensions in VAMPIRE and SIVA platforms was poor.  
Another reason for this finding could lie in the moment when the retinal photograph is 
taken. The cardiac cycle may affect the size of retinal vessels. Hao et al (2012) 
demonstrated that there was a significant variation in the diameter of individual 
retinal vessels over the cardiac cycle, and both arterioles and venules were affected 
by this. Although the vessels width summary (CRAE and CRVE) and tortuosity were 
relatively consistent across the cardiac cycle using SIVA software, the formula used 
in this platform differs from the algorithm used in VAMPIRE (Hao et al, 2012). 
Additionally, camera factors and ocular factors can also have a bearing on the 
degree of magnification, and therefore, measurements from the fundal photography, 
as well as the degree of eccentricity of the measured object from the optical axis 
could alter the diameter measurement. Magnification of the fundal photographs 
should be known in order to make comparisons because this may differ according to 
the type of camera used. Biometric factors of the eye could affect ocular factors. 
These biometric factors include the axial length of the eye, anterior and posterior 
radii of curvature of the cornea and the lens, the corneal and lenticular thickness and 
anterior chamber depth (Patton et al, 2006). Correction for any or all such factors 
should be performed. It is unknown whether the previous studies have performed 
such a correction in their dataset, and these may alter the measurements of the 
retinal parameters.  
 
8.1.3 Vascular tortuosity (arteriolar and venular) and cardiovascular 
events  
This study found a significant association between mean arteriolar tortuosity and 
incident cardiovascular events (e.g. stroke). This finding is similar to the results 
reported by Saraf et al (2019) in relation to the familial vascular tortuosity syndrome. 
Retinal arteriolar tortuosity could be an indicator of vascular disease, as it is a 
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measurement that depends directly on the retinal vascular morphology (e.g. how, 
and how many times, the vessel bends). This retinal trait is a potential biomarker, 
which has previously shown association not only with cardiovascular complications 
(Sasongko et al, 2016; Sasongko et al, 2011) but also with genetic (and hence, 
biological) mutations in the vascular structural components such as collagen 
(Beyens et al, 2016). This retinal parameter showed the highest correlation between 
the right and left eye of all the retinal parameters examined in this study. These 
findings support this vascular parameter as a potentially informative retinal biomarker 
for exploring vascular complications.  
As with the other retinal parameters analysed in this study, there are methodological 
considerations to be taken into account when quantifying retinal tortuosity. A recent 
study (Ramos et al, 2018) identified a limitation in the measurement of retinal 
vascular tortuosity, which was the lack of precise and standard guidance for 
tortuosity assessment regarding the image acquisition, measurement location and 
consequent calculation. Based on the approach implemented in the VAMPIRE 
platform, the quantification consists of a measure only depending on the vessel 
skeleton curvature. Ramos and colleagues (2018) also compared different 
algorithms, and the metrics that performed best were those, which combined the 
number of segments with constant convexity within a vessel with the evaluation of 
such segments. This means that the best results come from the methodologies, 
which integrate information about how many times a vessel changes its convexity. 
There are also limitations related to the availability of normative retinal data due to 
the absence of unified public datasets. This, along with the lack of standardised 
analyses regarding the computational algorithms hinder the validation of the 
available methods to measure retinal vessel tortuosity.  
 
8.1.4 Multifractal dimensions and cardiovascular events  
Another major finding of this study was the significant association between 
multifractal dimensions DO, D1 and D2 and incident stroke. Recent studies (McGrory 
et al, 2019; Wu et al, 2017; Kawasaki et al, 2011) have reported an association in 
the similar direction. Multifractal dimension is a parameter, which summarises the 
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complexity of the vascular tree. The main attraction of fractal geometry is based on 
the ability to describe the irregular or fragmented shape of natural features as well as 
other complex objects (e.g. the retinal vasculature) that traditional Eucledian 
geometry fails to analyse (Lopes et al, 2009). This retinal biomarker (with all its 
intrinsic limitations as a mathematical model) may be used as an objective and 
quantitative parameter for the evaluation of the retinal vasculature (Tālu et al, 2017).  
Like the other retinal parameters, the multifractal dimension significantly varies 
across different measurement methods. One consideration is the region of interest to 
analyse, and this should be standardised across platforms. In addition, vessel 
segmentation results in high variability in the methods incorporated, and it has been 
suggested that a threshold value for creating a high accuracy binary vessel 
segmentation map is required (Huang et al, 2016).  
 
8.1.5 Association between quantitative retinal traits and GWAS data 
In the imputed data from the ET2DS dataset, a number of SNPs were identified 
which surpassed the genome-wide suggestive significant threshold (p value < 1.0 x 
10-6) located in the genes COL4A1, COL4A2, MYH11 and ADAMTSL1. Variants of 
these genes are involved in the physiopathology of vascular disease including 
thrombosis, cell aggregation, and atherosclerosis (Mejia-Renteria et al, 2018). 
In this study, the variants rs7991332 and rs2172724 located in COL4A2 and the 
variant rs7319323 of COL4A1 gene were associated with minimum arteriolar 
tortuosity. Previous studies have reported a similar association between these genes 
and familial arterial tortuosity and stroke (Rannikmäe et al, 2015). 
The role of the genetic variants identified in my GWAS warrant further consideration 
in relation to findings from previous research. The COL4A1 gene encodes the alpha-
1 subunit of collagen type IV, a component of basement membrane in the retinal 
vessels and the renal glomeruli. Different phenotypes have been linked to mutations 
of COL4A1, mainly in the brain and retinal structures. The main phenotype 
associated with this gene is stroke. Recent GWAS of white matter hyperintensity 
volumes and stroke (Traylor et al, 2016; Rannikmäe et al, 2015) reported a novel 
association of a variant in the COL4A2 gene with these traits. Mutations in this gene 
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are closely related to the COL4A1 gene. This particular phenotype suggests that the 
white matter changes seen on the brain magnetic resonance imaging scans of 
otherwise healthy elderly people reflect a similar disease process, the more severe 
forms of which underlie cerebral small vessel disease in patients with stroke. Studies 
in mice and humans have shown that mutations in both genes lead to basement 
membrane defects, which, as a consequence, weaken the blood vessels and alter 
vascular functions. Additionally, missense mutations in the intronic regions of this 
gene result in retention of mutant intracellular protein leading to a reticular 
endoplasmic dysfunction and stress (Rannikmäe et al, 2015).  
Furthermore, this study also identified an association between the variant 
rs34013641 in gene MYH11 and minimum venular tortuosity. This variant is located 
in the myosin 11 gene, which encodes myosin heavy chain family-protein. This 
protein has been found to be associated with multiple vascular disorders including 
heritable thoracic aortic disease, aortic stiffness, and aneurysms (Yamasaki et al, 
2019; Keravnou et al, 2018). This protein is a cytoskeletal marker, encoded by this 
gene, and it plays an important role in the contraction of the smooth muscle cells of 
the vascular structure as well as in the development of atherosclerosis. Additionally, 
properties of the cytoskeleton include tissue remodelling, mechano-sensing and cell 
migration. All these actions are involved in the atherosclerotic process (Simmons et 
al, 2016). These proteins are also important markers of cytological tracing of cell 
type in the atherosclerotic plaque (Hansmeier et al, 2018).  
Finally, the study also revealed an association between the loci rs10963694 and 
rs4977506 in ADAMTSL1 gene with multifractal dimensions. Members of the 
ADAMTSL (a desintegrin and metalloproteinase with thrombospondin motifs-like 
protein) family are included in the abundant extracellular matrix proteins and are 
associated with the ADAMTS enzymes (proteases). The protein encoded, 
ADAMTSL-1, is suspected to be involved in extracellular matrix turnover. Generally, 
extracellular proteases are known to be involved in the breakdown of specific 
extracellular matrix elements, whereas intracellular proteases reorganise the 
cytoskeleton, and govern cell migration and differentiation. Both mechanisms are 
involved in the development of atherosclerosis. Interestingly, evidence has shown 
that these extracellular proteases play a critical role in de-establishing the fibrous 
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cap, leading to atherosclerotic plaque rupture (Hansmeier et al, 2018). This 
association adds more evidence of the multifactorial development of vascular 
diseases resulting in cerebrovascular disorders probably mediated by 
atherothrombotic processes. Gene defects in ADAMTLS-1 raise the hypothesis that 
reduced integrity of the endothelial wall, together with inflammatory processes and 
defective vascular remodelling, plays an important role in the development of 
cerebral aneurysms (Arning et al, 2016). These processes could interact in the 
development of major cardiovascular outcomes such as stroke or cerebral 
aneurysms.  
Overall, the most promising variants were located in genes, which encode three 
types of protein that may interfere in the causation of cardiovascular outcomes, 
mainly cerebrovascular disease. These genes are thus important in vascular function 
or involved in neuronal function. 
In considering the results of the GWAS, it is also important to take into account the 
genetic heritability (h2) of each retinal trait. The heritability estimates the degree of 
variation in a trait that is due to genetic variation between individuals in a specific 
population (Mayhew and Meyre, 2017). AVR has shown the lowest heritability in 
previous studies. In the Danish dataset of healthy twins, AVR heritability was 18% 
(Taarnhøj et al, 2006). While, in the Flemish analysis (Liu et al, 2013), after 
adjustment for traditional cardiovascular risk factors, AVR heritability was 27%; Kirin 
et al (2017) also reported a similar estimate of 27%. Conversely, in terms of CRAE 
and CRVE, genetic heritability estimates have shown some degree of variation. Twin 
studies have reported estimates of 70% and 83% (Taarnhøj et al, 2006) and 66% 
and 72% (Fahy et al, 2011), respectively. Studies in the general population have 
reported lower genetic heritability for CRAE and CRVE; 32% and 43%  (Kirin et al, 
2017) and 21% and 34% (Liu et al, 2013), respectively. Despite the variations in 
these findings, all discussed studies suggest that CRVE has the higher component 
of genetic heritability.  
Only two studies have analysed the genetic heritability for retinal tortuosity. Taarnhøj 
et al (2008) showed a genetic heritability of 82% for retinal arteriolar tortuosity, while 
Kirin et al (2017) reported estimates of 55% and 21%, respectively. Importantly, in 
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the latter study, there was a high degree of genetic correlation (60%) between 
arteriolar and venular tortuosity. Heritability of multifractal dimension has not 
currently been analysed, but heritability of monofractal dimension (using the box 
counting method) was 79% in the Danish Twin Study (Vergmann et al, 2017) and 
only 22% in the general population in Orkney (Kirin et al, 2017). 
Retinal arteriolar tortuosity appears to be a vascular trait with an important genetic 
component that could lead to vascular disease. Findings of this study thus lays 
important foundations for enhancing the knowledge of genetic risk factors underlying 
retinal vasculature and its possible association with vascular disease. 
 
8.1.6 Possible pathophysiological mechanisms underlying 
associations of retinal traits with major cerebrovascular 
events  
The association of arteriolar tortuosity with incident cerebrovascular events was one 
of the main findings of this study. One explanation for this association could lie in the 
fact that retinal vessels share common anatomical and physiological features with 
cerebral arterioles.  Impaired microcirculation of the brain (cerebral small vessel 
disease), is increasingly recognised as a cause of cognitive decline and 
neurodegenerative disorders as well as contributing to stroke (McGrory et al, 2019; 
Rannikmäe et al, 2015).  
Findings from this study on arteriolar retinal tortuosity, multifractal dimensions and 
genetic variants appear to be consistent with the biological mechanisms that are 
involved in the development of cerebrovascular disease. These mechanisms could 
also contribute to a series of degenerative changes in the cerebral vasculature such 
as fibrinoid degeneration, fibrous nodules, fibrohyalinoid thickening and calcification 
(Wu et al, 2017).   
Arteriolar retinal tortuosity has been found in people with T2D (Sasongko et al, 
2016). This finding had been associated with longer duration of diabetes and early 
stages of diabetic retinopathy. Possible mechanisms involved in this process include 
hyperglycaemia-mediated loss of auto regulatory function of the vessels (e.g. 
compromised function of endothelium), resulting in impaired compensatory 
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mechanism for hydrostatic pressure. This may result tin instability of the wall 
arterioles against longitudinal traction and transmural pressure causing tortuous 
vessels and dilation (Ciurica et al, 2019).  Buckling instability is a possible 
mechanism that may lead to arteriolar tortuosity and also, the ratio of the media 
thickness to the adventitia thickness is shown to have a dramatic impact in arteriolar 
instability (Vandiver, 2015). Factors involved in these processes include the genetic 
defects in elastogenesis or collagen synthesis. In aging arteries, collagen 
degradation, deposition, and structural alteration may also occur.  
Cerebral microvascular abnormalities could be caused by micro-atheroma, 
endothelial dysfunction or inflammation (Davis and Donnan, 2014). The endothelial 
cells of the cerebral vascular tissues play a role in the vasomotor control regulating 
cerebral blood flow, with the perfusion of the capillaries controlled by the regulation 
of the upstream arterioles (Mejía-Renteria, et al 2018).   
Basement membranes adjoining the endothelium, comprise of key proteins (e.g. 
COL4A1 and COL4A2) which may then influence the structure of the retinal vessel 
and thereby the cerebral microvasculature. Additionally, the presence of impaired 
blood flow (e.g. turbulent) brought on by cardiovascular risk factors like hypertension, 
may induce activation of the endothelium. The activation of intracellular pathways 
and gene expression induces changes in the vessel tone (vasoconstriction), 
structural changes in the basement membrane, cytoskeleton and extracellular 
matrix, increased production of inflammatory cytokines, high oxidative stress and a 
leaky cell barrier. This process may lead to a “weak” vessel, which as consequence 
can modify the structural strength of the vessels, resulting in more tortuous arterioles 
and venules. These key proteins (ADAMTSL-1) may also play an important role in 
the development of atherosclerotic plaque and rupture.   
 
8.2 Strengths and weaknesses of the research 
8.2.1 Study population  
The ET2DS is a well-phenotyped prospective cohort in which study participants were 
sampled and recruited directly from, and are therefore representative of, the Lothian 
region of Scotland (using the Lothian Diabetes register), as opposed to using the 
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subgroup of people with diabetes participating  in a larger study, which is generally 
the case for other studies in this topic area. The Lothian region includes not only the 
city of Edinburgh but also smaller towns and rural communities in the surrounding 
area in East Scotland. While other cohort studies have usually recruited people from 
a single city or town, and often do not specify the type of population included. 
Furthermore, the ET2DS included people who managed their type 2 diabetes from a 
range of treatment methods, including from diet control to insulin treatment.   
At baseline, participants in the ET2DS were largely similar with respect to 
demographic and clinical features compared to those who did not participate in the 
study (Price et al, 2008). There were slightly more men than women recruited into 
the study and  people from the least deprived socio-economic status group were 
more likely to agree to participate than those from the most deprived socio-economic 
group. Nonetheless, these differences were small, and overall, the participants were 
largely representative and findings generalisable to the target population. 
 
8.2.2 Accuracy and completeness of data collection 
The ET2DS is a cohort thoroughly characterised phenotypically for a wide range of 
risk factors and biomarkers. Data were carefully collected by trained research staff 
according to strict protocols (standard operating procedures), ensuring that this 
process was consistent between research staff and over time, accurate, and with 
only a small amount of missing data. Strict quality control measures were used in the 
processing of the biomarkers and genotyping. This extensive phenotyping, quality 
control and accuracy of data collection are key strengths of the ET2DS cohort.  
 
8.2.3 Prospective design of the ET2DS and follow up for 
cardiovascular events  
The prospective design of the ET2DS is essential for longitudinal analyses to 
investigate the relationship of baseline cardiovascular risk factors with the 
development of subsequent cardiovascular events. Complete data on incident and 
recurrent cardiovascular events was required for my analyses of the association of 
quantitative retinal traits with cardiovascular risk. These incident events were 
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collected and recorded, following pre-defined protocols and using a systematic 
approach to reduce loss of follow-up and misdiagnosis of the clinical events at the 
four and eight-year stage of the study. ET2DS researchers used several sources to 
identify and confirm events. At the four-year follow-up, this included self-completion 
questionnaires, assessment of electrocardiograms and ISD data linkage. At the 
eight-year follow-up, a combination of procedures was used, including ISD data 
linkage combined with a review of clinical notes. The identification of events was as 
comprehensive as possible during the four and eight-years follow-up, however, 
events could be missed in participants who moved outside Scotland.  
 
8.2.4 Method used to analyse retinal images 
The software used in this study, Vascular Assessment and Measurement Platform 
for Images of the REtina (VAMPIRE), is a semi-automatic software application 
developed by consortia of the University of Edinburgh and University of Dundee. 
This software quantifies some parameters of the retinal vasculature using images 
from the fundus camera taken in clinics. This free software is user-friendly; it can be 
easily installed and used on Windows platforms. Each software version presents 
improvements and updated algorithms for the analysis of the retinal quantitative 
traits. This software has been used in different datasets including UK Biobank 
(MacGillivray et al, 2015), the Lothian Birth Cohort 1936 (McGrory et al, 2019; 
McGrory et al, 2017) and ORCADES from the Orkney Islands in Scotland (Kirin et al, 
2017). The use of this platform across multiple studies demonstrates its feasibility to 
measure the retinal vasculature in a cost-efficient way. 
VAMPIRE uses a modified 2-D Gabor wavelet supervised classification algorithm for 
automatic vessel detection and locates centre lines through skeletonisation of the 
binary vessel map (McGrory et al, 2018). This enhances the detection of arterioles 
and venules. Optic disc automatic detection algorithm is also included in the 
analysis, whereas other software applications, such as SIVA (Singapore “I” Vessel 
Assessment), require the operator to assign and select the area of the optic disc. 
This may create bias due to inter-operator differences. Automatic detection of the 
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optic disc optimises the application to detect accurately either arterioles or venules 
and saves time in this process.  
8.2.5 ET2DS genotyping and imputation 
Genotyping of the ET2DS was performed used MetaboChip array. This array was 
developed using hundreds of loci for type 2 diabetes, coronary artery disease, 
myocardial infarction, cardiometabolic traits including, glucose, insulin levels, lipids 
levels, blood pressure and anthropometric traits such as body mass index (Voight et 
al, 2012). The MetaboChip genotyping array was designed to establish associations 
with these cardiometabolic loci, which included nearly 200 000 SNP markers. This 
assay offers a powerful and cost-effective approach to follow-up large-scale 
genotyping and for further genotype imputation.  
The ability to use imputed data was a strength of my analysis of the ET2DS. Several 
GWAS have systematically evaluated the contributions of genetic factors to various 
complex diseases along with quantitative traits including blood pressure, human 
height and cholesterol levels. These contributions have revealed important factors 
involved in the pathophysiology of these traits, and are expected to enable the 
development of new therapeutic drugs. GWAS analyses have greatly changed 
human genetics in the last 10 years by providing a new, systematic method that can 
provide deeper insights into disease biology (Das et al, 2018). Low frequent variant 
genotypes that are not directly included in the GWAS array can be reconstructed by 
comparing each sample to a reference panel of sequenced genomes. This method, 
which is known as genotype imputation, involves estimating genotypes that have not 
been directly genotyped. 1000 Genotypes haplotypes panel offers a particularly large 
and dense reference panel that is commonly used as an imputation reference panel, 
particularly in GWAS studies. Imputation has thus helped to accelerate fine-mapping 
efforts, aid the combination of factors across meta-analyses, and increase the power 
of gene mapping analyses. Imputation was done in the ET2DS on cleaned 
genotypes in three phases - chunking, phasing and imputing - and the resulting final 
file contained approximately 4.5 million autosomal SNPs, which were then available 
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8.2.6 Design of the analyses 
Special care was taken in developing the analysis plan to arrive at the most accurate 
and clinically informative results. Prospective analyses, as used in my study, which 
consider the time relationship between predictor (retinal vessel traits) and outcome 
(cardiovascular disease), can be more accurate than cross-sectional studies. This is 
because such analyses involve repeated observations of study participants over time 
and often represent the most comprehensive method as they use all available 
information of the population over the risk period (Pearce et al, 2012). Furthermore, 
the choice of the covariates in the models performed was made according to 
traditional cardiovascular risk factors, which have been identified in well-established 
cohorts such as the Framingham Study. Analyses were performed using different 
models in order to explore the independence of the association (if established) of 
quantitative retinal traits with the cardiovascular outcomes.  
I performed the analyses carefully performed and placed special attention on the 
distribution of all quantitative retinal traits. Since, it is assumed that these traits are 
normally distributed; I adopted a stringent adherence to quality control and the 
statistical analyses. Violation of the assumption that the quantitative traits are 
normally distributed can severely affect the power and lead to type I error (Feingold, 
2002). Thus, in this study, I tested harmonisation using parametric transformation to 
approximate to normality.  
In this study, GWAS analysis was included to increase the understanding of major 
vascular complications associated with retinal parameters. Indeed, one key criterion 
to develop a GWAS is to acquire further informative results, which inform us about 
the pathophysiology of the retinal vasculature and cardiovascular events. Data 
generated from previous GWAS studies have been exploited for addressing many 
scientific questions other than SNP- trait associations (Visscher et al, 2017). GWAS 
have also been successfully implemented for better defining the relative role of 
genes and the environment in disease risk enabling preventative and personalised 
medicine (Visscher et al, 2017). For example, GWAS signals are known druggable 
targets and these potential variants may be used in further phase clinical trials, 
potentially saving huge costs for pharmaceutical production, which can be especial 
beneficial for public health systems.  
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Furthermore, GWAS of quantitative retinal traits were adjusted for sex and age, in 
this study. Recently, a large number of GWAS have been published for human traits 
adjusted for correlated traits. Adjustment for covariates in GWAS can have two 
purposes: first, to account for potential confounding factors that can bias SNP effect 
estimates and second, to improve statistical power by reducing residual variance. 
Adjustment for environmental or demographic factors such as age and sex may 
increase statistical power. This is because accounting for true risk factors decreases 
the residual variance of the outcome and hence increases the ratio of the true effect 
size of a predictor of interest over the total phenotypic variance resulting in better 
statistical power (Aschard et al, 2015).  
 
8.3 Limitations  
 
8.3.1 Generalisability 
Although, the ET2DS is representative of the target population (older people with 
type 2 diabetes), care must be taken when generalising the results beyond that 
target population.  Firstly, the participants recruited into the ET2DS are older adults 
aged between 60 and 75 years at baseline, so the results may differ from those of 
other studies, which recruited younger participants. Moreover, there is a potential 
impact of a healthy survivor bias, as people recruited at age 60 years or above might 
be biologically different to those who died when they were younger. Secondly, the 
majority of the population are north Europeans, reflecting the limited ethnic variability 
in this region of the UK. This limits generalisability of the results to multi-ethnic 
populations. Thirdly, people recruited into the ET2DS already had type 2 diabetes. 
This itself is a cardiovascular risk factor that may cover up other vascular risk factors, 
which are important in the development of cardiovascular complications. It is well 
known that the duration of type 2 diabetes, higher BMI and poor glycaemic control 
are risk factors for cardiovascular complications (Einarson et al, 2018). In fact, 
endothelial function and its regulation including vasodilation and vasoconstriction, 
may be impaired in hyperglycaemic people with type 2 diabetes, which results in a 
greater risk of developing major cardiovascular events (Loader et al, 2015). For 
instance, a recent study (Liu et al, 2018)  using Mendelian randomization analysis 
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provided evidence to suggest that type 2 diabetes may be causally associated with 
cerebral small vessel disease (e.g. lacunar stroke) and fractional anisotropy.  
 
8.3.2 Missing data 
The loss of follow-up and missing outcome data is a major limitation of prospective 
cohort studies. Despite previous data cleaning, the baseline variables used for this 
thesis still included missing data for covariates for a few cases, prior to carrying out 
formal analysis. However, the number of missing data in the covariates used in this 
thesis was below 5% of the total number of the individuals included. Schafer (1999) 
emphasised that a missing rate of 5% or less is inconsequential. Generally, in 
regression models, only complete cases are analysed at each stage of the model. This 
in practice leads to more cases being part of the analysis in models adjusted for age 
and sex, than fully adjusted models, where a case with any of the covariates missing 
is excluded from the analysis. Therefore, each step in the regression models may not 
include the exact same cases.  
Missing data with respect to multifractal dimensions from the retinal images was 
close to 5% of the total number of individuals in the ET2DS. While this loss of data 
might suggest a small risk of bias, Bennett (2001) asserts that statistical analysis is 
more likely to be biased when more than 10% of data are missing. 
 
8.3.3 Analysis plan 
There are some limitations of the statistical analysis used in this study. Individuals in 
the study reported taking lipid-lowering and antihypertensive medications; this may 
have altered the results of total cholesterol and blood pressure, which were included 
as covariates in the analysis. Including medication use in the definition of 
‘hypertension’ or ‘hypercholestoreamia’ may be more reflective of a person’s  
increased lifetime risk of vascular damage due to these conditions, but this could be 
mitigated by the positive effects of the treatment. 
  
 
  209 
Use of one-off measures of cholesterol and BP on the other hand could 
underestimate the effect of (treated) hypertension and hypercholesterolaemia. If aim 
is to assess prediction rather than knowing about aetiology, likely that both measures 
would need to be tested in developing best predictive models. Therefore, this may 
have introduced bias in the results.    
In this study, I used eGFR as a covariate for renal function in the analysis models. 
Although, eGFR is a common biomarker of renal impairment and has been 
associated with cardiovascular prognosis and mortality (Fung et al, 2017), 
microalbuminuria is known to be the earliest clinical evidence of kidney disease in 
this population (Collins et al, 2010). Epidemiologic studies suggest that population 
patterns of chronic kidney disease among adults with type 2 diabetes, are not as 
uniform as those noted among adults with type 1 diabetes. Focusing solely on urine 
albumin excretion to screen for chronic kidney disease may miss a substantial 
number of cases in adults with type 2 diabetes, a more heterogeneous group of 
patients who are generally older and have more comorbid conditions at diagnosis 
compared with adults with type 1 diabetes (Kramer et al, 2018). Other etiologies for 
chronic kidney disease, which are not associated with increased urine albumin 
excretion, may be present at the time of diagnosis of type 2 diabetes and over the 
course of the disease, such as renal vascular disease and cholesterol emboli. Also, 
tubulointerstitial changes due to the presence of comorbid conditions, including long 
standing hypertension and senenscence of glomeruli due to aging may be present.  
Moreover, studies have shown that stage 3 or higher chronic kidney disease stage 
(GFR <60 ml/min/1.73 m2) may occur in the absence of increased urine albumin 
excretion in a substantial proportion of adults with diabetes, and screening this 
population for elevated urine albumin excretion alone will miss a considerable 
number of chronic kidney disease cases (Alicic et al, 2017). Importantly, the use of  
angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers 
(ARBs) leads to decreased development microalbuminuria to macroalbuminuria and 
results in a reduced risk for CVD and mortality (Persson et al, 2016). These 
medications were taken by people of ET2DS; hence, microalbuminuria could have 
been mitigated by the positive effect of these medications. 
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Thus, taking into account these aforementioned limitations of microalbuminuria, I 
decided to include the biomarker of eGFR as a covariate of renal function in this 
population in my analysis models.  
The power to discover new disease-associated genetic variants critically depends on 
the underlying genetic architecture, i.e., the number of risk loci and their frequencies 
and effect sizes. It has been stipulated that GWAS requires larger sample sizes to 
achieve an adequate statistical power as it evaluates thousands of SNPs. GWAS 
studies on quantitative traits in recent times, have included large sample sizes of 
more than 1 000 000 individuals (Wuttke et al, 2019). Testing a large number of SNP 
markers leads to a large number of multiple comparisons (multiple testing) and thus 
increased false positive rates (Hong and Park, 2012). Statistical methods, such as 
Bonferroni correction, are generally applied to avoid false positive (type I error) rates. 
However, its use to set the significance threshold might be too strict when 
considering the correlation among genetic variants. Increasing sample size may 
avoid these considerations and lead to adequate statistical power, which is essential 
to elucidate genetic associations.    
In modern statistics, it is important to use tools when handling large-scale multiple 
testing datasets. Benjamini and Hochberg (1995) introduced the false discovery rate 
as a useful tool when multiple comparisons are carried out . This method is based on 
setting a limit on the false discovery rate, and this is generally preferable 
(Colquhoun, 2014). False discovery rate control is suggested as complementary to 
the use of point estimate and confidence intervals. It helps to evaluate the extent to 
which effect sizes are over-estimated, especially in underpower experiments. 
Following further recommendations, false discovery rate was examined in all 
significant models in the analysis, corroborating the findings of these analyses. 
For my findings, a larger sample size would thus help demonstrate whether results 
still remain significant. Replication or meta-analysis including other datasets would 
be recommended to reproduce the original results and confirm true findings. This 
step was beyond the scope of this thesis. Nevertheless, it is important to consider 
that GWAS for quantitative retinal traits has been explored in few studies compared 
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to other human traits such as blood pressure or serum cholesterol, supporting the 
rationale for undertaking these exploratory analyses. 
 
8.3.4 Method used to analyse retinal images 
The method used to analyse retinal image may have introduced certain limitations 
including the analysis of only one image, a limited area of the retinal vasculature 
analysed, few traits obtained and non-established algorithms across different 
platforms. 
First, for this analysis, I used only the best quality image from either the right or left 
eye. Despite moderate correlation of the retinal measurements between the two 
eyes (see methods chapter), variations may exist. High correlation (r ≥ 0.70) is 
usually expected to consider the use of only one side. Measurements of both sides 
could have been done but this option was excluded due to the excessive work 
involved and time limitation for the purposes of this study.   
Second, I only used the centrally located image in the analysis. However, for each 
participant, seven field images were taken for each eye at baseline. These images 
involved extensive retinal vasculature that may have offered an enriched 
assessment of the vasculature, as it includes other characteristics such as vessel 
length or multiple branching.  
Third, VAMPIRE software measures only a limited number of retinal traits, and other 
traits may provide further insights into the association of the retinal vasculature with 
cardiovascular disease. Currently, other available software applications measure 
several additional traits of the retinal vasculature, including number of first branching 
arterioles and venules, branching coefficient for arteriole and venule, junctional 
exponent deviation for arterioles and venules and length-to-diameter ratio arteriole 
and venule (e.g. SIVA, Singapore ‘‘I’’ Vessel Assessment, National University of 
Singapore). Further research can include the use of such traits to examine the retinal 
vasculature and its links with cardiovascular disease. 
Whilst multiple software applications have offered the opportunity to explore the role 
of the retinal microvasculature in the physiopathology of cardiovascular disorders, 
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the application of these retinal measurements in the clinical settings is yet to be fully 
established, partially due to methodological limitations. In the absence of ground 
truth measurements of the retinal vasculature, the accuracy (or the degree to which 
an instrument measures the true value of a variable) of such software applications 
remains to be determined (McGrory et al, 2018). Potential sources of variations 
among the software application include physiological characteristics of the eye, 
angle of imaging, image quality, type of camera used, algorithms, and intra-observer 
variability (Trucco et al, 2013). Method-comparison studies have been used to 
assess how measurements from different software applications agree, including 
agreement between SIVA and VAMPIRE software. McGrory et al (2018) reported 
intra-class correlation coefficients for vessel width, fractal dimensions and tortuosity 
indicated poor to limited agreement. The study also revealed proportional bias in the 
majority of measurements, and systematic bias in all measurements.   
Since semi-automated retinal vasculature assessment appears to be software 
dependent, it is important that future studies work on standardisation and validation 
across software platforms. McGrory et al (2018) take this recommendation further by 
suggesting the formation of a consortia of retinal imaging clinicians and software 
developers to conduct such comparative analysis.  
 
8.4 Conclusions and recommendations for future research 
Coronary heart disease and cerebrovascular disease are two of the main causes of 
mortality in the UK and worldwide, hence, there is little doubt that research in both 
fields is urgently required to improve our understanding of these diseases and 
translate these insights into clinical solutions. Similarities between the retinal 
vasculature and other microcirculations suggest that exploration and examination of 
the retinal vasculature can be a vital avenue of research in this area. Despite 
increasing evidence, many aspects of the relationship between retinal vasculature 
and major cardiovascular events (e.g. stroke) remain poorly understood. The results 
from this study firstly point out the significant association between quantitative retinal 
traits and cerebrovascular events, and indicate that these traits, namely arteriolar 
tortuosity, venular tortuosity and multifractal dimensions can be used as potential 
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imaging traits which could provide important knowledge on the pathogenesis of 
cerebrovascular events.  
While these results were found to be significant, external validation of the same, in 
larger datasets is required. In order to expand the generalisability of future results, 
such datasets should include younger individuals, multi-ethnic populations, and if 
sufficient number of cardiovascular events are captured, restrict analyses to people 
with no previous CVD. It would be also interesting to analyse prospectively the 
association of quantitative retinal traits with more specific cardiovascular phenotypes 
including the stroke subtypes (e.g. lacunar, cardioembolic, haemorrhagic), since 
there may be differences between these groups.  
Another key recommendation for further research is the replication of the GWAS 
findings to ensure that the genetic associations observed represent credible 
associations and are not chance findings or an artefact due to uncontrolled biases 
(Hill, 1965). This forms part of reproducibility, which is a key step in the scientific 
method. Epidemiologically, the repeated observations of the association carried out 
by different teams, in different datasets, using different methodologies are taken as 
true evidence of the association. This is because the repeated observations add 
quantitative and qualitative evidence. While the former informs us that the 
association is not due to chance alone, the latter informs us that replication across 
different designs and populations is not due to uncontrolled bias affecting a single 
study (Kraft et al, 2009).  
Two approaches can be used for replicating the GWAS findings. First, consortia of 
multiple GWAS have contributed to replicating associations of GWAS results and 
this approach would help confirm the results obtained from the quantitative retinal 
traits in this thesis. Increasingly, larger sample sizes will be needed to detect and 
reproduce the increasingly small effect sizes at common genetic variants that remain 
undetected in early analyses (Kraft et al, 2009). Second, further research should 
consider meta-analysis of multiple GWAS of quantitative retinal traits, and of note, in 
Scotland, GWAS of quantitative retinal traits has already been conducted in the 
ORCADES dataset (Kirin et al, 2017). An extended meta-analysis can also satisfy 
the requirement for replication in the context of discovery of novel genetic variants, 
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without the need to genotype yet more samples, as long as the combined evidence 
for association is robust and consistent.   
Cardiovascular risk prediction is essential in identifying and managing people at risk 
for cardiovascular disorders. Phenotypic information from the retinal vasculature may 
provide prognostic information on risk of CVD and improve CVD risk stratification 
when incorporated into established risk models in people with T2D (Ho et al, 2017). 
Artificial intelligence and machine learning may help to analyse retinal parameters in 
a cost-efficient and accurate way. Recent medical studies have used deep learning, 
a subtype of machine learning, to generate algorithms that diagnose diabetic 
complications such as diabetic retinopathy, from retinal images. The accuracy of the 
results of such studies are comparable to human experts (Poplin et al, 2018). This 
study also showed that application of deep learning to retinal fundus images alone 
helped to predict cardiovascular risk factors such as age, gender and systolic blood 
pressure. These findings demonstrate that the vascular retinal traits contain 
information on cardiovascular disease and that these traits could be measured with a 
high degree of precision using such techniques.  
Validation of the findings from future studies will also help to determine whether the 
analysis of the quantitative retinal traits may be able to improve or replace some of 
the other cardiovascular risk biomarkers such as lipids profile, to produce a more 
precise cardiovascular risk score (Poplin et al, 2018). A combination of the 
approaches discussed above along with robust epidemiological methods using 
quantitative retinal parameters will thus enrich our understanding of the association 
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Chapter 10 Appendices 
 
10.1 Appendix 1: Search strategy 
1. isch$emic heart disease.mp.  
2. exp cardiovascular diseases/  
3. exp myocardial ischemia/  
4. exp arteriosclerosis/  
5. acute coronary syndrome.mp.  
6. exp angina pectoris/  
7. exp coronary disease/  
8. exp myocardial infarction/  
9. coronary.tw.  
10. exp coronary vessel anomalies/  
11. coronary atherosclerosis.mp.  
12. coronary angiography.mp.  
13. exp heart diseases/  
14. (heart attack or acs$ or heart isch?emi$ or CHD$ or coronary artery 
disease$).tw.  
15. (retina* adj2 (microvascular or microvasculature or microcirculation) adj2 
abnormal*).mp.  
16. retina* microangiopath*.mp.  
17. retina* vascul*.mp.  
18. retina* microvascul*.mp.  
19. retina* arter*.mp.  
20. retina* vein*.mp.  
21. retina* venul*.mp.  
22. retina* vascu*.mp.  
23. retina* arteriovenous.mp.  
24. retina* tortuosity.mp.  
25. retina* calib*.mp.  
26. retina* vascular calib*.mp.  
27. retinopath*.mp.  
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28. microaneurysm.mp.  
29. retina* exudate*.mp.  
30. retina* h$emorrhage*.mp.  
31. retina* cotton wool.mp.  
32. fractal analysis.mp.  
33. multifractal.mp.  
34. monofractal.mp.  
35. retina* arteriol*.mp.  
36. retina* microvessel*.mp.  
37. (retina* arter* adj2 ratio).mp.  
38. (retina* adj2 ratio).mp.  
39. exp Retinal Vessels/  
40. exp Fractals/  
41. fractal dimension$.mp.  
42. fractal analysis.mp.  
43. exp mortality/  
44. exp epidemiologic studies/  
45. incidence.mp.  
46. exp prognosis/  
47. prognos$.tw.  
48. predict$.mp.  
49. course.tw.  
50. (score or scoring or scored).tw.  
51. observ$.mp.  
52. risk:.mp.  
53. between group:.tw.  
54. exp photography/  
55. photo$.tw.  
56. image$.tw.  
57. exp Ophthalmoscopy/  
58. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14  
59. 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 
29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42  
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60. 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53  
61. 54 or 55 or 56 or 57  
62. 58 and 59 and 60 and 61  
63. "animals not humans"/  
64. 62 not 63  
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women aged 49-75 
years, smaller AVR 
and  lower CRAE 
were associated with 
CHD death (HR 1.5, 
95% CI 1.1-2.2) and 
(HR 1.9, 95% CI 1.0-
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CRAE in women and 
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CRVE in men were 
associated with 
increased odds of 
having at least one 
stenosis ≥50% in the 
epicardial coronary 
arteries (OR 2.22; 
95% CI 1.09-  4.53 
and OR 1.54; 95% 
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CI 1.03- 2.29, 
respectively). 
Moreover, women in 
the lowest versus the 
highest tertile of 
CRAE had greater 
odds of having 
higher Extent scores 
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10.3 Appendix 3:  Criteria used to define prevalent 
cardiovascular events at baseline in the ET2DS 
 
The following criteria were used to define a prevalent cardiovascular event: 
Myocardial Infarction (MI): This was recorded if two of the first three of the 
following criteria were met, or if both the first and the last criteria were met. 
(i) Self-report of a doctor diagnosis  
(ii) Myocardial infarction according to the WHO chest pain 
questionnaire 
(iii) Electrocardiographic evidence from Minnesota codes 
(iv) Hospital discharge record with the code for MI (ICD-10 codes I21, 
I23, I252) 
Angina: This was recorded if two of the first three of the following criteria 
were met, or if both the first and the last criteria were met. 
(i) Self-report of a doctor diagnosis of angina pectoris or on regular 
medication for angina 
(ii) Positive WHO chest pain questionnaire 
(iii) Electrocardiographic evidence from Minnesota codes 
(iv) Hospital discharge record with relevant codes (ICD10 codes I20 - 
I25) 
Coronary intervention: The diagnosis of coronary intervention was made 
using the appropriate codes from the hospital discharge record (Office of 
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Population Censuses and Surveys, OPCS -4 codes K40-K44 ) (Office of 
Population Censuses and Surveys, 1993). 
Stroke: This was recorded if two out of the three following criteria were met: 
 
(i) Self- report of a doctor diagnosis of stroke 
(ii) Hospital discharge record with appropriate code (ICD10 codes I20 
-I25) 
(iii) Confirmation in the clinical notes that event was not a transient 
ischaemic attack 
Transient ischaemic attack (TIA): The diagnosis of TIA was recorded if two 
out of the three of the following criteria were present: 
(i) Self-reported doctor diagnosis of “mini stroke” or “slight stroke” 
(ii) Hospital discharge record with appropriate code (ICD10 G45, 
G659) 
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10.4 Appendix 4: Criteria used to define incident 
cardiovascular events during follow-up in the 
ET2DS 
 
The following criteria were used to define incident or recurrent cardiovascular 
events between baseline and year four in the ET2DS. 
Myocardial Infarction (MI): The diagnosis was recorded if two of the first 
three of the following criteria were met, or if both the first and the last criteria 
were met. 
(i) Self-report of doctor diagnosis  
(ii) New diagnosis of myocardial infarction according to the WHO 
chest pain questionnaire 
(iii) New electrocardiographic evidence of coronary ischaemia 
(iv) Hospital discharge record with the code for MI (ICD-10 for I21, I23, 
I252) 
Angina: This was recorded if two of the first three of the following criteria 
were met, or if both the first and the last criteria were met. 
(i) Self-report of new angina pectoris event or taking antianginal drugs 
after baseline  
(ii) New diagnosis of angina pectoris according to WHO chest pain 
questionnaire 
(iii) New evidence of electrocardiographic evidence of angina pectoris 
(iv) Hospital discharge record with code for ischaemic heart disease 
(ICD10 codes I20 -I25) 
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Coronary intervention: OPCS-4 code for coronary intervention on hospital 
discharge record. 
 
Fatal myocardial infarction: This was recorded according to primary or 
secondary ICD-10 code for MI on death certificate and with clinical and 
electrocardiographic criteria for non-fatal MI within 4 weeks of 
explained/sudden death. 
Stroke: This was recorded if two out of the three following criteria were met: 
(i) New self- report  
(ii) Clinical notes from the hospital discharge with stroke codes (ICD10 
codes I20 -I25) after baseline 
(iii) Confirmation in the clinical notes that transient ischaemic attack 
(TIA) has not been diagnosed  
Transient ischaemic attack (TIA): The diagnosis of TIA was recorded if two 
out of the three of the following criteria were present: 
(i) New self-reported diagnosis of “mini stroke” or “slight stroke” 
(ii) Clinical notes from hospital discharge with TIA codes (ICD10 G45, 
G659) 
(iii) Confirmation with the clinical notes review with TIA after baseline. 
Fatal stroke: This was recorded according to ICD-10 code for stroke on 
death certificate or clinical criteria for non-fatal stroke within 6 weeks of 
unexplained sudden death. 
After 8 years from baseline, incident and recurrent cardiovascular events 
were identified by a further phase of record linkage.  If there was uncertainty 
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as to whether criteria had been met, hospital notes were obtained and 
individual cases were discussed by researchers and senior clinicians to 
reach a consensus. 
The following criteria were used to define incident or recurrent cardiovascular 
events between years 4 to 8 of follow-up. Unlike at baseline and year 4, data 
sources for the eight year follow-up were limited to ISD record linkage and 
clinical notes from the hospital. 
Myocardial Infarction 
ICD-10 code for MI (I21-I23) as primary diagnosis on discharge record, or 
ICD-10 code for MI or previous MI (I252) as non-primary diagnosis according 
to clinical notes.  
Angina  
No evidence of angina at baseline or four years follow-up plus ICD-10 code 
for angina (I20) as diagnosis code on discharge record. 
Coronary intervention  
OPCS-4 code for coronary intervention (K40-K44, K49) on discharge record 
Fatal ischaemic heart disease  
Subjects who did not meet any criteria for MI and had an ICD-10 code for 
ischaemic heart disease (I209, I249, I258, I259) as primary cause of death. 
Stroke 
ICD-10 code for stroke (I61, I63-I64) as primary diagnosis on discharge 
record, or 
ICD-10 code for stroke as secondary diagnosis confirmed in the clinical notes 
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Transient ischaemic stroke (TIA)  
ICD-10 code for TIA (G45) as primary diagnosis on discharge record, or 
Secondary ICD-10 code for TIA confirmed in the clinical notes  
Fatal stroke 
ICD-10 code for stroke (I61, I63, I64) as primary cause of death, or 
Secondary ICD-10 code for stroke on death record confirmed with inspection 
of the clinical notes. 
 
For my analyses, 4 year and 8 year follow-up incident cardiovascular events 
were combined,and events were defined as all cardiovascular events (first 
fatal or non-fatal MI, diagnosis of angina, fatal or non-fatal stroke, TIA, 
coronary intervention or fatal other ischaemic heart disease experience by a 
participant since baseline), coronary events (first fatal or non-fatal MI, 
diagnosis of angina, coronary intervention or fatal other ischaemic heart 
disease experienced by a participant since baseline) and cerebrovascular 
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10.5 Appendix 5: Q-Q plots 
AVR Q-Q plot – Genomic inflation of 0.993 
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CRVE Q-Q plot – Genomic inflation of 1.002 
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Arteriolar minimum tortusity Q-Q plot – Genomic inflation of 0.998 
 
 
Arteriolar maximum tortuosity Q-Q plot – Genomic inflation of 1.004 
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Venular mean tortuosity Q-Q plot – Genomic inflation of 1.016 
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Venular maximum tortuosity Q-Q plot – Genomic inflation of 1.026 
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Multifractal dimensions D1 Q-Q plot – Genomic inflation of 1.011 
 
Multifractal dimensions D2 Q-Q plot – Genomic inflation of 1.011 
 
